CAS 1199-18-4 | 1,2,4-Benzenetriol, 5-(2-aminoethyl)- | CAS Number 1199-18-4

Title	Journal
Protective effects of pituitary adenylate cyclase activating polypeptide against neurotoxic agents.	Neurotoxicology 20180501
Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins.	Chemico-biological interactions 20180105
An autophagic mechanism is involved in the 6-hydroxydopamine-induced neurotoxicity in vivo.	Toxicology letters 20171005
Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways.	Molecular neurobiology 20161001
Early expression of the receptor for advanced glycation end products in a toxic model produced by 6-hydroxydopamine in the rat striatum.	Chemico-biological interactions 20160405
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.	Neuropharmacology 20150801
Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson's disease.	Journal of molecular neuroscience : MN 20150301
Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.	Journal of neural transmission (Vienna, Austria : 1996) 20150201
Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction.	Chemico-biological interactions 20150105
Induction of Pi form of glutathione S-transferase by carnosic acid is mediated through PI3K/Akt/NF-κB pathway and protects against neurotoxicity.	Chemical research in toxicology 20141117
Involvement of activation of the Nrf2/ARE pathway in protection against 6-OHDA-induced SH-SY5Y cell death by α-iso-cubebenol.	Neurotoxicology 20140901
RTP801 regulates maneb- and mancozeb-induced cytotoxicity via NF-κB.	Journal of biochemical and molecular toxicology 20140701
Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures.	Neurotoxicology 20140301
Impairment of Atg5-dependent autophagic flux promotes paraquat- and MPP⁺-induced apoptosis but not rotenone or 6-hydroxydopamine toxicity.	Toxicological sciences : an official journal of the Society of Toxicology 20131101
Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells.	Nature cell biology 20131001
AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson's disease rat model.	ACS chemical neuroscience 20130918
The Nrf2/SKN-1-dependent glutathione S-transferase π homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism.	Neurotoxicology 20130901
PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice.	Neuroscience 20130614
Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease.	Neurotoxicology 20130501
Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.	Neuroscience 20130416
Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.	Neuropharmacology 20130301
A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons.	CNS neuroscience & therapeutics 20130301
Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease.	Brain and behavior 20130301
Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats.	The Journal of toxicological sciences 20130201
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.	Neuro-degenerative diseases 20130101
Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.	Neurotoxicology 20130101
Glutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease.	Antioxidants & redox signaling 20121215
A novel strategy for intrastriatal dopaminergic cell transplantation: sequential 'nest' grafting influences survival and behavioral recovery in a rat model of Parkinson's disease.	Experimental cell research 20121210
A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder.	Biological psychiatry 20121201
7-Nitroindazole down-regulates dopamine/DARPP-32 signaling in neostriatal neurons in a rat model of Parkinson's disease.	Neuropharmacology 20121201
Chemical and biological evaluation of nephrocizin in protecting nerve growth factor-differentiated PC12 cells by 6-hydroxydopamine-induced neurotoxicity.	Phytochemistry 20121201
Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.	Neuropharmacology 20121201
Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.	Neuropharmacology 20121201
Dysregulated expression of secretogranin III is involved in neurotoxin-induced dopaminergic neuron apoptosis.	Journal of neuroscience research 20121201
Evaluation of dopamine transporters and D2 receptors in hemiparkinsonian rat brains in vivo using consecutive PET scans of [18F]FPCIT and [18F]fallypride.	Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20121201
Serotonergic neuroepithelial cells of the skin in developing zebrafish: morphology, innervation and oxygen-sensitive properties.	The Journal of experimental biology 20121115
Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.	Journal of molecular neuroscience : MN 20121101
GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones.	Journal of neuroendocrinology 20121101
Insulin-like growth factor-1 inhibits 6-hydroxydopamine-mediated endoplasmic reticulum stress-induced apoptosis via regulation of heme oxygenase-1 and Nrf2 expression in PC12 cells.	The International journal of neuroscience 20121101
Neurokinin receptor 3 peptide exacerbates 6-hydroxydopamine-induced dopaminergic degeneration in rats through JNK pathway.	Journal of neurochemistry 20121101
6-Hydroxydopamine upregulates iron regulatory protein 1 by activating certain protein kinase C isoforms in the dopaminergic MES23.5 cell line.	The international journal of biochemistry & cell biology 20121101
Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptors.	The European journal of neuroscience 20121101
Altered transcription factor trafficking in oxidatively-stressed neuronal cells.	Biochimica et biophysica acta 20121101
Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6-hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells.	Biochimica et biophysica acta 20121101
Novel codrugs with GABAergic activity for dopamine delivery in the brain.	International journal of pharmaceutics 20121101
Loss of parvalbumin-positive neurons from the globus pallidus in animal models of Parkinson disease.	Journal of neuropathology and experimental neurology 20121101
Chronic restraint stress aggravated arthritic joint swell of rats through regulating nitric oxide production.	Nitric oxide : biology and chemistry 20121015
6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats.	Brain research 20121005
Eppendorf finalist. Striatal interneurons: causes of or cures for movement disorders?	Science (New York, N.Y.) 20121005
Proliferation of external globus pallidus-subthalamic nucleus synapses following degeneration of midbrain dopamine neurons.	The Journal of neuroscience : the official journal of the Society for Neuroscience 20121003
Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease.	The Journal of nutritional biochemistry 20121001
Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson's disease.	Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20121001
Alcoholic extract of Bacopa monniera Linn. protects against 6-hydroxydopamine-induced changes in behavioral and biochemical aspects: a pilot study.	Cellular and molecular neurobiology 20121001
A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease.	The Journal of pharmacology and experimental therapeutics 20121001
Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase.	Neurochemical research 20121001
Characterization of mitophagy in the 6-hydoxydopamine Parkinson's disease model.	Toxicological sciences : an official journal of the Society of Toxicology 20121001
Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.	Neuropeptides 20121001
Immunohistochemical and morphological changes in neurons and neuroglia in the cerebral nigrostriatal structures under conditions of experimental nigral neurodegeneration.	Bulletin of experimental biology and medicine 20121001
Visualizing dopamine transporter integrity with iodine-123-FP-CIT SPECT in combination with high resolution MRI in the brain of the common marmoset monkey.	Journal of neuroscience methods 20120930
A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study.	Journal of neuroscience methods 20120930
SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of Parkinson's disease.	Journal of ethnopharmacology 20120928
Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.	Toxicology letters 20120918
Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis.	Chemical research in toxicology 20120917
Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.	Neurobiology of aging 20120901
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias.	Neurobiology of aging 20120901
Effect of maternal separation on mitochondrial function and role of exercise in a rat model of Parkinson's disease.	Metabolic brain disease 20120901
Preparation of rotigotine-loaded microspheres and their combination use with L-DOPA to modify dyskinesias in 6-OHDA-lesioned rats.	Pharmaceutical research 20120901
Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice.	Neuropharmacology 20120901
Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.	Neurobiology of disease 20120901
Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson's disease.	Journal of molecular neuroscience : MN 20120901
DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats.	Brain research bulletin 20120901
Activation of subthalamic alpha 2 noradrenergic receptors induces motor deficits as a consequence of neuronal burst firing.	Neurobiology of disease 20120901
Characterizing effects of subthalamic nucleus deep brain stimulation on methamphetamine-induced circling behavior in hemi-Parkinsonian rats.	IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 20120901
Quantitative video-based gait pattern analysis for hemiparkinsonian rats.	Medical & biological engineering & computing 20120901
Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation.	Journal of neurochemistry 20120901
Do α-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model?	Experimental neurology 20120901
The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease.	The European journal of neuroscience 20120901
RETRACTED: S-allyl cysteine protects against 6-hydroxydopamine-induced neurotoxicity in the rat striatum: involvement of Nrf2 transcription factor activation and modulation of signaling kinase cascades.	Free radical biology & medicine 20120901
Medaka fish Parkinson's disease model.	Experimental neurobiology 20120901
L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease.	Neuroscience 20120830
Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.	Brain research 20120830
Impact of dopamine versus serotonin cell transplantation for the development of graft-induced dyskinesia in a rat Parkinson model.	Brain research 20120827
Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCα and PI3K/AKT signaling pathways.	Journal of agricultural and food chemistry 20120822
Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model.	Autonomic neuroscience : basic & clinical 20120816
Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors.	European journal of pharmacology 20120815
Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death.	Free radical biology & medicine 20120815
Circadian rhythms of gastrointestinal function are regulated by both central and peripheral oscillators.	American journal of physiology. Gastrointestinal and liver physiology 20120815
Isolation, identification, and biological evaluation of Nrf2-ARE activator from the leaves of green perilla (Perilla frutescens var. crispa f. viridis).	Free radical biology & medicine 20120815
Infusion of Sydenham's chorea antibodies in striatum with up-regulated dopaminergic receptors: a pilot study to investigate the potential of SC antibodies to increase dopaminergic activity.	Neuroscience letters 20120815
Neurotrophic effects of serum- and glucocorticoid-inducible kinase on adult murine mesencephalic dopamine neurons.	The Journal of neuroscience : the official journal of the Society for Neuroscience 20120815
Lesioning noradrenergic neurons of the locus coeruleus in C57Bl/6 mice with unilateral 6-hydroxydopamine injection, to assess molecular, electrophysiological and biochemical changes in noradrenergic signaling.	Neuroscience 20120802
Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease.	Age (Dordrecht, Netherlands) 20120801
Evaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine.	Neurotoxicity research 20120801
Effect of quercetin and its glucuronide metabolite upon 6-hydroxydopamine-induced oxidative damage in Neuro-2a cells.	Free radical research 20120801
Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease.	British journal of pharmacology 20120801
The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.	Neurotoxicity research 20120801
2-Benzazepine nitrones protect dopaminergic neurons against 6-hydroxydopamine-induced oxidative toxicity.	Archiv der Pharmazie 20120801
High intake of folic acid or complex of B vitamins provides anti-Parkinsonism effect: no role for serum level of homocysteine.	Behavioural brain research 20120801
Presynaptic modulation by somatostatin in the rat neostriatum is altered in a model of parkinsonism.	Journal of neurophysiology 20120801
L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson's disease patients.	Medical hypotheses 20120801
Programmed cell death in Parkinson's disease.	Cold Spring Harbor perspectives in medicine 20120801
The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.	Die Pharmazie 20120801
Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat.	Neuroscience 20120726
Dopamine depletion increases the power and coherence of high-voltage spindles in the globus pallidus and motor cortex of freely moving rats.	Brain research 20120717
Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.	Behavioural brain research 20120715
Enhanced expression of nesfatin/nucleobindin-2 in white adipose tissue of ventromedial hypothalamus-lesioned rats.	Neuroscience letters 20120711
Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease.	Neurotoxicity research 20120701
Effect of oxytocin on neuroblastoma cell viability and growth.	Cellular and molecular neurobiology 20120701
Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.	Synapse (New York, N.Y.) 20120701
Sympathetic denervation of one white fat depot changes norepinephrine content and turnover in intact white and brown fat depots.	Obesity (Silver Spring, Md.) 20120701
Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by sulforaphane through the activation of Nrf2 nuclear translocation.	Molecular medicine reports 20120701
Renal sympathetic nerve activity during asphyxia in fetal sheep.	American journal of physiology. Regulatory, integrative and comparative physiology 20120701
Hydrogen sulfide protects SH-SY5Y cells against 6-hydroxydopamine-induced endoplasmic reticulum stress.	American journal of physiology. Cell physiology 20120701
6-Hydroxydopamine leads to T2 hyperintensity, decreased claudin-3 immunoreactivity and altered aquaporin 4 expression in the striatum.	Behavioural brain research 20120615
Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).	Behavioural brain research 20120615
Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.	Brain research 20120606
Neurotoxin-based models of Parkinson's disease.	Neuroscience 20120601
Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.	Synapse (New York, N.Y.) 20120601
Drosophila melanogaster as a model to study drug addiction.	Human genetics 20120601
Cranial and related sensorimotor impairments in rodent models of Parkinson's disease.	Behavioural brain research 20120601
Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: a correlation study.	Neuroscience research 20120601
Animal models of L-DOPA-induced dyskinesia: an update on the current options.	Neuroscience 20120601
Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy.	Journal of neuroscience research 20120601
Low level of glutathione can intensify the toxic effect of salsolinol in SH-SY5Y neuroblastoma cell line.	Neurotoxicology 20120601
Modeling Parkinson's disease using induced pluripotent stem cells.	Current neurology and neuroscience reports 20120601
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease.	Brain : a journal of neurology 20120601
Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease.	Neuroscience bulletin 20120601
The effects of short-term nicotine administration on behavioral and oxidative stress deficiencies induced in a rat model of Parkinson's disease.	Psychiatria Danubina 20120601
Proteomic analysis reveals a protective role for DJ-1 during 6-hydroxydopamine-induced cell death.	Biochemical and biophysical research communications 20120525
NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease.	Antioxidants & redox signaling 20120515
Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.	NeuroImage 20120515
Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia.	European journal of pharmacology 20120515
Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats.	European journal of pharmacology 20120515
Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.	Journal of neuroimmunology 20120515
Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.	The international journal of neuropsychopharmacology 20120501
Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.	Journal of molecular neuroscience : MN 20120501
Evaluation of a multiple system atrophy model in rats using multitracer microPET.	Acta neurochirurgica 20120501
Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease.	Behavioural brain research 20120501
Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson's disease.	Journal of molecular neuroscience : MN 20120501
Contralateral retinal dopamine decrease and melatonin increase in progression of hemiparkinsonium rat.	Neurochemical research 20120501
Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls.	Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501
α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease.	Current drug targets 20120501
Investigate the chronic neurotoxic effects of diquat.	Neurochemical research 20120501
Evolution of the dynamic properties of the cortex-basal ganglia network after dopaminergic depletion in rats.	Neurobiology of disease 20120501
Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease.	Pharmacological research 20120501
Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.	Experimental neurology 20120501
Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease.	The Journal of urology 20120501
Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats.	Neurobiology of learning and memory 20120501
Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat.	The Journal of pharmacy and pharmacology 20120501
In vivo dopamine transporter imaging in a unilateral 6-hydroxydopamine rat model of Parkinson disease using 11C-methylphenidate PET.	Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120501
Nootropic activity of acetaminophen against colchicine induced cognitive impairment in rats.	Journal of clinical biochemistry and nutrition 20120501
Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP+ toxicity: dual roles for ERK1/2.	Cell death & disease 20120501
Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia.	The Journal of neuroscience : the official journal of the Society for Neuroscience 20120425
Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons.	Nature communications 20120424
Long-term changes in morphology, D2R expression and targets of regenerated dopaminergic terminals in the striatum after a partial lesion in the substantia nigra in the rat.	Brain research 20120423
Deep brain stimulation of the subthalamic nucleus in the 6-hydroxydopamine rat model of Parkinson's disease: effects on sensorimotor gating.	Behavioural brain research 20120421
Different involvement of ventral and dorsal norepinephrine pathways on norepinephrine reuptake inhibitor-induced locomotion and antidepressant-like effects in rats.	Neuroscience letters 20120418
Functional neuroimaging of the 6-OHDA lesion rat model of Parkinson's disease.	Neuroscience letters 20120404
Combined elemental and biomolecular mass spectrometry imaging for probing the inventory of tissue at a micrometer scale.	Analytical chemistry 20120403
Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease.	Neurobiology of aging 20120401
Neurotrophic effects of growth/differentiation factor 5 in a neuronal cell line.	Neurotoxicity research 20120401
L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats.	Neurotoxicity research 20120401
First appearance and location of catecholaminergic cells during experimental arthritis and elimination by chemical sympathectomy.	Arthritis and rheumatism 20120401
Ether-à-go-go 1 (Eag1) potassium channel expression in dopaminergic neurons of basal ganglia is modulated by 6-hydroxydopamine lesion.	Neurotoxicity research 20120401
Toxicity of 6-hydroxydopamine: live cell imaging of cytoplasmic redox flux.	Cell biology and toxicology 20120401
Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.	Behavioural pharmacology 20120401
Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses.	Toxicological sciences : an official journal of the Society of Toxicology 20120401
Animal models of Parkinson's disease.	The FEBS journal 20120401
Selective bilateral lesion to caudate nucleus modulates the acute and chronic methylphenidate effects.	Pharmacology, biochemistry, and behavior 20120401
Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease.	The Journal of urology 20120401
The effects of nigrostriatal dopamine depletion on the thalamic parafascicular nucleus.	Brain research 20120329
Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice.	The Journal of neuroscience : the official journal of the Society for Neuroscience 20120321
Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.	Journal of medicinal chemistry 20120308
Modeling mitochondrial dysfunctions in the brain: from mice to men.	Journal of inherited metabolic disease 20120301
HRD1 levels increased by zonisamide prevented cell death and caspase-3 activation caused by endoplasmic reticulum stress in SH-SY5Y cells.	Journal of molecular neuroscience : MN 20120301
The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.	Journal of physiology and biochemistry 20120301
Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model.	Molecular therapy : the journal of the American Society of Gene Therapy 20120301
Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens.	Cognitive, affective & behavioral neuroscience 20120301
Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery.	Molecular therapy : the journal of the American Society of Gene Therapy 20120301
Paeonol attenuates microglia-mediated inflammation and oxidative stress-induced neurotoxicity in rat primary microglia and cortical neurons.	Shock (Augusta, Ga.) 20120301
Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence.	Neurochemical research 20120301
Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.	Journal of neuroscience research 20120301
Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning.	Journal of neurochemistry 20120301
Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites.	Behavioural brain research 20120301
Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease.	Apoptosis : an international journal on programmed cell death 20120301
Evaluation of periodic limb movements in a putative animal model of restless leg syndrome.	Movement disorders : official journal of the Movement Disorder Society 20120301
The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats.	Neuroscience research 20120301
Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K/Akt-dependent manner.	Molecular medicine reports 20120301
Lonicera japonica THUNB. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-κB in SH-SY5Y cells.	Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20120301
Endogenous neural precursors influence grafted neural stem cells and contribute to neuroprotection in the parkinsonian rat.	The European journal of neuroscience 20120301
Novel roles of peroxiredoxins in inflammation, cancer and innate immunity.	Journal of clinical biochemistry and nutrition 20120301
Protective effect of theaflavins on neuron against 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells.	Journal of clinical biochemistry and nutrition 20120301
IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells.	European journal of pharmacology 20120227
Small molecule inhibition of RISC loading.	ACS chemical biology 20120217
Frequency selectivity and dopamine-dependence of plasticity at glutamatergic synapses in the subthalamic nucleus.	Neuroscience 20120217
Intranasally applied L-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions.	Brain research bulletin 20120210
Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's disease.	Journal of medicinal chemistry 20120209
Mild dopaminergic lesions are accompanied by robust changes in subthalamic nucleus activity.	Neuroscience letters 20120206
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine.	Neurobiology of aging 20120201
The glutamatergic component of the mesocortical pathway emanating from different subregions of the ventral midbrain.	Cerebral cortex (New York, N.Y. : 1991) 20120201
Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease.	Neurotoxicity research 20120201
Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.	Neurotoxicity research 20120201
Neonatal 6-hydroxydopamine lesioning enhances quinpirole-induced vertical jumping in rats that were quinpirole primed during postnatal ontogeny.	Neurotoxicity research 20120201
In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET.	NeuroImage 20120201
Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved.	Neuropharmacology 20120201
The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses.	Annals of the rheumatic diseases 20120201
AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth.	Molecular therapy : the journal of the American Society of Gene Therapy 20120201
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study.	European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120201
Retigabine, a K(V)7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats.	Neuropharmacology 20120201
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.	The Journal of pharmacology and experimental therapeutics 20120201
Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells.	Cell research 20120201
Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson's disease: a self-perpetuating crosstalk?	Biochimica et biophysica acta 20120201
Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia.	Nature neuroscience 20120201
Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?	Molecular neurobiology 20120201
Striatal dopamine depletion in rats produces variable effects on contingency detection: task-related influences.	The European journal of neuroscience 20120201
The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.	PLoS genetics 20120201
Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.	Neuroscience 20120127
The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle.	Neuroscience 20120127
RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits.	Neuron 20120126
Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats.	ACS chemical neuroscience 20120118
Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease.	Neuroscience letters 20120117
Automated gait analysis in bilateral parkinsonian rats and the role of L-DOPA therapy.	Behavioural brain research 20120115
Lesions of the dopaminergic innervation of the nucleus accumbens medial shell delay the generation of preference for sucrose, but not of sexual pheromones.	Behavioural brain research 20120115
Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action.	Neuroscience letters 20120111
Unchanged expression of the ceramide transfer protein in the acute 6-OHDA neurodegenerative model.	Neuroscience letters 20120106
The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias.	Brain research bulletin 20120104
Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration.	Neurobiology of aging 20120101
Liver growth factor promotes the survival of grafted neural stem cells in a rat model of Parkinson's disease.	Current stem cell research & therapy 20120101
Changes in the mRNA levels of α2A and α2C adrenergic receptors in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.	Journal of molecular neuroscience : MN 20120101
Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.	Cell transplantation 20120101
Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease.	Journal of molecular neuroscience : MN 20120101
Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish.	Cellular and molecular neurobiology 20120101
Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine.	Evidence-based complementary and alternative medicine : eCAM 20120101
Phytochemical characteristics, free radical scavenging activities, and neuroprotection of five medicinal plant extracts.	Evidence-based complementary and alternative medicine : eCAM 20120101
Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum.	Journal of molecular neuroscience : MN 20120101
An autoradiographic study on the pathogenesis of levodopa-induced dyskinesia: regulation of dopamine transporter by levodopa in a rat model of Parkinson's disease.	Neuro-degenerative diseases 20120101
A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission.	Experimental neurology 20120101
Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia.	Behavioural brain research 20120101
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.	Pharmacology, biochemistry, and behavior 20120101
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.	Neurobiology of disease 20120101
Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.	Neurotoxicity research 20120101
Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.	Parkinson's disease 20120101
Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model.	Experimental neurology 20120101
Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.	Neurobiology of disease 20120101
Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress.	Cytotherapy 20120101
Reliance on habits at the expense of goal-directed control following dopamine precursor depletion.	Psychopharmacology 20120101
Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.	Psychopharmacology 20120101
Animal models of Parkinson's disease.	Parkinsonism & related disorders 20120101
Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system.	Brain : a journal of neurology 20120101
Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.	The European journal of neuroscience 20120101
Non-cell autonomous influence of the astrocyte system xc- on hypoglycaemic neuronal cell death.	ASN neuro 20120101
ADHD animal model characterization: transcriptomics and proteomics analyses.	Methods in molecular biology (Clifton, N.J.) 20120101
Noisy galvanic vestibular stimulation promotes GABA release in the substantia nigra and improves locomotion in hemiparkinsonian rats.	PloS one 20120101
Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways.	PloS one 20120101
Human excretion of bisphenol A: blood, urine, and sweat (BUS) study.	Journal of environmental and public health 20120101
Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation.	PloS one 20120101
The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.	Parkinson's disease 20120101
Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism.	Chinese medicine 20120101
Transfer of neuroplasticity from nucleus accumbens core to shell is required for cocaine reward.	PloS one 20120101
Gene regulation systems for gene therapy applications in the central nervous system.	Neurology research international 20120101
The cortical and striatal gene expression profile of 100 hz electroacupuncture treatment in 6-hydroxydopamine-induced Parkinson's disease model.	Evidence-based complementary and alternative medicine : eCAM 20120101
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease.	International journal of nanomedicine 20120101
Curcumin in neurology.	Journal of neurosciences in rural practice 20120101
Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1.	Scientific reports 20120101
Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.	Journal of neuroinflammation 20120101
Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism.	PloS one 20120101
Reduced proliferation in the adult mouse subventricular zone increases survival of olfactory bulb interneurons.	PloS one 20120101
Ephrin-A1-mediated dopaminergic neurogenesis and angiogenesis in a rat model of Parkinson's disease.	PloS one 20120101
Minocycline markedly reduces acute visceral nociception via inhibiting neuronal ERK phosphorylation.	Molecular pain 20120101
Use of PC12 cells and rat superior cervical ganglion sympathetic neurons as models for neuroprotective assays relevant to Parkinson's disease.	Methods in molecular biology (Clifton, N.J.) 20120101
A 6-hydroxydopamine in vivo model of Parkinson's disease.	Methods in molecular biology (Clifton, N.J.) 20120101
Iptakalim: A novel multi-utility potassium channel opener.	Journal of pharmacology & pharmacotherapeutics 20120101
Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease.	Journal of visualized experiments : JoVE 20120101
The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment.	Scientific reports 20120101
CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.	PloS one 20120101
Multiscale autoregressive identification of neuroelectrophysiological systems.	Computational and mathematical methods in medicine 20120101
Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action.	Frontiers in pharmacology 20120101
Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration.	Frontiers in pharmacology 20120101
DJ-1 null dopaminergic neuronal cells exhibit defects in mitochondrial function and structure: involvement of mitochondrial complex I assembly.	PloS one 20120101
Relevance of animal models to human tardive dyskinesia.	Behavioral and brain functions : BBF 20120101
Neurotrophic actions of dopamine on the development of a serotonergic feeding circuit in Drosophila melanogaster.	BMC neuroscience 20120101
Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat.	PloS one 20120101
Acquisition of 'Start' and 'Stop' response thresholds in peak-interval timing is differentially sensitive to protein synthesis inhibition in the dorsal and ventral striatum.	Frontiers in integrative neuroscience 20120101
Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system.	Surgical neurology international 20120101
N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity.	PloS one 20120101
Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons.	Bioscience, biotechnology, and biochemistry 20120101
Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.	ISRN neurology 20120101
Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice.	PloS one 20120101
Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation.	BMC neuroscience 20120101
Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.	PloS one 20120101
Diverse Roles of JNK and MKK Pathways in the Brain.	Journal of signal transduction 20120101
Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model.	Journal of pharmacological sciences 20120101
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.	Frontiers in cellular neuroscience 20120101
Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells.	PloS one 20120101
Restoration of the striatal circuitry: from developmental aspects toward clinical applications.	Frontiers in cellular neuroscience 20120101
Endocannabinoid-dopamine interactions in striatal synaptic plasticity.	Frontiers in pharmacology 20120101
Nerve-cancer interactions in the stromal biology of pancreatic cancer.	Frontiers in physiology 20120101
Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy.	Parkinson's disease 20120101
Classic and new animal models of Parkinson's disease.	Journal of biomedicine & biotechnology 20120101
Pharmacological enhancement of treatment for amblyopia.	Clinical ophthalmology (Auckland, N.Z.) 20120101
Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys.	PloS one 20120101
Oxidative stress and microglial cells in Parkinson's disease.	Mediators of inflammation 20120101
Hormone replacement therapy and risk for neurodegenerative diseases.	International journal of Alzheimer's disease 20120101
Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study.	Stem cells international 20120101
Genetic rat models of Parkinson's disease.	Parkinson's disease 20120101
Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies.	Parkinson's disease 20120101
Rehabilitation and Parkinson's disease.	Parkinson's disease 20120101
Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment.	PloS one 20120101
Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease.	PloS one 20120101
Antidepressant-Like Activity of the Ethanolic Extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice.	Evidence-based complementary and alternative medicine : eCAM 20120101
Differential patterns of synaptotagmin7 mRNA expression in rats with kainate- and pilocarpine-induced seizures.	PloS one 20120101
Ih current is necessary to maintain normal dopamine fluctuations and sleep consolidation in Drosophila.	PloS one 20120101
Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease.	Mediators of inflammation 20120101
Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis.	Parkinson's disease 20120101
Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity.	PloS one 20120101
Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.	PloS one 20120101
Role of vitamin d in Parkinson's disease.	ISRN neurology 20120101
Gene therapy for Parkinson's disease.	Parkinson's disease 20120101
Sense and nonsense in metabolic control of reproduction.	Frontiers in endocrinology 20120101
Drug discovery models and toxicity testing using embryonic and induced pluripotent stem-cell-derived cardiac and neuronal cells.	Stem cells international 20120101
The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.	Frontiers in pharmacology 20120101
1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated by NF-κB/RelA acetylation at Lys310.	PloS one 20120101
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia.	Parkinson's disease 20120101
Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks.	Frontiers in physiology 20120101
The secret language of destiny: stress imprinting and transgenerational origins of disease.	Frontiers in genetics 20120101
The antioxidant 3H-1,2-dithiole-3-thione potentiates advanced glycation end-product-induced oxidative stress in SH-SY5Y cells.	Experimental diabetes research 20120101
The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection.	Oxidative medicine and cellular longevity 20120101
Understanding and prevention of 'therapy-' induced dyskinesias.	Parkinson's disease 20120101
Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival.	PloS one 20120101
On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity.	Frontiers in pharmacology 20120101
Endocannabinoid modulation of dopaminergic motor circuits.	Frontiers in pharmacology 20120101
The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease.	Frontiers in psychiatry 20120101
Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects.	Oxidative medicine and cellular longevity 20120101
Intensive rehabilitation treatment in parkinsonian patients with dyskinesias: a preliminary study with 6-month followup.	Parkinson's disease 20120101
Non-stationary discharge patterns in motor cortex under subthalamic nucleus deep brain stimulation.	Frontiers in integrative neuroscience 20120101
Intracerebral injection of low amounts of norharman induces moderate Parkinsonism-like behavioral symptoms in rat.	Neurotoxicology and teratology 20120101
Human albumin prevents 6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo.	PloS one 20120101
The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats.	PloS one 20120101
Mitochondrial dynamics and mitophagy in the 6-hydroxydopamine preclinical model of Parkinson's disease.	Parkinson's disease 20120101
Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death.	PloS one 20120101
Detoxification of 6-hydroxydopamine-induced dopaminergic neurodegeneration by 5,5-dimethyl-1-pyrroline N-oxide, a radical trapper, in hemiparkinsonian rats.	Biological & pharmaceutical bulletin 20120101
Inhibition of the acquisition of conditioned place aversion by dopaminergic lesions of the central nucleus of the amygdala in morphine-treated rats.	Physiological research 20120101
Mangiferin ameliorates 6-hydroxydopamine-induced cytotoxicity and oxidative stress in ketamine model of schizophrenia.	Pharmacological reports : PR 20120101
Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line.	International journal of molecular sciences 20120101
Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells.	PloS one 20120101
Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway.	Neuroscience 20111229
Contribution of pre-synaptic mechanisms to L-DOPA-induced dyskinesia.	Neuroscience 20111215
Motor disorders and impaired electrical power of pallidal EEG improved by gallic acid in animal model of Parkinson's disease.	Pakistan journal of biological sciences : PJBS 20111215
Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia.	Journal of neural transmission (Vienna, Austria : 1996) 20111201
Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats.	Journal of neural transmission (Vienna, Austria : 1996) 20111201
Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.	Journal of neural transmission (Vienna, Austria : 1996) 20111201
Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing.	Journal of psychopharmacology (Oxford, England) 20111201
Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.	Journal of neural transmission (Vienna, Austria : 1996) 20111201
Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.	Neuropathology and applied neurobiology 20111201
Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease.	Cell death and differentiation 20111201
Antidepressant-like properties of sarizotan in experimental Parkinsonism.	Psychopharmacology 20111201
Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.	Neurochemical research 20111201
Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.	Neuropharmacology 20111201
Tacrine(2)-ferulic acid, a novel multifunctional dimer, attenuates 6-hydroxydopamine-induced apoptosis in PC12 cells by activating Akt pathway.	Neurochemistry international 20111201
Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.	Experimental neurology 20111201
Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation.	Experimental neurology 20111201
Regeneration of dopaminergic neurons after 6-hydroxydopamine-induced lesion in planarian brain.	Journal of neurochemistry 20111201
Roles of serotonergic and adrenergic receptors in the antinociception of selective cyclooxygenase-2 inhibitor in the rat spinal cord.	The Korean journal of pain 20111201
Effect of DHEA on recovery of muscle atrophy induced by Parkinson's disease.	Journal of Korean Academy of Nursing 20111201
The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model.	Brain research bulletin 20111125
Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exacerbates [corrected] parkinsonian symptoms.	Neuroscience 20111124
Young and middle-aged rats exhibit isometric forelimb force control deficits in a model of early-stage Parkinson's disease.	Behavioural brain research 20111120
Acute versus long-term effects of 6-hydroxydopamine on oxidative stress and dopamine depletion in the striatum of mice.	Journal of neuroscience methods 20111115
Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats.	Biological psychiatry 20111115
A quantitative comparison of basal ganglia neuronal activities of normal and Parkinson's disease model rats.	Neuroscience letters 20111114
Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells.	Seminars in immunopathology 20111101
Contamination of mesenchymal stem-cells with fibroblasts accelerates neurodegeneration in an experimental model of Parkinson's disease.	Stem cell reviews 20111101
Protective effects of walnut extract against amyloid beta peptide-induced cell death and oxidative stress in PC12 cells.	Neurochemical research 20111101
Ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity.	Neurochemical research 20111101
Induction of dopaminergic neuronal-like cells from CD44+ human amniotic fluids that are ameliorative to behavioral recovery in a Parkinson's disease rat model.	International journal of molecular medicine 20111101
Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration.	Apoptosis : an international journal on programmed cell death 20111101
Arsenic exposure and motor function among children in Bangladesh.	Environmental health perspectives 20111101
The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.	Hypertension research : official journal of the Japanese Society of Hypertension 20111101
Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitor.	The Journal of pharmacology and experimental therapeutics 20111101
Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease.	Toxicology and applied pharmacology 20111101
c-Fos expression after deep brain stimulation of the pedunculopontine tegmental nucleus in the rat 6-hydroxydopamine Parkinson model.	Journal of chemical neuroanatomy 20111101
Overhauser-enhanced magnetic resonance imaging characterization of mitochondria functional changes in the 6-hydroxydopamine rat model.	Neurochemistry international 20111101
Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death.	Journal of neural transmission (Vienna, Austria : 1996) 20111101
Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion.	Hormones and behavior 20111101
The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats.	Brain : a journal of neurology 20111101
Natural toxins implicated in the development of Parkinson's disease.	Therapeutic advances in neurological disorders 20111101
[Neonatal lesions of catecholaminergic system prevents maturation of cholinergic innervation of the rat neocortex].	Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20111101
Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats.	Neuroscience letters 20111031
Blockade of mGluR5 reverses abnormal firing of subthalamic nucleus neurons in 6-hydroxydopamine partially lesioned rats.	The Chinese journal of physiology 20111031
Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease.	Brain research 20111028
Modulation of the activity of globus pallidus by dopamine D1-like receptors in parkinsonian rats.	Neuroscience 20111027
Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.	Human molecular genetics 20111015
Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism.	Neuroscience 20111013
Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.	Biochemical and biophysical research communications 20111007
An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats.	Fundamental & clinical pharmacology 20111001
Neuroprotection by estradiol: some important considerations.	Human & experimental toxicology 20111001
17β-estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis gene BCL2.	Journal of molecular neuroscience : MN 20111001
JNK isoforms differentially regulate neurite growth and regeneration in dopaminergic neurons in vitro.	Journal of molecular neuroscience : MN 20111001
Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain.	Journal of molecular neuroscience : MN 20111001
The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl) pyridine decreases striatal VGlut2 expression in association with an attenuation of L-DOPA-induced dyskinesias.	Synapse (New York, N.Y.) 20111001
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.	British journal of pharmacology 20111001
Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats.	Pharmacology, biochemistry, and behavior 20111001
Unilateral lesion of the nigrostriatal pathway decreases the response of fast-spiking interneurons in the medial prefrontal cortex to 5-HT1A receptor agonist and expression of the receptor in parvalbumin-positive neurons in the rat.	Neurochemistry international 20111001
L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.	Molecular & cellular proteomics : MCP 20111001
Effects of dopamine depletion on information flow between the subthalamic nucleus and external globus pallidus.	Journal of neurophysiology 20111001
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.	Behavioural pharmacology 20111001
The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death.	The European journal of neuroscience 20111001
Antiparkinsonian properties of a nerve growth factor dipeptide mimetic GK-2 in in vivo experiments.	Bulletin of experimental biology and medicine 20111001
Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.	Behavioural brain research 20110930
Posterior hypothalamic nucleus deep brain stimulation restores locomotion in rats with haloperidol-induced akinesia but not skilled forelimb use in pellet reaching and lever pressing.	Neuroscience 20110929
Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo.	Neuroscience 20110929
Lesions of the ventral ascending noradrenergic bundles decrease the stress response to occlusal disharmony in rats.	Neuroscience letters 20110926
Taltirelin, a thyrotropin-releasing hormone analog, alleviates mechanical allodynia through activation of descending monoaminergic neurons in persistent inflammatory pain.	Brain research 20110926
Tongue force and timing deficits in a rat model of Parkinson disease.	Behavioural brain research 20110923
Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.	Biochemical and biophysical research communications 20110923
Sustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats.	Neuroscience letters 20110915
Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion.	Behavioural brain research 20110912
Noradrenergic projections to the ventromedial hypothalamus regulate fat metabolism during endurance exercise.	Neuroscience 20110908
In vivo effect of 5-HT₇ receptor agonist on pyramidal neurons in medial frontal cortex of normal and 6-hydroxydopamine-lesioned rats: an electrophysiological study.	Neuroscience 20110908
Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine.	Neuron 20110908
Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults.	Nature neuroscience 20110904
Mice lacking major brain gangliosides develop parkinsonism.	Neurochemical research 20110901
Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia.	Neurobiology of disease 20110901
Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat.	Neurobiology of disease 20110901
Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease.	Neuroscience research 20110901
Noradrenergic regulation of itch transmission in the spinal cord mediated by α-adrenoceptors.	Neuropharmacology 20110901
Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors.	The Journal of pharmacology and experimental therapeutics 20110901
High frequency stimulation of the subthalamic nucleus acutely rescues motor deficits and neocortical movement representations following 6-hydroxydopamine administration in rats.	Experimental neurology 20110901
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease.	Neurobiology of disease 20110901
GDNF-pretreatment enhances the survival of neural stem cells following transplantation in a rat model of Parkinson's disease.	Neuroscience research 20110901
Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.	Journal of ethnopharmacology 20110901
Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease.	Disease models & mechanisms 20110901
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels.	Journal of neurochemistry 20110901
Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease.	Journal of neuropathology and experimental neurology 20110901
Differential DAergic Control of D1 and D2 Receptor Agonist Over Locomotor Activity and GABA Level in the Striatum.	Experimental neurobiology 20110901
A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats.	Brain and behavior 20110901
Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease.	The Journal of neuroscience : the official journal of the Society for Neuroscience 20110831
Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.	International journal of pharmaceutics 20110830
Increased efficacy of the 6-hydroxydopamine lesion of the median forebrain bundle in small rats, by modification of the stereotaxic coordinates.	Journal of neuroscience methods 20110830
[High-frequency electro-acupuncture stimulation modulates intracerebral γ-aminobutyric acid content in rat model of Parkinson's disease].	Sheng li xue bao : [Acta physiologica Sinica] 20110825
[Effects and mechanism of low frequency stimulation of pedunculopontine nucleus on spontaneous discharges of ventrolateral thalamic nucleus in rats].	Sheng li xue bao : [Acta physiologica Sinica] 20110825
Dynamics of executive control and motor deficits in parkinsonian rats.	The Journal of neuroscience : the official journal of the Society for Neuroscience 20110817
Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease.	Movement disorders : official journal of the Movement Disorder Society 20110815
Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum.	Neuroscience letters 20110815
Blood pressure increased dramatically in hypertensive rats after left hemisphere lesions with 6-hydroxydopamine.	Neuroscience letters 20110815
[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].	Zhonghua yi xue za zhi 20110809
Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals.	Neurobiology of aging 20110801
Protective potential of 17β-estradiol against co-exposure of 4-hydroxynonenal and 6-hydroxydopamine in PC12 cells.	Human & experimental toxicology 20110801
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease.	British journal of pharmacology 20110801
The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.	Neurobiology of disease 20110801
Curcumin mediates both dilation and constriction of peripheral arterioles via adrenergic receptors.	The Journal of investigative dermatology 20110801
Mortalin inhibition in experimental Parkinson's disease.	Movement disorders : official journal of the Movement Disorder Society 20110801
Commentary on chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Merja H. Voutilainen et al.	Experimental neurology 20110801
MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress.	Naunyn-Schmiedeberg's archives of pharmacology 20110801
Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.	Journal of neurochemistry 20110801
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.	Brain : a journal of neurology 20110801
Methamphetamine induces endoplasmic reticulum stress related gene CHOP/Gadd153/ddit3 in dopaminergic cells.	Cell and tissue research 20110801
Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425.	Nuclear medicine and biology 20110801
Alterations in brain connectivity underlying beta oscillations in Parkinsonism.	PLoS computational biology 20110801
Pedunculopontine nucleus deep brain stimulation in Parkinson's disease.	Archives of medical science : AMS 20110801
6-Hydroxydopamine lesions of the ventral tegmental area suppress ghrelin's ability to elicit food-reinforced behavior.	Neuroscience letters 20110720
Alterations of emotion, cognition and firing activity of the basolateral nucleus of the amygdala after partial bilateral lesions of the nigrostriatal pathway in rats.	Brain research bulletin 20110715
Overexpression of Nrdp1/FLRF sensitizes cells to oxidative stress.	Biochemical and biophysical research communications 20110715
Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.	Journal of medicinal chemistry 20110714
Cortical stimulation evokes abnormal responses in the dopamine-depleted rat basal ganglia.	The Journal of neuroscience : the official journal of the Society for Neuroscience 20110713
Behavioral outcome measures used for human neural stem cell transplantation in rat stroke models.	Neurology international 20110705
Trophic and immunoregulatory properties of neural precursor cells: benefit for intracerebral transplantation.	Experimental neurology 20110701
Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.	Neurochemistry international 20110701
Progressive impairment in motor skill learning at 12 and 20 weeks post 6-OHDA- SNc lesion in rats.	Parkinsonism & related disorders 20110701
Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson's rat: functional recovery with bone marrow cells, serotonin and GABA.	Molecular and cellular biochemistry 20110701
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.	Neurobiology of disease 20110701
Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia.	Journal of neurochemistry 20110701
Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models.	Circulation. Cardiovascular imaging 20110701
A Caenorhabditis elegans p38 MAP kinase pathway mutant protects from dopamine, methamphetamine, and MDMA toxicity.	Neuroscience letters 20110701
Correlative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's.	Nuclear medicine and biology 20110701
Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.	International journal of environmental research and public health 20110701
Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury.	Neuroscience letters 20110622
Three-dimensional motion analysis of postural adjustments during over-ground locomotion in a rat model of Parkinson's disease.	Behavioural brain research 20110620
Distribution, level, pharmacology, regulation, and signaling of 5-HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism.	The Journal of comparative neurology 20110615
Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability.	Human molecular genetics 20110615
Dynamic changes of striatal dopamine D2 receptor binding at later stages after unilateral lesions of the medial forebrain bundle in Parkinsonian rat models.	Neuroscience letters 20110608
Modeling neurodegeneration in zebrafish.	Current neurology and neuroscience reports 20110601
Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats.	Cerebellum (London, England) 20110601
Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.	Neurobiology of disease 20110601
The influence of autonomic interventions on the sleep-wake-related changes in gastric myoelectrical activity in rats.	Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20110601
Effect of different doses of estrogen on the nigrostriatal dopaminergic system in two 6-hydroxydopamine-induced lesion models of Parkinson's disease.	Neurochemical research 20110601
Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.	Experimental neurology 20110601
Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.	The Journal of pharmacology and experimental therapeutics 20110601
Brain stem catecholamines circuitry: activation by alcohol and role in the hypothalamic-pituitary-adrenal response to this drug.	Journal of neuroendocrinology 20110601
GluR1 phosphorylation and persistent expression of levodopa-induced motor response alterations in the Hemi-Parkinsonian rat.	Neurochemical research 20110601
The effect of catecholaminergic depletion within the prelimbic and infralimbic medial prefrontal cortex on recognition memory for recency, location, and objects.	Behavioral neuroscience 20110601
Differential expression of FosB, c-Fos, and Zif268 in forebrain regions after acute or chronic L-DOPA treatment in a rat model of Parkinson's disease.	Neuroscience letters 20110601
Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease.	Journal of neurochemistry 20110601
The nucleus locus coeruleus/subcoeruleus contributes to antinociception during freezing behavior following the air-puff startle in rats.	Brain research 20110601
Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6-OHDA-lesioned rats.	The European journal of neuroscience 20110601
Animal models of intellectual disability: towards a translational approach.	Clinics (Sao Paulo, Brazil) 20110601
A microfluidic-based neurotoxin concentration gradient for the generation of an in vitro model of Parkinson's disease.	Biomicrofluidics 20110601
Kainic Acid-induced neurotoxicity: targeting glial responses and glia-derived cytokines.	Current neuropharmacology 20110601
Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease.	Neuroscience letters 20110527
Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in parkinsonian rats.	Journal of the neurological sciences 20110515

Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.

Neuropharmacology 20150801

Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson's disease.

Journal of molecular neuroscience : MN 20150301

Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.

Journal of neural transmission (Vienna, Austria : 1996) 20150201

Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction.

Chemico-biological interactions 20150105

Induction of Pi form of glutathione S-transferase by carnosic acid is mediated through PI3K/Akt/NF-κB pathway and protects against neurotoxicity.

Chemical research in toxicology 20141117

Involvement of activation of the Nrf2/ARE pathway in protection against 6-OHDA-induced SH-SY5Y cell death by α-iso-cubebenol.

Neurotoxicology 20140901

RTP801 regulates maneb- and mancozeb-induced cytotoxicity via NF-κB.

Journal of biochemical and molecular toxicology 20140701

Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures.

Neurotoxicology 20140301

Impairment of Atg5-dependent autophagic flux promotes paraquat- and MPP⁺-induced apoptosis but not rotenone or 6-hydroxydopamine toxicity.

Toxicological sciences : an official journal of the Society of Toxicology 20131101

Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells.

Nature cell biology 20131001

AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson's disease rat model.

ACS chemical neuroscience 20130918

The Nrf2/SKN-1-dependent glutathione S-transferase π homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism.

Neurotoxicology 20130901

PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice.

Neuroscience 20130614

Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease.

Neurotoxicology 20130501

Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.

Neuroscience 20130416

Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.

Neuropharmacology 20130301

A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons.

CNS neuroscience & therapeutics 20130301

Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease.

Brain and behavior 20130301

Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats.

The Journal of toxicological sciences 20130201

Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.

Neuro-degenerative diseases 20130101

Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.

Neurotoxicology 20130101

Glutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease.

Antioxidants & redox signaling 20121215

A novel strategy for intrastriatal dopaminergic cell transplantation: sequential 'nest' grafting influences survival and behavioral recovery in a rat model of Parkinson's disease.

Experimental cell research 20121210

A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder.

Biological psychiatry 20121201

7-Nitroindazole down-regulates dopamine/DARPP-32 signaling in neostriatal neurons in a rat model of Parkinson's disease.

Neuropharmacology 20121201

Chemical and biological evaluation of nephrocizin in protecting nerve growth factor-differentiated PC12 cells by 6-hydroxydopamine-induced neurotoxicity.

Phytochemistry 20121201

Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.

Neuropharmacology 20121201

Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Neuropharmacology 20121201

Dysregulated expression of secretogranin III is involved in neurotoxin-induced dopaminergic neuron apoptosis.

Journal of neuroscience research 20121201

Evaluation of dopamine transporters and D2 receptors in hemiparkinsonian rat brains in vivo using consecutive PET scans of [18F]FPCIT and [18F]fallypride.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20121201

Serotonergic neuroepithelial cells of the skin in developing zebrafish: morphology, innervation and oxygen-sensitive properties.

The Journal of experimental biology 20121115

Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.

Journal of molecular neuroscience : MN 20121101

GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones.

Journal of neuroendocrinology 20121101

Insulin-like growth factor-1 inhibits 6-hydroxydopamine-mediated endoplasmic reticulum stress-induced apoptosis via regulation of heme oxygenase-1 and Nrf2 expression in PC12 cells.

The International journal of neuroscience 20121101

Neurokinin receptor 3 peptide exacerbates 6-hydroxydopamine-induced dopaminergic degeneration in rats through JNK pathway.

Journal of neurochemistry 20121101

6-Hydroxydopamine upregulates iron regulatory protein 1 by activating certain protein kinase C isoforms in the dopaminergic MES23.5 cell line.

The international journal of biochemistry & cell biology 20121101

Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptors.

The European journal of neuroscience 20121101

Altered transcription factor trafficking in oxidatively-stressed neuronal cells.

Biochimica et biophysica acta 20121101

Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6-hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells.

Biochimica et biophysica acta 20121101

Novel codrugs with GABAergic activity for dopamine delivery in the brain.

International journal of pharmaceutics 20121101

Loss of parvalbumin-positive neurons from the globus pallidus in animal models of Parkinson disease.

Journal of neuropathology and experimental neurology 20121101

Chronic restraint stress aggravated arthritic joint swell of rats through regulating nitric oxide production.

Nitric oxide : biology and chemistry 20121015

6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats.

Brain research 20121005

Eppendorf finalist. Striatal interneurons: causes of or cures for movement disorders?

Science (New York, N.Y.) 20121005

Proliferation of external globus pallidus-subthalamic nucleus synapses following degeneration of midbrain dopamine neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20121003

Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease.

The Journal of nutritional biochemistry 20121001

Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson's disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20121001

Alcoholic extract of Bacopa monniera Linn. protects against 6-hydroxydopamine-induced changes in behavioral and biochemical aspects: a pilot study.

Cellular and molecular neurobiology 20121001

A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 20121001

Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase.

Neurochemical research 20121001

Characterization of mitophagy in the 6-hydoxydopamine Parkinson's disease model.

Toxicological sciences : an official journal of the Society of Toxicology 20121001

Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.

Neuropeptides 20121001

Immunohistochemical and morphological changes in neurons and neuroglia in the cerebral nigrostriatal structures under conditions of experimental nigral neurodegeneration.

Bulletin of experimental biology and medicine 20121001

Visualizing dopamine transporter integrity with iodine-123-FP-CIT SPECT in combination with high resolution MRI in the brain of the common marmoset monkey.

Journal of neuroscience methods 20120930

A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study.

Journal of neuroscience methods 20120930

SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of Parkinson's disease.

Journal of ethnopharmacology 20120928

Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.

Toxicology letters 20120918

Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis.

Chemical research in toxicology 20120917

Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.

Neurobiology of aging 20120901

Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias.

Neurobiology of aging 20120901

Effect of maternal separation on mitochondrial function and role of exercise in a rat model of Parkinson's disease.

Metabolic brain disease 20120901

Preparation of rotigotine-loaded microspheres and their combination use with L-DOPA to modify dyskinesias in 6-OHDA-lesioned rats.

Pharmaceutical research 20120901

Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice.

Neuropharmacology 20120901

Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.

Neurobiology of disease 20120901

Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson's disease.

Journal of molecular neuroscience : MN 20120901

DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats.

Brain research bulletin 20120901

Activation of subthalamic alpha 2 noradrenergic receptors induces motor deficits as a consequence of neuronal burst firing.

Neurobiology of disease 20120901

Characterizing effects of subthalamic nucleus deep brain stimulation on methamphetamine-induced circling behavior in hemi-Parkinsonian rats.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 20120901

Quantitative video-based gait pattern analysis for hemiparkinsonian rats.

Medical & biological engineering & computing 20120901

Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation.

Journal of neurochemistry 20120901

Do α-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model?

Experimental neurology 20120901

The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease.

The European journal of neuroscience 20120901

RETRACTED: S-allyl cysteine protects against 6-hydroxydopamine-induced neurotoxicity in the rat striatum: involvement of Nrf2 transcription factor activation and modulation of signaling kinase cascades.

Free radical biology & medicine 20120901

Medaka fish Parkinson's disease model.

Experimental neurobiology 20120901

L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease.

Neuroscience 20120830

Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.

Brain research 20120830

Impact of dopamine versus serotonin cell transplantation for the development of graft-induced dyskinesia in a rat Parkinson model.

Brain research 20120827

Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCα and PI3K/AKT signaling pathways.

Journal of agricultural and food chemistry 20120822

Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model.

Autonomic neuroscience : basic & clinical 20120816

Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors.

European journal of pharmacology 20120815

Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death.

Free radical biology & medicine 20120815

Circadian rhythms of gastrointestinal function are regulated by both central and peripheral oscillators.

American journal of physiology. Gastrointestinal and liver physiology 20120815

Isolation, identification, and biological evaluation of Nrf2-ARE activator from the leaves of green perilla (Perilla frutescens var. crispa f. viridis).

Free radical biology & medicine 20120815

Infusion of Sydenham's chorea antibodies in striatum with up-regulated dopaminergic receptors: a pilot study to investigate the potential of SC antibodies to increase dopaminergic activity.

Neuroscience letters 20120815

Neurotrophic effects of serum- and glucocorticoid-inducible kinase on adult murine mesencephalic dopamine neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20120815

Lesioning noradrenergic neurons of the locus coeruleus in C57Bl/6 mice with unilateral 6-hydroxydopamine injection, to assess molecular, electrophysiological and biochemical changes in noradrenergic signaling.

Neuroscience 20120802

Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease.

Age (Dordrecht, Netherlands) 20120801

Evaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine.

Neurotoxicity research 20120801

Effect of quercetin and its glucuronide metabolite upon 6-hydroxydopamine-induced oxidative damage in Neuro-2a cells.

Free radical research 20120801

Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease.

British journal of pharmacology 20120801

The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.

Neurotoxicity research 20120801

2-Benzazepine nitrones protect dopaminergic neurons against 6-hydroxydopamine-induced oxidative toxicity.

Archiv der Pharmazie 20120801

High intake of folic acid or complex of B vitamins provides anti-Parkinsonism effect: no role for serum level of homocysteine.

Behavioural brain research 20120801

Presynaptic modulation by somatostatin in the rat neostriatum is altered in a model of parkinsonism.

Journal of neurophysiology 20120801

L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson's disease patients.

Medical hypotheses 20120801

Programmed cell death in Parkinson's disease.

Cold Spring Harbor perspectives in medicine 20120801

The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.

Die Pharmazie 20120801

Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat.

Neuroscience 20120726

Dopamine depletion increases the power and coherence of high-voltage spindles in the globus pallidus and motor cortex of freely moving rats.

Brain research 20120717

Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.

Behavioural brain research 20120715

Enhanced expression of nesfatin/nucleobindin-2 in white adipose tissue of ventromedial hypothalamus-lesioned rats.

Neuroscience letters 20120711

Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease.

Neurotoxicity research 20120701

Effect of oxytocin on neuroblastoma cell viability and growth.

Cellular and molecular neurobiology 20120701

Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.

Synapse (New York, N.Y.) 20120701

Sympathetic denervation of one white fat depot changes norepinephrine content and turnover in intact white and brown fat depots.

Obesity (Silver Spring, Md.) 20120701

Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by sulforaphane through the activation of Nrf2 nuclear translocation.

Molecular medicine reports 20120701

Renal sympathetic nerve activity during asphyxia in fetal sheep.

American journal of physiology. Regulatory, integrative and comparative physiology 20120701

Hydrogen sulfide protects SH-SY5Y cells against 6-hydroxydopamine-induced endoplasmic reticulum stress.

American journal of physiology. Cell physiology 20120701

6-Hydroxydopamine leads to T2 hyperintensity, decreased claudin-3 immunoreactivity and altered aquaporin 4 expression in the striatum.

Behavioural brain research 20120615

Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).

Behavioural brain research 20120615

Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.

Brain research 20120606

Neurotoxin-based models of Parkinson's disease.

Neuroscience 20120601

Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.

Synapse (New York, N.Y.) 20120601

Drosophila melanogaster as a model to study drug addiction.

Human genetics 20120601

Cranial and related sensorimotor impairments in rodent models of Parkinson's disease.

Behavioural brain research 20120601

Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: a correlation study.

Neuroscience research 20120601

Animal models of L-DOPA-induced dyskinesia: an update on the current options.

Neuroscience 20120601

Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy.

Journal of neuroscience research 20120601

Low level of glutathione can intensify the toxic effect of salsolinol in SH-SY5Y neuroblastoma cell line.

Neurotoxicology 20120601

Modeling Parkinson's disease using induced pluripotent stem cells.

Current neurology and neuroscience reports 20120601

Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease.

Brain : a journal of neurology 20120601

Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease.

Neuroscience bulletin 20120601

The effects of short-term nicotine administration on behavioral and oxidative stress deficiencies induced in a rat model of Parkinson's disease.

Psychiatria Danubina 20120601

Proteomic analysis reveals a protective role for DJ-1 during 6-hydroxydopamine-induced cell death.

Biochemical and biophysical research communications 20120525

NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease.

Antioxidants & redox signaling 20120515

Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.

NeuroImage 20120515

Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia.

European journal of pharmacology 20120515

Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats.

European journal of pharmacology 20120515

Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.

Journal of neuroimmunology 20120515

Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.

The international journal of neuropsychopharmacology 20120501

Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.

Journal of molecular neuroscience : MN 20120501

Evaluation of a multiple system atrophy model in rats using multitracer microPET.

Acta neurochirurgica 20120501

Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease.

Behavioural brain research 20120501

Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson's disease.

Journal of molecular neuroscience : MN 20120501

Contralateral retinal dopamine decrease and melatonin increase in progression of hemiparkinsonium rat.

Neurochemical research 20120501

Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501

α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease.

Current drug targets 20120501

Investigate the chronic neurotoxic effects of diquat.

Neurochemical research 20120501

Evolution of the dynamic properties of the cortex-basal ganglia network after dopaminergic depletion in rats.

Neurobiology of disease 20120501

Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease.

Pharmacological research 20120501

Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.

Experimental neurology 20120501

Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease.

The Journal of urology 20120501

Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats.

Neurobiology of learning and memory 20120501

Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat.

The Journal of pharmacy and pharmacology 20120501

In vivo dopamine transporter imaging in a unilateral 6-hydroxydopamine rat model of Parkinson disease using 11C-methylphenidate PET.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120501

Nootropic activity of acetaminophen against colchicine induced cognitive impairment in rats.

Journal of clinical biochemistry and nutrition 20120501

Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP+ toxicity: dual roles for ERK1/2.

Cell death & disease 20120501

Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20120425

Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons.

Nature communications 20120424

Long-term changes in morphology, D2R expression and targets of regenerated dopaminergic terminals in the striatum after a partial lesion in the substantia nigra in the rat.

Brain research 20120423

Deep brain stimulation of the subthalamic nucleus in the 6-hydroxydopamine rat model of Parkinson's disease: effects on sensorimotor gating.

Behavioural brain research 20120421

Different involvement of ventral and dorsal norepinephrine pathways on norepinephrine reuptake inhibitor-induced locomotion and antidepressant-like effects in rats.

Neuroscience letters 20120418

Functional neuroimaging of the 6-OHDA lesion rat model of Parkinson's disease.

Neuroscience letters 20120404

Combined elemental and biomolecular mass spectrometry imaging for probing the inventory of tissue at a micrometer scale.

Analytical chemistry 20120403

Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease.

Neurobiology of aging 20120401

Neurotrophic effects of growth/differentiation factor 5 in a neuronal cell line.

Neurotoxicity research 20120401

L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats.

Neurotoxicity research 20120401

First appearance and location of catecholaminergic cells during experimental arthritis and elimination by chemical sympathectomy.

Arthritis and rheumatism 20120401

Ether-à-go-go 1 (Eag1) potassium channel expression in dopaminergic neurons of basal ganglia is modulated by 6-hydroxydopamine lesion.

Neurotoxicity research 20120401

Toxicity of 6-hydroxydopamine: live cell imaging of cytoplasmic redox flux.

Cell biology and toxicology 20120401

Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.

Behavioural pharmacology 20120401

Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses.

Toxicological sciences : an official journal of the Society of Toxicology 20120401

Animal models of Parkinson's disease.

The FEBS journal 20120401

Selective bilateral lesion to caudate nucleus modulates the acute and chronic methylphenidate effects.

Pharmacology, biochemistry, and behavior 20120401

Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease.

The Journal of urology 20120401

The effects of nigrostriatal dopamine depletion on the thalamic parafascicular nucleus.

Brain research 20120329

Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20120321

Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.

Journal of medicinal chemistry 20120308

Modeling mitochondrial dysfunctions in the brain: from mice to men.

Journal of inherited metabolic disease 20120301

HRD1 levels increased by zonisamide prevented cell death and caspase-3 activation caused by endoplasmic reticulum stress in SH-SY5Y cells.

Journal of molecular neuroscience : MN 20120301

The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.

Journal of physiology and biochemistry 20120301

Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model.

Molecular therapy : the journal of the American Society of Gene Therapy 20120301

Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens.

Cognitive, affective & behavioral neuroscience 20120301

Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery.

Molecular therapy : the journal of the American Society of Gene Therapy 20120301

Paeonol attenuates microglia-mediated inflammation and oxidative stress-induced neurotoxicity in rat primary microglia and cortical neurons.

Shock (Augusta, Ga.) 20120301

Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence.

Neurochemical research 20120301

Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.

Journal of neuroscience research 20120301

Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning.

Journal of neurochemistry 20120301

Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites.

Behavioural brain research 20120301

Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease.

Apoptosis : an international journal on programmed cell death 20120301

Evaluation of periodic limb movements in a putative animal model of restless leg syndrome.

Movement disorders : official journal of the Movement Disorder Society 20120301

The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats.

Neuroscience research 20120301

Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K/Akt-dependent manner.

Molecular medicine reports 20120301

Lonicera japonica THUNB. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-κB in SH-SY5Y cells.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20120301

Endogenous neural precursors influence grafted neural stem cells and contribute to neuroprotection in the parkinsonian rat.

The European journal of neuroscience 20120301

Novel roles of peroxiredoxins in inflammation, cancer and innate immunity.

Journal of clinical biochemistry and nutrition 20120301

Protective effect of theaflavins on neuron against 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells.

Journal of clinical biochemistry and nutrition 20120301

IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells.

European journal of pharmacology 20120227

Small molecule inhibition of RISC loading.

ACS chemical biology 20120217

Frequency selectivity and dopamine-dependence of plasticity at glutamatergic synapses in the subthalamic nucleus.

Neuroscience 20120217

Intranasally applied L-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions.

Brain research bulletin 20120210

Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's disease.

Journal of medicinal chemistry 20120209

Mild dopaminergic lesions are accompanied by robust changes in subthalamic nucleus activity.

Neuroscience letters 20120206

Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine.

Neurobiology of aging 20120201

The glutamatergic component of the mesocortical pathway emanating from different subregions of the ventral midbrain.

Cerebral cortex (New York, N.Y. : 1991) 20120201

Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease.

Neurotoxicity research 20120201

Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.

Neurotoxicity research 20120201

Neonatal 6-hydroxydopamine lesioning enhances quinpirole-induced vertical jumping in rats that were quinpirole primed during postnatal ontogeny.

Neurotoxicity research 20120201

In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET.

NeuroImage 20120201

Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved.

Neuropharmacology 20120201

The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses.

Annals of the rheumatic diseases 20120201

AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth.

Molecular therapy : the journal of the American Society of Gene Therapy 20120201

Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120201

Retigabine, a K(V)7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats.

Neuropharmacology 20120201

The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 20120201

Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells.

Cell research 20120201

Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson's disease: a self-perpetuating crosstalk?

Biochimica et biophysica acta 20120201

Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia.

Nature neuroscience 20120201

Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?

Molecular neurobiology 20120201

Striatal dopamine depletion in rats produces variable effects on contingency detection: task-related influences.

The European journal of neuroscience 20120201

The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.

PLoS genetics 20120201

Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.

Neuroscience 20120127

The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle.

Neuroscience 20120127

RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits.

Neuron 20120126

Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats.

ACS chemical neuroscience 20120118

Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease.

Neuroscience letters 20120117

Automated gait analysis in bilateral parkinsonian rats and the role of L-DOPA therapy.

Behavioural brain research 20120115

Lesions of the dopaminergic innervation of the nucleus accumbens medial shell delay the generation of preference for sucrose, but not of sexual pheromones.

Behavioural brain research 20120115

Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action.

Neuroscience letters 20120111

Unchanged expression of the ceramide transfer protein in the acute 6-OHDA neurodegenerative model.

Neuroscience letters 20120106

The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias.

Brain research bulletin 20120104

Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration.

Neurobiology of aging 20120101

Liver growth factor promotes the survival of grafted neural stem cells in a rat model of Parkinson's disease.

Current stem cell research & therapy 20120101

Changes in the mRNA levels of α2A and α2C adrenergic receptors in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.

Journal of molecular neuroscience : MN 20120101

Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.

Cell transplantation 20120101

Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease.

Journal of molecular neuroscience : MN 20120101

Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish.

Cellular and molecular neurobiology 20120101

Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine.

Evidence-based complementary and alternative medicine : eCAM 20120101

Phytochemical characteristics, free radical scavenging activities, and neuroprotection of five medicinal plant extracts.

Evidence-based complementary and alternative medicine : eCAM 20120101

Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum.

Journal of molecular neuroscience : MN 20120101

An autoradiographic study on the pathogenesis of levodopa-induced dyskinesia: regulation of dopamine transporter by levodopa in a rat model of Parkinson's disease.

Neuro-degenerative diseases 20120101

A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission.

Experimental neurology 20120101

Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia.

Behavioural brain research 20120101

Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.

Pharmacology, biochemistry, and behavior 20120101

In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.

Neurobiology of disease 20120101

Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Neurotoxicity research 20120101

Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.

Parkinson's disease 20120101

Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model.

Experimental neurology 20120101

Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.

Neurobiology of disease 20120101

Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress.

Cytotherapy 20120101

Reliance on habits at the expense of goal-directed control following dopamine precursor depletion.

Psychopharmacology 20120101

Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.

Psychopharmacology 20120101

Animal models of Parkinson's disease.

Parkinsonism & related disorders 20120101

Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system.

Brain : a journal of neurology 20120101

Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.

The European journal of neuroscience 20120101

Non-cell autonomous influence of the astrocyte system xc- on hypoglycaemic neuronal cell death.

ASN neuro 20120101

ADHD animal model characterization: transcriptomics and proteomics analyses.

Methods in molecular biology (Clifton, N.J.) 20120101

Noisy galvanic vestibular stimulation promotes GABA release in the substantia nigra and improves locomotion in hemiparkinsonian rats.

PloS one 20120101

Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways.

PloS one 20120101

Human excretion of bisphenol A: blood, urine, and sweat (BUS) study.

Journal of environmental and public health 20120101

Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation.

PloS one 20120101

The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.

Parkinson's disease 20120101

Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism.

Chinese medicine 20120101

Transfer of neuroplasticity from nucleus accumbens core to shell is required for cocaine reward.

PloS one 20120101

Gene regulation systems for gene therapy applications in the central nervous system.

Neurology research international 20120101

The cortical and striatal gene expression profile of 100 hz electroacupuncture treatment in 6-hydroxydopamine-induced Parkinson's disease model.

Evidence-based complementary and alternative medicine : eCAM 20120101

Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease.

International journal of nanomedicine 20120101

Curcumin in neurology.

Journal of neurosciences in rural practice 20120101

Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1.

Scientific reports 20120101

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.

Journal of neuroinflammation 20120101

Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism.

PloS one 20120101

Reduced proliferation in the adult mouse subventricular zone increases survival of olfactory bulb interneurons.

PloS one 20120101

Ephrin-A1-mediated dopaminergic neurogenesis and angiogenesis in a rat model of Parkinson's disease.

PloS one 20120101

Minocycline markedly reduces acute visceral nociception via inhibiting neuronal ERK phosphorylation.

Molecular pain 20120101

Use of PC12 cells and rat superior cervical ganglion sympathetic neurons as models for neuroprotective assays relevant to Parkinson's disease.

Methods in molecular biology (Clifton, N.J.) 20120101

A 6-hydroxydopamine in vivo model of Parkinson's disease.

Methods in molecular biology (Clifton, N.J.) 20120101

Iptakalim: A novel multi-utility potassium channel opener.

Journal of pharmacology & pharmacotherapeutics 20120101

Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease.

Journal of visualized experiments : JoVE 20120101

The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment.

Scientific reports 20120101

CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.

PloS one 20120101

Multiscale autoregressive identification of neuroelectrophysiological systems.

Computational and mathematical methods in medicine 20120101

Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action.

Frontiers in pharmacology 20120101

Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration.

Frontiers in pharmacology 20120101

DJ-1 null dopaminergic neuronal cells exhibit defects in mitochondrial function and structure: involvement of mitochondrial complex I assembly.

PloS one 20120101

Relevance of animal models to human tardive dyskinesia.

Behavioral and brain functions : BBF 20120101

Neurotrophic actions of dopamine on the development of a serotonergic feeding circuit in Drosophila melanogaster.

BMC neuroscience 20120101

Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat.

PloS one 20120101

Acquisition of 'Start' and 'Stop' response thresholds in peak-interval timing is differentially sensitive to protein synthesis inhibition in the dorsal and ventral striatum.

Frontiers in integrative neuroscience 20120101

Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system.

Surgical neurology international 20120101

N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity.

PloS one 20120101

Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons.

Bioscience, biotechnology, and biochemistry 20120101

Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.

ISRN neurology 20120101

Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice.

PloS one 20120101

Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation.

BMC neuroscience 20120101

Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.

PloS one 20120101

Diverse Roles of JNK and MKK Pathways in the Brain.

Journal of signal transduction 20120101

Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model.

Journal of pharmacological sciences 20120101

Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.

Frontiers in cellular neuroscience 20120101

Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells.

PloS one 20120101

Restoration of the striatal circuitry: from developmental aspects toward clinical applications.

Frontiers in cellular neuroscience 20120101

Endocannabinoid-dopamine interactions in striatal synaptic plasticity.

Frontiers in pharmacology 20120101

Nerve-cancer interactions in the stromal biology of pancreatic cancer.

Frontiers in physiology 20120101

Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy.

Parkinson's disease 20120101

Classic and new animal models of Parkinson's disease.

Journal of biomedicine & biotechnology 20120101

Pharmacological enhancement of treatment for amblyopia.

Clinical ophthalmology (Auckland, N.Z.) 20120101

Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys.

PloS one 20120101

Oxidative stress and microglial cells in Parkinson's disease.

Mediators of inflammation 20120101

Hormone replacement therapy and risk for neurodegenerative diseases.

International journal of Alzheimer's disease 20120101

Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study.

Stem cells international 20120101

Genetic rat models of Parkinson's disease.

Parkinson's disease 20120101

Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies.

Parkinson's disease 20120101

Rehabilitation and Parkinson's disease.

Parkinson's disease 20120101

Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment.

PloS one 20120101

Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease.

PloS one 20120101

Antidepressant-Like Activity of the Ethanolic Extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice.

Evidence-based complementary and alternative medicine : eCAM 20120101

Differential patterns of synaptotagmin7 mRNA expression in rats with kainate- and pilocarpine-induced seizures.

PloS one 20120101

Ih current is necessary to maintain normal dopamine fluctuations and sleep consolidation in Drosophila.

PloS one 20120101

Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease.

Mediators of inflammation 20120101

Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis.

Parkinson's disease 20120101

Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity.

PloS one 20120101

Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.

PloS one 20120101

Role of vitamin d in Parkinson's disease.

ISRN neurology 20120101

Gene therapy for Parkinson's disease.

Parkinson's disease 20120101

Sense and nonsense in metabolic control of reproduction.

Frontiers in endocrinology 20120101

Drug discovery models and toxicity testing using embryonic and induced pluripotent stem-cell-derived cardiac and neuronal cells.

Stem cells international 20120101

The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.

Frontiers in pharmacology 20120101

1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated by NF-κB/RelA acetylation at Lys310.

PloS one 20120101

Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia.

Parkinson's disease 20120101

Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks.

Frontiers in physiology 20120101

The secret language of destiny: stress imprinting and transgenerational origins of disease.

Frontiers in genetics 20120101

The antioxidant 3H-1,2-dithiole-3-thione potentiates advanced glycation end-product-induced oxidative stress in SH-SY5Y cells.

Experimental diabetes research 20120101

The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection.

Oxidative medicine and cellular longevity 20120101

Understanding and prevention of 'therapy-' induced dyskinesias.

Parkinson's disease 20120101

Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival.

PloS one 20120101

On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity.

Frontiers in pharmacology 20120101

Endocannabinoid modulation of dopaminergic motor circuits.

Frontiers in pharmacology 20120101

The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease.

Frontiers in psychiatry 20120101

Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects.

Oxidative medicine and cellular longevity 20120101

Intensive rehabilitation treatment in parkinsonian patients with dyskinesias: a preliminary study with 6-month followup.

Parkinson's disease 20120101

Non-stationary discharge patterns in motor cortex under subthalamic nucleus deep brain stimulation.

Frontiers in integrative neuroscience 20120101

Intracerebral injection of low amounts of norharman induces moderate Parkinsonism-like behavioral symptoms in rat.

Neurotoxicology and teratology 20120101

Human albumin prevents 6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo.

PloS one 20120101

The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats.

PloS one 20120101

Mitochondrial dynamics and mitophagy in the 6-hydroxydopamine preclinical model of Parkinson's disease.

Parkinson's disease 20120101

Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death.

PloS one 20120101

Detoxification of 6-hydroxydopamine-induced dopaminergic neurodegeneration by 5,5-dimethyl-1-pyrroline N-oxide, a radical trapper, in hemiparkinsonian rats.

Biological & pharmaceutical bulletin 20120101

Inhibition of the acquisition of conditioned place aversion by dopaminergic lesions of the central nucleus of the amygdala in morphine-treated rats.

Physiological research 20120101

Mangiferin ameliorates 6-hydroxydopamine-induced cytotoxicity and oxidative stress in ketamine model of schizophrenia.

Pharmacological reports : PR 20120101

Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line.

International journal of molecular sciences 20120101

Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells.

PloS one 20120101

Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway.

Neuroscience 20111229

Contribution of pre-synaptic mechanisms to L-DOPA-induced dyskinesia.

Neuroscience 20111215

Motor disorders and impaired electrical power of pallidal EEG improved by gallic acid in animal model of Parkinson's disease.

Pakistan journal of biological sciences : PJBS 20111215

Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia.

Journal of neural transmission (Vienna, Austria : 1996) 20111201

Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats.

Journal of neural transmission (Vienna, Austria : 1996) 20111201

Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996) 20111201

Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing.

Journal of psychopharmacology (Oxford, England) 20111201

Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996) 20111201

Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.

Neuropathology and applied neurobiology 20111201

Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease.

Cell death and differentiation 20111201

Antidepressant-like properties of sarizotan in experimental Parkinsonism.

Psychopharmacology 20111201

Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.

Neurochemical research 20111201

Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.

Neuropharmacology 20111201

Tacrine(2)-ferulic acid, a novel multifunctional dimer, attenuates 6-hydroxydopamine-induced apoptosis in PC12 cells by activating Akt pathway.

Neurochemistry international 20111201

Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.

Experimental neurology 20111201

Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation.

Experimental neurology 20111201

Regeneration of dopaminergic neurons after 6-hydroxydopamine-induced lesion in planarian brain.

Journal of neurochemistry 20111201

Roles of serotonergic and adrenergic receptors in the antinociception of selective cyclooxygenase-2 inhibitor in the rat spinal cord.

The Korean journal of pain 20111201

Effect of DHEA on recovery of muscle atrophy induced by Parkinson's disease.

Journal of Korean Academy of Nursing 20111201

The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model.

Brain research bulletin 20111125

Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exacerbates [corrected] parkinsonian symptoms.

Neuroscience 20111124

Young and middle-aged rats exhibit isometric forelimb force control deficits in a model of early-stage Parkinson's disease.

Behavioural brain research 20111120

Acute versus long-term effects of 6-hydroxydopamine on oxidative stress and dopamine depletion in the striatum of mice.

Journal of neuroscience methods 20111115

Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats.

Biological psychiatry 20111115

A quantitative comparison of basal ganglia neuronal activities of normal and Parkinson's disease model rats.

Neuroscience letters 20111114

Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells.

Seminars in immunopathology 20111101

Contamination of mesenchymal stem-cells with fibroblasts accelerates neurodegeneration in an experimental model of Parkinson's disease.

Stem cell reviews 20111101

Protective effects of walnut extract against amyloid beta peptide-induced cell death and oxidative stress in PC12 cells.

Neurochemical research 20111101

Ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity.

Neurochemical research 20111101

Induction of dopaminergic neuronal-like cells from CD44+ human amniotic fluids that are ameliorative to behavioral recovery in a Parkinson's disease rat model.

International journal of molecular medicine 20111101

Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration.

Apoptosis : an international journal on programmed cell death 20111101

Arsenic exposure and motor function among children in Bangladesh.

Environmental health perspectives 20111101

The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.

Hypertension research : official journal of the Japanese Society of Hypertension 20111101

Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitor.

The Journal of pharmacology and experimental therapeutics 20111101

Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease.

Toxicology and applied pharmacology 20111101

c-Fos expression after deep brain stimulation of the pedunculopontine tegmental nucleus in the rat 6-hydroxydopamine Parkinson model.

Journal of chemical neuroanatomy 20111101

Overhauser-enhanced magnetic resonance imaging characterization of mitochondria functional changes in the 6-hydroxydopamine rat model.

Neurochemistry international 20111101

Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death.

Journal of neural transmission (Vienna, Austria : 1996) 20111101

Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion.

Hormones and behavior 20111101

The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats.

Brain : a journal of neurology 20111101

Natural toxins implicated in the development of Parkinson's disease.

Therapeutic advances in neurological disorders 20111101

[Neonatal lesions of catecholaminergic system prevents maturation of cholinergic innervation of the rat neocortex].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20111101

Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats.

Neuroscience letters 20111031

Blockade of mGluR5 reverses abnormal firing of subthalamic nucleus neurons in 6-hydroxydopamine partially lesioned rats.

The Chinese journal of physiology 20111031

Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease.

Brain research 20111028

Modulation of the activity of globus pallidus by dopamine D1-like receptors in parkinsonian rats.

Neuroscience 20111027

Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.

Human molecular genetics 20111015

Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism.

Neuroscience 20111013

Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.

Biochemical and biophysical research communications 20111007

An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats.

Fundamental & clinical pharmacology 20111001

Neuroprotection by estradiol: some important considerations.

Human & experimental toxicology 20111001

17β-estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis gene BCL2.

Journal of molecular neuroscience : MN 20111001

JNK isoforms differentially regulate neurite growth and regeneration in dopaminergic neurons in vitro.

Journal of molecular neuroscience : MN 20111001

Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain.

Journal of molecular neuroscience : MN 20111001

The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl) pyridine decreases striatal VGlut2 expression in association with an attenuation of L-DOPA-induced dyskinesias.

Synapse (New York, N.Y.) 20111001

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

British journal of pharmacology 20111001

Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats.

Pharmacology, biochemistry, and behavior 20111001

Unilateral lesion of the nigrostriatal pathway decreases the response of fast-spiking interneurons in the medial prefrontal cortex to 5-HT1A receptor agonist and expression of the receptor in parvalbumin-positive neurons in the rat.

Neurochemistry international 20111001

L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.

Molecular & cellular proteomics : MCP 20111001

Effects of dopamine depletion on information flow between the subthalamic nucleus and external globus pallidus.

Journal of neurophysiology 20111001

Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.

Behavioural pharmacology 20111001

The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death.

The European journal of neuroscience 20111001

Antiparkinsonian properties of a nerve growth factor dipeptide mimetic GK-2 in in vivo experiments.

Bulletin of experimental biology and medicine 20111001

Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.

Behavioural brain research 20110930

Posterior hypothalamic nucleus deep brain stimulation restores locomotion in rats with haloperidol-induced akinesia but not skilled forelimb use in pellet reaching and lever pressing.

Neuroscience 20110929

Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo.

Neuroscience 20110929

Lesions of the ventral ascending noradrenergic bundles decrease the stress response to occlusal disharmony in rats.

Neuroscience letters 20110926

Taltirelin, a thyrotropin-releasing hormone analog, alleviates mechanical allodynia through activation of descending monoaminergic neurons in persistent inflammatory pain.

Brain research 20110926

Tongue force and timing deficits in a rat model of Parkinson disease.

Behavioural brain research 20110923

Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.

Biochemical and biophysical research communications 20110923

Sustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats.

Neuroscience letters 20110915

Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion.

Behavioural brain research 20110912

Noradrenergic projections to the ventromedial hypothalamus regulate fat metabolism during endurance exercise.

Neuroscience 20110908

In vivo effect of 5-HT₇ receptor agonist on pyramidal neurons in medial frontal cortex of normal and 6-hydroxydopamine-lesioned rats: an electrophysiological study.

Neuroscience 20110908

Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine.

Neuron 20110908

Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults.

Nature neuroscience 20110904

Mice lacking major brain gangliosides develop parkinsonism.

Neurochemical research 20110901

Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia.

Neurobiology of disease 20110901

Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat.

Neurobiology of disease 20110901

Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease.

Neuroscience research 20110901

Noradrenergic regulation of itch transmission in the spinal cord mediated by α-adrenoceptors.

Neuropharmacology 20110901

Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors.

The Journal of pharmacology and experimental therapeutics 20110901

High frequency stimulation of the subthalamic nucleus acutely rescues motor deficits and neocortical movement representations following 6-hydroxydopamine administration in rats.

Experimental neurology 20110901

Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease.

Neurobiology of disease 20110901

GDNF-pretreatment enhances the survival of neural stem cells following transplantation in a rat model of Parkinson's disease.

Neuroscience research 20110901

Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Journal of ethnopharmacology 20110901

Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease.

Disease models & mechanisms 20110901

Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels.

Journal of neurochemistry 20110901

Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease.

Journal of neuropathology and experimental neurology 20110901

Differential DAergic Control of D1 and D2 Receptor Agonist Over Locomotor Activity and GABA Level in the Striatum.

Experimental neurobiology 20110901

A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats.

Brain and behavior 20110901

Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20110831

Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.

International journal of pharmaceutics 20110830

Increased efficacy of the 6-hydroxydopamine lesion of the median forebrain bundle in small rats, by modification of the stereotaxic coordinates.

Journal of neuroscience methods 20110830

[High-frequency electro-acupuncture stimulation modulates intracerebral γ-aminobutyric acid content in rat model of Parkinson's disease].

Sheng li xue bao : [Acta physiologica Sinica] 20110825

[Effects and mechanism of low frequency stimulation of pedunculopontine nucleus on spontaneous discharges of ventrolateral thalamic nucleus in rats].

Sheng li xue bao : [Acta physiologica Sinica] 20110825

Dynamics of executive control and motor deficits in parkinsonian rats.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20110817

Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20110815

Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum.

Neuroscience letters 20110815

Blood pressure increased dramatically in hypertensive rats after left hemisphere lesions with 6-hydroxydopamine.

Neuroscience letters 20110815

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

Zhonghua yi xue za zhi 20110809

Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals.

Neurobiology of aging 20110801

Protective potential of 17β-estradiol against co-exposure of 4-hydroxynonenal and 6-hydroxydopamine in PC12 cells.

Human & experimental toxicology 20110801

Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease.

British journal of pharmacology 20110801

The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.

Neurobiology of disease 20110801

Curcumin mediates both dilation and constriction of peripheral arterioles via adrenergic receptors.

The Journal of investigative dermatology 20110801

Mortalin inhibition in experimental Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20110801

Commentary on chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Merja H. Voutilainen et al.

Experimental neurology 20110801

MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress.

Naunyn-Schmiedeberg's archives of pharmacology 20110801

Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.

Journal of neurochemistry 20110801

Endogenous morphine-like compound immunoreactivity increases in parkinsonism.

Brain : a journal of neurology 20110801

Methamphetamine induces endoplasmic reticulum stress related gene CHOP/Gadd153/ddit3 in dopaminergic cells.

Cell and tissue research 20110801

Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425.

Nuclear medicine and biology 20110801

Alterations in brain connectivity underlying beta oscillations in Parkinsonism.

PLoS computational biology 20110801

Pedunculopontine nucleus deep brain stimulation in Parkinson's disease.

Archives of medical science : AMS 20110801

6-Hydroxydopamine lesions of the ventral tegmental area suppress ghrelin's ability to elicit food-reinforced behavior.

Neuroscience letters 20110720

Alterations of emotion, cognition and firing activity of the basolateral nucleus of the amygdala after partial bilateral lesions of the nigrostriatal pathway in rats.

Brain research bulletin 20110715

Overexpression of Nrdp1/FLRF sensitizes cells to oxidative stress.

Biochemical and biophysical research communications 20110715

Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.

Journal of medicinal chemistry 20110714

Cortical stimulation evokes abnormal responses in the dopamine-depleted rat basal ganglia.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20110713

Behavioral outcome measures used for human neural stem cell transplantation in rat stroke models.

Neurology international 20110705

Trophic and immunoregulatory properties of neural precursor cells: benefit for intracerebral transplantation.

Experimental neurology 20110701

Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.

Neurochemistry international 20110701

Progressive impairment in motor skill learning at 12 and 20 weeks post 6-OHDA- SNc lesion in rats.

Parkinsonism & related disorders 20110701

Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson's rat: functional recovery with bone marrow cells, serotonin and GABA.

Molecular and cellular biochemistry 20110701

PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.

Neurobiology of disease 20110701

Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia.

Journal of neurochemistry 20110701

Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models.

Circulation. Cardiovascular imaging 20110701

A Caenorhabditis elegans p38 MAP kinase pathway mutant protects from dopamine, methamphetamine, and MDMA toxicity.

Neuroscience letters 20110701

Correlative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's.

Nuclear medicine and biology 20110701

Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.

International journal of environmental research and public health 20110701

Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury.

Neuroscience letters 20110622

Three-dimensional motion analysis of postural adjustments during over-ground locomotion in a rat model of Parkinson's disease.

Behavioural brain research 20110620

Distribution, level, pharmacology, regulation, and signaling of 5-HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism.

The Journal of comparative neurology 20110615

Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability.

Human molecular genetics 20110615

Dynamic changes of striatal dopamine D2 receptor binding at later stages after unilateral lesions of the medial forebrain bundle in Parkinsonian rat models.

Neuroscience letters 20110608

Modeling neurodegeneration in zebrafish.

Current neurology and neuroscience reports 20110601

Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats.

Cerebellum (London, England) 20110601

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

Neurobiology of disease 20110601

The influence of autonomic interventions on the sleep-wake-related changes in gastric myoelectrical activity in rats.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20110601

Effect of different doses of estrogen on the nigrostriatal dopaminergic system in two 6-hydroxydopamine-induced lesion models of Parkinson's disease.

Neurochemical research 20110601

Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.

Experimental neurology 20110601

Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.

The Journal of pharmacology and experimental therapeutics 20110601

Brain stem catecholamines circuitry: activation by alcohol and role in the hypothalamic-pituitary-adrenal response to this drug.

Journal of neuroendocrinology 20110601

GluR1 phosphorylation and persistent expression of levodopa-induced motor response alterations in the Hemi-Parkinsonian rat.

Neurochemical research 20110601

The effect of catecholaminergic depletion within the prelimbic and infralimbic medial prefrontal cortex on recognition memory for recency, location, and objects.

Behavioral neuroscience 20110601

Differential expression of FosB, c-Fos, and Zif268 in forebrain regions after acute or chronic L-DOPA treatment in a rat model of Parkinson's disease.

Neuroscience letters 20110601

Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease.

Journal of neurochemistry 20110601

The nucleus locus coeruleus/subcoeruleus contributes to antinociception during freezing behavior following the air-puff startle in rats.

Brain research 20110601

Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6-OHDA-lesioned rats.

The European journal of neuroscience 20110601

Animal models of intellectual disability: towards a translational approach.

Clinics (Sao Paulo, Brazil) 20110601

A microfluidic-based neurotoxin concentration gradient for the generation of an in vitro model of Parkinson's disease.

Biomicrofluidics 20110601

Kainic Acid-induced neurotoxicity: targeting glial responses and glia-derived cytokines.

Current neuropharmacology 20110601

Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease.

Neuroscience letters 20110527

Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in parkinsonian rats.

Journal of the neurological sciences 20110515

Cellular antioxidant adaptive survival response to 6-hydroxydopamine-induced nitrosative cell death in C6 glioma cells.

Toxicology 20110510

Exploring aversion in an animal model of pre-motor stage Parkinson's disease.

Neuroscience 20110505

Ontogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamine.

Neurotoxicity research 20110501

Nestin (+) stem cells independently contribute to neural remodelling of the ischemic heart.

Journal of cellular physiology 20110501

Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.

Journal of cellular physiology 20110501

Anterograde axonal transport of AAV2-GDNF in rat basal ganglia.

Molecular therapy : the journal of the American Society of Gene Therapy 20110501

Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats.

Neuropharmacology 20110501

Decrease of lymphoproliferative response by amphetamine is mediated by dopamine from the nucleus accumbens: influence on splenic met-enkephalin levels.

Brain, behavior, and immunity 20110501

Detoxification of 6-hydroxydopamine-induced Parkinsonian neurodegeneration by G-CYPMPO, a novel radical trapper.

Neurochemistry international 20110501

Upregulation of D2-class signaling in dopamine-denervated striatum is in part mediated by D3 receptors acting on Ca V 2.1 channels via PIP2 depletion.

Journal of neurophysiology 20110501

Effect of sympathetic nerves on proliferation of splenic lymphocytes and antioxidant function of maternal spleen in early pregnant mice.

Anatomical record (Hoboken, N.J. : 2007) 20110501

Restoration of motor control and dopaminergic activity in rats with unilateral 6-hydroxy-dopamine lesions.

Regenerative medicine 20110501

Involvement of nitric oxide in learning & memory processes.

The Indian journal of medical research 20110501

[Effects of penetration therapy with scalp electroacupuncture on gene expressions of nerve growth factors in substantia nigra of rats with Parkinson's disease].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20110501

Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.

The Chinese journal of physiology 20110430

Phenylbutyrate up-regulates the DJ-1 protein and protects neurons in cell culture and in animal models of Parkinson disease.

The Journal of biological chemistry 20110429

Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells.

Brain research 20110428

Reduction of an afterhyperpolarization current increases excitability in striatal cholinergic interneurons in rat parkinsonism.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20110427

Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD).

Neuroscience letters 20110420

The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease.

Brain research 20110412

Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors.

Neurobiology of aging 20110401

Increased in vitro lysosomal function in oxidative stress-induced cell lines.

Applied biochemistry and biotechnology 20110401

Noise benefit in prepulse inhibition of the acoustic startle reflex.

Psychopharmacology 20110401

Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine.

Psychopharmacology 20110401

Necdin and neurotrophin receptors: interactors of relevance for neuronal resistance to oxidant stress.

Pediatric research 20110401

Dopaminergic neurons of system x(c)⁻-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20110401

Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons.

Acta neuropathologica 20110401

Context-driven changes in L-DOPA-induced behaviours in the 6-OHDA lesioned rat.

Neurobiology of disease 20110401

Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine.

Rejuvenation research 20110401

Sex-related differences in descending norepinephrine and serotonin controls of spinal withdrawal reflex during intramuscular saline induced muscle nociception in rats.

Experimental neurology 20110401

Assessment of salsolinol N-methyltransferase activity in rat peripheral lymphocytes by liquid chromatography-electrospray time-of-flight mass spectrometry.

Analytical and bioanalytical chemistry 20110401

In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson's disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model.

The European journal of neuroscience 20110401

[Resveratrol derived from rhizoma et radix polygoni cuspidati and its liposomal form protect nigral cells of Parkinsonian rats].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20110401

Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse.

Brain research 20110325

Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models.

Journal of ethnopharmacology 20110324

Progressive motor cortex functional reorganization following 6-hydroxydopamine lesioning in rats.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20110323

Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway.

Neuroscience 20110317

Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease.

Brain research 20110310

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.

Cell stem cell 20110304

Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease.

The international journal of neuropsychopharmacology 20110301

Phencyclidine (PCP)-induced disruption in cognitive performance is gender-specific and associated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female rat brain.

Journal of molecular neuroscience : MN 20110301

Iron mediates neuritic tree collapse in mesencephalic neurons treated with 1-methyl-4-phenylpyridinium (MPP+).

Journal of neural transmission (Vienna, Austria : 1996) 20110301

Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease?

Antioxidants & redox signaling 20110301

Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain.

Journal of neural transmission (Vienna, Austria : 1996) 20110301

Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats.

Psychopharmacology 20110301

Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.

Neurobiology of disease 20110301

Phosphorylation of p66shc mediates 6-hydroxydopamine cytotoxicity.

Free radical research 20110301

BN82451 attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.

Neuropharmacology 20110301

Reduced dopamine function within the medial shell of the nucleus accumbens enhances latent inhibition.

Pharmacology, biochemistry, and behavior 20110301

Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease.

Free radical biology & medicine 20110301

Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease.

Experimental neurology 20110301

Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.

Neurochemical research 20110301

Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity.

Experimental neurology 20110301

In vivo 6-OHDA-induced neurodegeneration and nigral autophagic markers expression.

Neurochemistry international 20110301

C-terminal mechano-growth factor induces heme oxygenase-1-mediated neuroprotection of SH-SY5Y cells via the protein kinase Cϵ/Nrf2 pathway.

Journal of neuroscience research 20110301

Gain of survival signaling by down-regulation of three key miRNAs in brain of calorie-restricted mice.

Aging 20110301

[Effects and mechanism of Plastrum testudinis extracts on PC12 apoptosis].

Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20110301

CSC counteracts l-DOPA-induced overactivity of the corticostriatal synaptic ultrastructure and function in 6-OHDA-lesioned rats.

Brain research 20110227

Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions.

Brain research bulletin 20110227

Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat.

Neuroscience 20110223

Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20110216

Curcumin I protects the dopaminergic cell line SH-SY5Y from 6-hydroxydopamine-induced neurotoxicity through attenuation of p53-mediated apoptosis.

Neuroscience letters 20110211

Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20110209

Lever pressing responses under a fixed-ratio schedule of mice with 6-hydroxydopamine-induced dopamine depletion in the nucleus accumbens.

Behavioural brain research 20110202

The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20110202

Identification of nigral dopaminergic neuron-enriched genes in adult rats.

Neurobiology of aging 20110201

Possible regulatory factors for intra-abdominal fat mass in a rat model of Parkinson's disease.

Nutrition (Burbank, Los Angeles County, Calif.) 20110201

Stereotypic progressions in psychotic behavior.

Neurotoxicity research 20110201

In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese.

Environmental health perspectives 20110201

Minor retinal degeneration in Parkinson's disease.

Medical hypotheses 20110201

Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease.

Neurobiology of disease 20110201

The hydrolysis of striatal adenine- and guanine-based purines in a 6-hydroxydopamine rat model of Parkinson's disease.

Neurochemical research 20110201

6-Hydroxydopamine-induced PC12 cell death is mediated by MEF2D down-regulation.

Neurochemical research 20110201

Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor α in the nigrostriatal dopaminergic circuit of adult mice.

Experimental neurology 20110201

Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish.

International journal of molecular medicine 20110201

Parkinson's disease involves autophagy and abnormal distribution of cathepsin L.

Neuroscience letters 20110201

Effects of unilateral 6-OHDA lesions on [3H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat.

Neurochemistry international 20110201

Positive association between striatal serotonin level and abnormal involuntary movements in chronic L-DOPA-treated hemiparkinsonian rats.

Brain research bulletin 20110201

Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration.

Journal of neural transmission (Vienna, Austria : 1996) 20110201

Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia.

Brain : a journal of neurology 20110201

Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.

Rejuvenation research 20110201

Mesencephalic astrocyte-derived neurotrophic factor (MANF) has a unique mechanism to rescue apoptotic neurons.

The Journal of biological chemistry 20110128

Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease.

Journal of ethnopharmacology 20110127

Dangguijakyak-san, a medicinal herbal formula, protects dopaminergic neurons from 6-hydroxydopamine-induced neurotoxicity.

Journal of ethnopharmacology 20110127

Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: time course of protection and neurorestoration.

Brain research 20110125

The role of dopamine in the dorsomedial striatum in place and response learning.

Neuroscience 20110113

Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies.

Brain research 20110112

Deletion of adenosine A₁ or A(₂A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease.

Brain research 20110107

Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20110105

Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease.

Molecular therapy : the journal of the American Society of Gene Therapy 20110104

Knockdown of glycogen synthase kinase 3 beta attenuates 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells.

Neuroscience letters 20110103

San-Huang-Xie-Xin-Tang Protects against Activated Microglia- and 6-OHDA-Induced Toxicity in Neuronal SH-SY5Y Cells.

Evidence-based complementary and alternative medicine : eCAM 20110101

Development of bladder dysfunction in a rat model of dopaminergic brain lesion.

Neurourology and urodynamics 20110101

Striatal dopaminergic fiber recovery after acute L-DOPA treatment in 6-hydroxydopamine (6-OHDA) lesioned rats.

Cell biochemistry and biophysics 20110101

L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata.

Neurobiology of disease 20110101

Environmental exposure, obesity, and Parkinson's disease: lessons from fat and old worms.

Environmental health perspectives 20110101

Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.

Neurotoxicology and teratology 20110101

Endoplasmic reticulum stress inducers provide protection against 6-hydroxydopamine-induced cytotoxicity.

Neurochemistry international 20110101

The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model.

Sleep medicine 20110101

Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants.

Journal of pharmacological and toxicological methods 20110101

HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease.

Nature neuroscience 20110101

Kainic acid-induced neurodegenerative model: potentials and limitations.

Journal of biomedicine & biotechnology 20110101

Overview of animal models of attention deficit hyperactivity disorder (ADHD).

Current protocols in neuroscience 20110101

Manganese inhalation as a Parkinson disease model.

Parkinson's disease 20110101

Limitations of animal models of Parkinson's disease.

Parkinson's disease 20110101

6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death.

Molecular neurodegeneration 20110101

Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease.

Parkinson's disease 20110101

Toxin-induced and genetic animal models of Parkinson's disease.

Parkinson's disease 20110101

Iron and mechanisms of neurotoxicity.

International journal of Alzheimer's disease 20110101

Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.

Parkinson's disease 20110101

Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation.

Journal of biomedical science 20110101

Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.

PloS one 20110101

Effect of Bushen Huoxue Decoction on the orphan receptor and tyrosine hydroxylase in the brain of rats with Parkinson's disease.

Chinese journal of integrative medicine 20110101

CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease.

Journal of neuroinflammation 20110101

Treatment of Parkinson's disease: nanostructured sol-gel silica-dopamine reservoirs for controlled drug release in the central nervous system.

International journal of nanomedicine 20110101

Enhanced survival of dopaminergic neuronal transplants in hemiparkinsonian rats by the p53 inactivator PFT-α.

Cell transplantation 20110101

BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.

PloS one 20110101

Nr4a1-eGFP is a marker of striosome-matrix architecture, development and activity in the extended striatum.

PloS one 20110101

The endotoxin-induced neuroinflammation model of Parkinson's disease.

Parkinson's disease 20110101

Sympathetic renal innervation and resistant hypertension.

International journal of hypertension 20110101

Behavioral impairment and oxidative damage induced by chronic application of nonylphenol.

International journal of molecular sciences 20110101

The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.

International journal of molecular sciences 20110101

Neurotrophic effects of a cyanine dye via the PI3K-Akt pathway: attenuation of motor discoordination and neurodegeneration in an ataxic animal model.

PloS one 20110101

Carbon tetrachloride induced kidney and lung tissue damages and antioxidant activities of the aqueous rhizome extract of Podophyllum hexandrum.

BMC complementary and alternative medicine 20110101

Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease.

PloS one 20110101

Tonic inhibition of allergic itch signaling by the descending noradrenergic system in mice.

Journal of pharmacological sciences 20110101

Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease.

PloS one 20110101

Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model.

PloS one 20110101

Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases.

Journal of Alzheimer's disease : JAD 20110101

The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease.

Parkinson's disease 20110101

Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day.

PloS one 20110101

In vivo imaging neurotransmitter function. The rat 6-hydroxydopamine model and its relevance for human Parkinson's disease.

Nuklearmedizin. Nuclear medicine 20110101

Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment.

Stem cell research & therapy 20110101

Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson's disease.

Patient preference and adherence 20110101

Post-translational modification biology of glutamate receptors and drug addiction.

Frontiers in neuroanatomy 20110101

BmDJ-1 is a key regulator of oxidative modification in the development of the silkworm, Bombyx mori.

PloS one 20110101

Temporal profiles of age-dependent changes in cytokine mRNA expression and glial cell activation after status epilepticus in postnatal rat hippocampus.

Journal of neuroinflammation 20110101

Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism.

Neuro-degenerative diseases 20110101

Regulation of Substantia Nigra Pars Reticulata GABAergic Neuron Activity by H₂O₂ via Flufenamic Acid-Sensitive Channels and K(ATP) Channels.

Frontiers in systems neuroscience 20110101

Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies.

Parkinson's disease 20110101

Effect of vitamin E (Tri E®) on antioxidant enzymes and DNA damage in rats following eight weeks exercise.

Nutrition journal 20110101

Catecholaminergic depletion in nucleus accumbens enhances trace conditioning.

Advances in medical sciences 20110101

Adult human neurogenesis: from microscopy to magnetic resonance imaging.

Frontiers in neuroscience 20110101

Eriocaulon buergerianum extract protects PC12 cells and neurons in zebrafish against 6-hydroxydopamine-induced damage.

Chinese medicine 20110101

Neural tissue engineering using embryonic and induced pluripotent stem cells.

Stem cell research & therapy 20110101

Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease.

Molecular neurodegeneration 20110101

Chronic methamphetamine administration causes differential regulation of transcription factors in the rat midbrain.

PloS one 20110101

Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells.

PloS one 20110101

Neuroprotective effects of ginsenosides Rh1 and Rg2 on neuronal cells.

Chinese medicine 20110101

Amnion-derived stem cells: in quest of clinical applications.

Stem cell research & therapy 20110101

Lipopolysaccharide animal models for Parkinson's disease.

Parkinson's disease 20110101

Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.

Parkinson's disease 20110101

Optimizing a rodent model of Parkinson's disease for exploring the effects and mechanisms of deep brain stimulation.

Parkinson's disease 20110101

Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?

Parkinson's disease 20110101

Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.

Parkinson's disease 20110101

The antioxidative effect of electro-acupuncture in a mouse model of Parkinson's disease.

PloS one 20110101

Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents.

PloS one 20110101

Potent antioxidant and genoprotective effects of boeravinone G, a rotenoid isolated from Boerhaavia diffusa.

PloS one 20110101

Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection.

PloS one 20110101

Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.

Retrovirology 20110101

Age sensitivity of behavioral tests and brain substrates of normal aging in mice.

Frontiers in aging neuroscience 20110101

Noradrenaline and Parkinson's disease.

Frontiers in systems neuroscience 20110101

Pleiotrophin over-expression provides trophic support to dopaminergic neurons in parkinsonian rats.

Molecular neurodegeneration 20110101

Stem cell biology and drug discovery.

BMC biology 20110101

Therapeutic effects of hydrogen in animal models of Parkinson's disease.

Parkinson's disease 20110101

The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease.

Parkinson's disease 20110101

The degenerating substantia nigra as a susceptible region for gene transfer-mediated inflammation.

Parkinson's disease 20110101

Neuroregeneration in neurodegenerative disorders.

BMC neurology 20110101

High fat diet intake during pre and periadolescence impairs learning of a conditioned place preference in adulthood.

Behavioral and brain functions : BBF 20110101

Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats.

Frontiers in systems neuroscience 20110101

Distribution of tyrosine hydroxylase-expressing interneurons with respect to anatomical organization of the neostriatum.

Frontiers in systems neuroscience 20110101

Role of Striatum in the Pause and Burst Generation in the Globus Pallidus of 6-OHDA-Treated Rats.

Frontiers in systems neuroscience 20110101

The Subthalamic Nucleus becomes a Generator of Bursts in the Dopamine-Depleted State. Its High Frequency Stimulation Dramatically Weakens Transmission to the Globus Pallidus.

Frontiers in systems neuroscience 20110101

The 5-HT(2A) Receptor Antagonist M100907 Produces Antiparkinsonian Effects and Decreases Striatal Glutamate.

Frontiers in systems neuroscience 20110101

Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses.

PloS one 20110101

Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats.

Molecular neurodegeneration 20110101

Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats.

Neoplasma 20110101

α-Synuclein Alters Toll-Like Receptor Expression.

Frontiers in neuroscience 20110101

The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia.

Frontiers in neuroanatomy 20110101

Neighboring Pallidal Neurons Do Not Exhibit more Synchronous Oscillations than Remote Ones in the MPTP Primate Model of Parkinson's Disease.

Frontiers in systems neuroscience 20110101

Nitric Oxide-Soluble Guanylyl Cyclase-Cyclic GMP Signaling in the Striatum: New Targets for the Treatment of Parkinson's Disease?

Frontiers in systems neuroscience 20110101

Quantitative mapping of cocaine-induced ΔFosB expression in the striatum of male and female rats.

PloS one 20110101

Donepezil, anti-Alzheimer's disease drug, prevents cardiac rupture during acute phase of myocardial infarction in mice.

PloS one 20110101

A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection.

Molecular neurodegeneration 20110101

Bridging molecular genetics and biomarkers in lewy body and related disorders.

International journal of Alzheimer's disease 20110101

MPTP Neurotoxicity and Testosterone Induce Dendritic Remodeling of Striatal Medium Spiny Neurons in the C57Bl/6 Mouse.

Parkinson's disease 20110101

Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.

Frontiers in systems neuroscience 20110101

Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration.

Journal of toxicology 20110101

Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies.

Journal of toxicology 20110101

Striatal Dopamine and the Interface between Motivation and Cognition.

Frontiers in psychology 20110101

Targeting neuronal populations of the striatum.

Frontiers in neuroanatomy 20110101

Distinctive left-sided distribution of adrenergic-derived cells in the adult mouse heart.

PloS one 20110101

Activation of protease activated receptor 1 increases the excitability of the dentate granule neurons of hippocampus.

Molecular brain 20110101

A brief review on recent developments in animal models of schizophrenia.

Indian journal of pharmacology 20110101

Renin angiotensin system and gender differences in dopaminergic degeneration.

Molecular neurodegeneration 20110101

Targeted training of ultrasonic vocalizations in aged and Parkinsonian rats.

Journal of visualized experiments : JoVE 20110101

Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke.

PloS one 20110101

Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.

PloS one 20110101

Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans.

PloS one 20110101

The corticostriatal and corticosubthalamic pathways: two entries, one target. So what?

Frontiers in systems neuroscience 20110101

FGF-2 deficiency does not influence FGF ligand and receptor expression during development of the nigrostriatal system.

PloS one 20110101

Sleep disturbances associated with Parkinson's disease.

Parkinson's disease 20110101

Identification of a specific assembly of the g protein golf as a critical and regulated module of dopamine and adenosine-activated cAMP pathways in the striatum.

Frontiers in neuroanatomy 20110101

Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.

Frontiers in neuroanatomy 20110101

[Comparative study of amantadine and hemantane effects on development of levodopa-induced dyskinesia in rat model of parkinsonian syndrome].

Eksperimental'naia i klinicheskaia farmakologiia 20110101

Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease.

Frontiers in systems neuroscience 20110101

MEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat model.

PloS one 20110101

Chopper is prodeath regardless of the effect of p75ICD on sensitivity to oxidative stress.

Oxidative medicine and cellular longevity 20110101

Experimental Models of l-DOPA-Induced Dyskinesia.

International review of neurobiology 20110101

Clinical and experimental experiences of graft-induced dyskinesia.

International review of neurobiology 20110101

Modeling dopamine neuron degeneration in Caenorhabditis elegans.

Methods in molecular biology (Clifton, N.J.) 20110101

Bladder, bowel, and sexual dysfunction in Parkinson's disease.

Parkinson's disease 20110101

The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study.

PloS one 20110101

Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury.

Journal of neuroinflammation 20110101

Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease.

BMC neurology 20110101

Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.

Frontiers in neuroanatomy 20110101

Oxidative stress in neurodegeneration.

Advances in pharmacological sciences 20110101

Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease.

Proteome science 20110101

An overview of brain-derived neurotrophic factor and implications for excitotoxic vulnerability in the hippocampus.

International journal of peptides 20110101

Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.

Journal of neuroinflammation 20110101

Effect of Trans-resveratrol on Rotenone-induced Cytotoxicity in Human Breast Adenocarcinoma Cells.

Toxicology international 20110101

Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease.

PloS one 20110101

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration.

Journal of neuroinflammation 20110101

Combined STN/SNr-DBS for the treatment of refractory gait disturbances in Parkinson's disease: study protocol for a randomized controlled trial.

Trials 20110101

Post-learning molecular reactivation underlies taste memory consolidation.

Frontiers in systems neuroscience 20110101

Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway.

PloS one 20110101

Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats.

Pharmacological reports : PR 20110101

Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice.

PloS one 20110101

HIV-1gp120 induces neuronal apoptosis through enhancement of 4-aminopyridine-senstive outward K+ currents.

PloS one 20110101

Identification of bilateral changes in TID1 expression in the 6-OHDA rat model of Parkinson's disease.

PloS one 20110101

Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic study.

PloS one 20110101

Pallidal hyperdopaminergic innervation underlying D2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF.

PloS one 20110101

L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission.

Frontiers in behavioral neuroscience 20110101

Excessive expression of hippocampal ezrin is induced by intrastriatal injection of 6-hydroxydopamine.

Biological & pharmaceutical bulletin 20110101

Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.

Journal of pharmacological sciences 20110101

Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases.

PloS one 20110101

Differential effects of accumbens core vs. shell lesions in a rat concurrent conditioned place preference paradigm for cocaine vs. social interaction.

PloS one 20110101

CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease.

Journal of neuroinflammation 20110101

Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors.

Frontiers in molecular neuroscience 20110101

Social Defeat during Adolescence and Adulthood Differentially Induce BDNF-Regulated Immediate Early Genes.

Frontiers in behavioral neuroscience 20110101

Multiple doublesex-related genes specify critical cell fates in a C. elegans male neural circuit.

PloS one 20110101

Metabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolites.

International journal of molecular sciences 20110101

Anti-UVC irradiation and metal chelation properties of 6-benzoyl-5,7-dihydroxy-4-phenyl-chromen-2-one: an implications for anti-cataract agent.

International journal of molecular sciences 20110101

Amygdala-prefrontal pathways and the dopamine system affect nociceptive responses in the prefrontal cortex.

BMC neuroscience 20110101

Pharmacological challenge and synaptic response - assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET).

Reviews in the neurosciences 20110101

A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death.

PloS one 20110101

A showcase of bench-to-bedside regenerative medicine at the 2010 ASNTR.

TheScientificWorldJournal 20110101

The promise of neuroprotective agents in Parkinson's disease.

Frontiers in neurology 20110101

Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs.

Molecular vision 20110101

Exploration of sex differences in Rhes effects in dopamine mediated behaviors.

Neuropsychiatric disease and treatment 20110101

Substitute of Animals in Drug Research: An Approach Towards Fulfillment of 4R's.

Indian journal of pharmaceutical sciences 20110101

nardosinane-type sesquiterpenoids from the formosan soft coral Paralemnalia thyrsoides.

Marine drugs 20110101

Ras-ERK Signaling in Behavior: Old Questions and New Perspectives.

Frontiers in behavioral neuroscience 20110101

Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease.

PloS one 20110101

Oxidation of DJ-1 induced by 6-hydroxydopamine decreasing intracellular glutathione.

PloS one 20110101

Application of medical gases in the field of neurobiology.

Medical gas research 20110101

Stress induced Salmonella Typhimurium recrudescence in pigs coincides with cortisol induced increased intracellular proliferation in macrophages.

Veterinary research 20110101

Disruption of spectrin-like cytoskeleton in differentiating keratinocytes by PKCδ activation is associated with phosphorylated adducin.

PloS one 20110101

Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons.

Molecular neurodegeneration 20110101

The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier.

Journal of drug delivery 20110101

Mildronate as a regulator of protein expression in a rat model of Parkinson's disease.

Medicina (Kaunas, Lithuania) 20110101

Comparison of Cannabinoid CB(1) Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [F]MK-9470.

International journal of molecular imaging 20110101

Detection of intranasally delivered bone marrow-derived mesenchymal stromal cells in the lesioned mouse brain: a cautionary report.

Stem cells international 20110101

Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives.

Oxidative medicine and cellular longevity 20110101

Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration.

PloS one 20110101

Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease.

PloS one 20110101

Anodal transcranial direct current stimulation relieves the unilateral bias of a rat model of Parkinson's disease.

Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20110101

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson's disease.

Frontiers in systems neuroscience 20110101

A role for locus coeruleus in Parkinson tremor.

Frontiers in human neuroscience 20110101

NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.

Journal of amino acids 20110101

gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury.

Frontiers in molecular neuroscience 20110101

Partial lesion of the dopaminergic innervation of the ventral striatum induces 'depressive-like' behavior of rats.

Pharmacological reports : PR 20110101

Effects of transplanted GDNF gene modified marrow stromal cells on focal cerebral ischemia in rats.

Frontiers in integrative neuroscience 20110101

Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons.

ISRN neurology 20110101

Regulation of adult neurogenesis in the hippocampus by stress, acetylcholine and dopamine.

Journal of natural science, biology, and medicine 20110101

5-HT(1A) receptor activation improves anti-cataleptic effects of levodopa in 6-hydroxydopamine-lesioned rats.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.

Frontiers in endocrinology 20110101

Male/Female differences in neuroprotection and neuromodulation of brain dopamine.

Frontiers in endocrinology 20110101

p-Hydroxyamphetamine causes prepulse inhibition disruptions in mice: contribution of dopamine neurotransmission.

Behavioural brain research 20101225

Long term exposure to norharman exacerbates 6-hydroxydopamine-induced parkinsonism: possible involvement of L-type Ca2+ channels.

Behavioural brain research 20101220

Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease.

Neuroscience letters 20101217

Paraquat induces cyclooxygenase-2 (COX-2) implicated toxicity in human neuroblastoma SH-SY5Y cells.

Toxicology letters 20101215

Effects of piclozotan (SUN N4057), a partial serotonin 1A receptor agonist, on motor complications induced by repeated administration of levodopa in parkinsonian rats.

European journal of pharmacology 20101215

Rg1 protects iron-induced neurotoxicity through antioxidant and iron regulatory proteins in 6-OHDA-treated MES23.5 cells.

Journal of cellular biochemistry 20101215

An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20101208

Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.

Neuroscience letters 20101203

The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats.

Brain research 20101202

Creating a ventral midbrain stem cell niche in an animal model for Parkinson's disease.

Stem cells and development 20101201

Lateralized response of oxytocinase activity in the medial prefrontal cortex of a unilateral rat model of Parkinson's disease.

Behavioural brain research 20101201

Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease.

Basic & clinical pharmacology & toxicology 20101201

Early toxic effect of 6-hydroxydopamine on extracellular concentrations of neurotransmitters in the rat striatum: an in vivo microdialysis study.

Neurotoxicology 20101201

The dopamine transporter is differentially regulated after dopaminergic lesion.

Neurobiology of disease 20101201

Levodopa and pramipexole effects on presynaptic dopamine PET markers and estimated dopamine release.

European journal of nuclear medicine and molecular imaging 20101201

Effects of simvastatin and 6-hydroxydopamine on histaminergic H1 receptor binding density in rat brains.

Progress in neuro-psychopharmacology & biological psychiatry 20101201

Neurocytoprotective effects of the bioactive constituents of Pueraria thomsonii in 6-hydroxydopamine (6-OHDA)-treated nerve growth factor (NGF)-differentiated PC12 cells.

Phytochemistry 20101201

Biomarkers of cell damage induced by oxidative stress in Parkinson's disease and related models.

Central nervous system agents in medicinal chemistry 20101201

Efficient regeneration by activation of neurogenesis in homeostatically quiescent regions of the adult vertebrate brain.

Development (Cambridge, England) 20101201

Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation.

Journal of neural transmission (Vienna, Austria : 1996) 20101201

The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20101201

Dissociable roles of dopamine within the core and medial shell of the nucleus accumbens in memory for objects and place.

Behavioral neuroscience 20101201

[Autophagy is involved in 6-OHDA-induced dopaminergic cell death].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20101201

Deep brain stimulation: technology at the cutting edge.

Journal of clinical neurology (Seoul, Korea) 20101201

[Effect of electroacupuncture on morphological changes and apoptosis of substantia nigra cells in Parkinson's disease rats].

Zhen ci yan jiu = Acupuncture research 20101201

In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease.

Journal of medicinal chemistry 20101125

Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat.

Behavioural brain research 20101112

Droplet microfluidics for characterizing the neurotoxin-induced responses in individual Caenorhabditis elegans.

Lab on a chip 20101107

Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain.

Brain research 20101104

Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.

Planta medica 20101101

Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101101

Involvement of the peripheral sensory and sympathetic nervous system in the vascular endothelial expression of ICAM-1 and the recruitment of opioid-containing immune cells to inhibit inflammatory pain.

Brain, behavior, and immunity 20101101

Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.

Neurochemistry international 20101101

The 6-hydroxydopamine-induced nigrostriatal neurodegeneration produces microglia-like NG2 glial cells in the rat substantia nigra.

Glia 20101101

Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats.

Neurochemistry international 20101101

Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-κB modulation.

Neurochemistry international 20101101

Antiparkinsonian trophic action of glial cell line-derived neurotrophic factor and transforming growth factor β1 is enhanced after co-infusion in rats.

Experimental neurology 20101101

α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease.

Molecular pharmacology 20101101

Endogenous descending modulation: spatiotemporal effect of dynamic imbalance between descending facilitation and inhibition of nociception.

The Journal of physiology 20101101

Expression and activation of β-adrenoceptors in the colorectal mucosa of rat and human.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20101101

Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.

Annals of neurology 20101101

Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death.

Journal of neuropathology and experimental neurology 20101101

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Archives of toxicology 20101101

Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: evidence for de-differentiation of resident astrocytes.

Cell and tissue research 20101101

Three-dimensional elemental bio-imaging of Fe, Zn, Cu, Mn and P in a 6-hydroxydopamine lesioned mouse brain.

Metallomics : integrated biometal science 20101101

Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20101101

Challenges facing quantification of rat locomotion along beams of varying widths.

Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine 20101101

Polyphenols and human health: prevention of disease and mechanisms of action.

Nutrients 20101101

Ras homolog enriched in brain (Rheb) enhances apoptotic signaling.

The Journal of biological chemistry 20101029

Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20101020

Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20101020

Graft-mediated functional recovery on a skilled forelimb use paradigm in a rodent model of Parkinson's disease is dependent on reward contingency.

Behavioural brain research 20101015

Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals.

Neuroscience letters 20101015

Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.

Cerebral cortex (New York, N.Y. : 1991) 20101001

Nanoparticles induce changes of the electrical activity of neuronal networks on microelectrode array neurochips.

Environmental health perspectives 20101001

Effects of zona incerta lesions on striatal neurochemistry and behavioral asymmetry in 6-hydroxydopamine-lesioned rats.

Journal of neuroscience research 20101001

Use of haptoglobin and transthyretin as potential biomarkers for the preclinical diagnosis of Parkinson's disease.

Neurochemistry international 20101001

Intranigral LPS administration produces dopamine, glutathione but not behavioral impairment in comparison to MPTP and 6-OHDA neurotoxin models of Parkinson's disease.

Neurochemical research 20101001

Within-session analysis of amphetamine-elicited rotation behavior reveals differences between young adult and middle-aged F344/BN rats with partial unilateral striatal dopamine depletion.

Pharmacology, biochemistry, and behavior 20101001

Cytoarchitectural impairments in the medium spiny neurons of the Nucleus Accumbens core of hyperactive juvenile rats.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20101001

Dose-response relationship between norepinephrine and erythropoiesis: evidence for a critical threshold.

The Journal of surgical research 20101001

Proteasome inhibition in medaka brain induces the features of Parkinson's disease.

Journal of neurochemistry 20101001

Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias.

Experimental neurology 20101001

Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.

American journal of physiology. Regulatory, integrative and comparative physiology 20101001

Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions.

Stem cells (Dayton, Ohio) 20101001

Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat.

Behavioural pharmacology 20101001

Experimental deep brain stimulation in animal models.

Neurosurgery 20101001

Progressive changes of orexin system in a rat model of 6-hydroxydopamine-induced Parkinson's disease.

Neuroscience bulletin 20101001

New insights into molecular targets for urinary incontinence.

Indian journal of pharmacology 20101001

Catecholaminergic depletion within the prelimbic medial prefrontal cortex enhances latent inhibition.

Neuroscience 20100929

Chemical or surgical sympathectomy prevents mechanical hyperalgesia induced by intraplantar injection of bee venom in rats.

Brain research 20100924

Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrier.

Brain research 20100917

p38(MAPK)/p53 signalling axis mediates neuronal apoptosis in response to tetrahydrobiopterin-induced oxidative stress and glucose uptake inhibition: implication for neurodegeneration.

The Biochemical journal 20100915

Interleukin-1β contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro.

Journal of neuroimmunology 20100914

Differential proteome of the striatum from hemiparkinsonian rats displays vivid structural remodeling processes.

Journal of proteome research 20100903

Skin-derived precursors differentiating into dopaminergic neuronal cells in the brains of Parkinson disease model rats.

Journal of neurosurgery 20100901

A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.

Neurobiology of disease 20100901

Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.

Journal of neuroscience research 20100901

In vivo modulation of the firing activity of putative slow- and fast-spiking interneurons in the medial prefrontal cortex by 5-HT3 receptors in 6-hydroxydopamine-induced Parkinsonian rats.

Neuroscience 20100901

The RGD-containing peptide fragment of osteopontin protects tyrosine hydroxylase positive cells against toxic insult in primary ventral mesencephalic cultures and in the rat substantia nigra.

Journal of neurochemistry 20100901

Design, synthesis and biological evaluation of L-dopa amide derivatives as potential prodrugs for the treatment of Parkinson's disease.

European journal of medicinal chemistry 20100901

Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease.

British journal of pharmacology 20100901

Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway.

British journal of pharmacology 20100901

[Effects of electroacupuncture on the expression of GDNF and Ret in Parkinson's disease model rats].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20100901

The role of mitochondria in brain aging and the effects of melatonin.

Current neuropharmacology 20100901

Neurotoxins: free radical mechanisms and melatonin protection.

Current neuropharmacology 20100901

A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.

Current neuropharmacology 20100901

A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death.

Neuroscience letters 20100830

Levodopa/benserazide-loaded biodegradable microspheres reduce dyskinesia in rats.

Neuroreport 20100823

Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.

Progress in neuro-psychopharmacology & biological psychiatry 20100816

Age-specific effects of 6-hydroxydopamine lesions of the rat medial prefrontal cortex on stress-induced c-fos expression in subcortical areas.

Progress in neuro-psychopharmacology & biological psychiatry 20100816

Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20100815

Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment.

Movement disorders : official journal of the Movement Disorder Society 20100815

The different performance among motor tasks during the increasing current intensity of deep brain stimulation of the subthalamic nucleus in rats with different degrees of the unilateral striatal lesion.

Neuroscience letters 20100809

[Relationship of oxidative DNA damage and expression of mitochondrial apoptotic proteins in rat striatum induced by 6-hydroxydopamine].

Zhonghua yi xue za zhi 20100803

Decreased RGS9 protein level in the striatum of rodents undergoing MPTP or 6-OHDA neurotoxicity.

Neuroscience letters 20100802

The roles of striatal serotonin and L -amino-acid decarboxylase on L-DOPA-induced Dyskinesia in a Hemiparkinsonian rat model.

Cellular and molecular neurobiology 20100801

Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model.

Neurochemistry international 20100801

An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's disease.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100801

Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression.

Experimental neurology 20100801

Selective lesion of the developing central noradrenergic system: short- and long-term effects and reinnervation by noradrenergic-rich tissue grafts.

Journal of neurochemistry 20100801

alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.

CNS & neurological disorders drug targets 20100801

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Acta neuropathologica 20100801

A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias.

Parkinsonism & related disorders 20100801

Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease.

Experimental neurology 20100801

[Effect of decreased locomotor activity on hindlimb muscles in a rat model of Parkinson's disease].

Journal of Korean Academy of Nursing 20100801

Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.

PLoS genetics 20100801

Effects of 6-hydroxydopamine lesioning of the medial prefrontal cortex on social interactions in adolescent and adult rats.

Brain research 20100730

Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.

Brain research bulletin 20100730

Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease--a rat model study.

Brain research 20100730

Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats.

Behavioural brain research 20100729

Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry.

Nature 20100729

Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20100721

Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in rats.

Proceedings of the National Academy of Sciences of the United States of America 20100720

Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.

Brain research 20100716

Dissociable responses to punishment in distinct striatal regions during reversal learning.

NeuroImage 20100715

Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

Neurotoxicity research 20100701

Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats.

Stem cells and development 20100701

Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.

The British journal of nutrition 20100701

Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss.

Neurobiology of disease 20100701

Neuroectodermally converted human mesenchymal stromal cells provide cytoprotective effects on neural stem cells and inhibit their glial differentiation.

Cytotherapy 20100701

Disconnection of the entorhinal cortex and dorsomedial striatum impairs the sensitivity to instrumental contingency degradation.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100701

Lack of effect of dopaminergic denervation on caudate-putamen hyperthermia or hypothermia induced by drugs and mild stressors.

Pharmacology, biochemistry, and behavior 20100701

Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease.

Journal of neurochemistry 20100701

Sympathetic modulation of the host defense response to infectious challenge during recovery from hemorrhage.

Neuroimmunomodulation 20100701

Cocaine reverses the changes in GABAA subunits and in glutamic acid decarboxylase isoenzymes mRNA expression induced by neonatal 6-hydroxydopamine.

Behavioural pharmacology 20100701

Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF signaling.

Acta pharmacologica Sinica 20100701

HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction.

PLoS biology 20100701

Applications of electron spin resonance spectrometry for reactive oxygen species and reactive nitrogen species research.

Journal of clinical biochemistry and nutrition 20100701

GPI-1046 increases presenilin-1 expression and restores NMDA channel activity.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20100701

Dopamine agonists increase perseverative instrumental responses but do not restore habit formation in a rat model of Parkinsonism.

Neuroscience 20100630

Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model.

Behavioural brain research 20100626

Locomotion analysis of Sprague-Dawley rats before and after injecting 6-OHDA.

Behavioural brain research 20100626

Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats.

Behavioural brain research 20100626

The nucleus locus coeruleus/subcoeruleus affects the defensive-like, immobile posture following an air-puff startle reaction in the rat.

Neuroscience 20100616

Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.

Brain research 20100614

The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine.

Proceedings of the Japan Academy. Series B, Physical and biological sciences 20100611

Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat.

Brain research 20100608

L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.

Neurobiology of aging 20100601

Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells.

The Journal of nutritional biochemistry 20100601

Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.

Journal of molecular neuroscience : MN 20100601

MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism.

Neuropharmacology 20100601

Diadenosine tetraphosphate protects sympathetic terminals from 6-hydroxydopamine-induced degeneration in the eye.

Acta physiologica (Oxford, England) 20100601

Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization.

The Journal of pharmacology and experimental therapeutics 20100601

Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4).

Peptides 20100601

Pre-synaptic glutamate-induced activation of DA release in the striatum after partial nigral lesion.

Journal of neurochemistry 20100601

Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule.

Free radical research 20100601

Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.

Journal of neurochemistry 20100601

On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079.

Journal of neural transmission (Vienna, Austria : 1996) 20100601

Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.

CNS neuroscience & therapeutics 20100601

Aged Tgfbeta2/Gdnf double-heterozygous mice show no morphological and functional alterations in the nigrostriatal system.

Journal of neural transmission (Vienna, Austria : 1996) 20100601

Effect of cdk5 antagonist on L-dopa-induced dyskinesias in a rat model of Parkinson's disease.

The International journal of neuroscience 20100601

Protective effect of Cyperi rhizoma against 6-hydroxydopamine-induced neuronal damage.

Journal of medicinal food 20100601

Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease.

The European journal of neuroscience 20100601

Acute stress enhances contact dermatitis by promoting nuclear factor-kappaB DNA-binding activity and interleukin-18 expression in mice.

The Journal of dermatology 20100601

Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice.

PLoS biology 20100601

[Biochemical changes in striatum of Parkinson's disease rat model observed by modified proton magnetic resonance spectroscopy].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20100601

Neurobehavioral manifestations of developmental impairment of the brain.

Interdisciplinary toxicology 20100601

Acquisition and performance in a rat sequential reaction time task is not affected by subtotal ventral striatal 6-OHDA lesions.

Neuroscience letters 20100526

Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20100526

[Protective effects of uric acid on nigrostriatal system injury induced by 6-hydroxydopamine in rats].

Zhonghua yi xue za zhi 20100518

High-frequency stimulation of the subthalamic nucleus restores neural and behavioral functions during reaction time task in a rat model of Parkinson's disease.

Journal of neuroscience research 20100515

Behavioral and electrophysiological effects of 5-HT in globus pallidus of 6-hydroxydopamine lesioned rats.

Journal of neuroscience research 20100515

Action of 6-amino-3-pyridinols as novel antioxidants against free radicals and oxidative stress in solution, plasma, and cultured cells.

Free radical biology & medicine 20100515

Dopamine D1 receptor gene expression studies in unilateral 6-hydroxydopamine-lesioned Parkinson's rat: effect of 5-HT, GABA, and bone marrow cell supplementation.

Journal of molecular neuroscience : MN 20100501

Mitochondrial uncoupling protein-2 (UCP2) mediates leptin protection against MPP+ toxicity in neuronal cells.

Neurotoxicity research 20100501

Functional changes in the frontal cortex in Parkinson's disease using a rat model.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100501

The Wld(S) mutation delays anterograde, but not retrograde, axonal degeneration of the dopaminergic nigro-striatal pathway in vivo.

Journal of neurochemistry 20100501

Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease.

Neurochemical research 20100501

Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo.

Journal of neural transmission (Vienna, Austria : 1996) 20100501

The Galectin-1 level in serum as a novel marker for stress.

Glycoconjugate journal 20100501

Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's disease.

Behavioural pharmacology 20100501

In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease.

Nuclear medicine and biology 20100501

Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis.

Clinics (Sao Paulo, Brazil) 20100501

[Disruption of latent inhibition in adult rats after prepubertal dopamine terminals lesions in the ventral hippocampus].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20100501

Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.

Brain research 20100430

Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.

Brain research bulletin 20100429

Alterations of Hrd1 expression in various encephalic regional neurons in 6-OHDA model of Parkinson's disease.

Neuroscience letters 20100426

Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease.

Science translational medicine 20100421

Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Molecules (Basel, Switzerland) 20100416

Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease.

Brain research 20100409

Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of alpha2-adrenoceptors in normal and medial forebrain bundle lesioned rats.

Brain research 20100409

Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat.

Brain research bulletin 20100405

The role of dopamine in the prelimbic cortex and the dorsomedial striatum in instrumental conditioning.

Cerebral cortex (New York, N.Y. : 1991) 20100401

Acute L: -DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of parkinsonian rats.

Neurotoxicity research 20100401

In vivo but not in vitro leptin enhances lymphocyte proliferation in Siberian hamsters (Phodopus sungorus).

General and comparative endocrinology 20100401

Torpor and ultradian rhythms require an intact signalling of the sympathetic nervous system.

Cryobiology 20100401

Brain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson disease.

Neurochemical research 20100401

Protective effects of standardized Thuja orientalis leaves against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells.

Toxicology in vitro : an international journal published in association with BIBRA 20100401

Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models.

Aging cell 20100401

Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat.

Neurobiology of disease 20100401

6-hydroxydopamine lesions in the rat neostriatum impair sequential learning in a serial reaction time task.

Neurotoxicity research 20100401

Metallocorroles as cytoprotective agents against oxidative and nitrative stress in cellular models of neurodegeneration.

Journal of neurochemistry 20100401

Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.

Neurobiology of disease 20100401

Proteomic characterization of the striatum and midbrain treated with 6-hydroxydopamine: alteration of 58-kDa glucose-regulated protein and C/EBP homologous protein.

Free radical research 20100401

Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with microSPECT and quantitative MRI.

Magma (New York, N.Y.) 20100401

Novel CDNF/MANF family of neurotrophic factors.

Developmental neurobiology 20100401

Transplantation of retinoic acid treated murine embryonic stem cells & behavioural deficit in Parkinsonian rats.

The Indian journal of medical research 20100401

Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease.

Biochemical and biophysical research communications 20100319

Striatal 6-OHDA lesion in mice: Investigating early neurochemical changes underlying Parkinson's disease.

Behavioural brain research 20100317

Site-specific action of L-3,4-dihydroxyphenylalanine in the striatum but not globus pallidus and substantia nigra pars reticulata evokes dyskinetic movements in chronic L-3,4-dihydroxyphenylalanine-treated 6-hydroxydopamine-lesioned rats.

Neuroscience 20100317

Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.

Experimental cell research 20100310

The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson's disease.

Neuroreport 20100310

Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats.

Cell stem cell 20100305

Different striatal D2-like receptor function in an early stage after unilateral striatal lesion and medial forebrain bundle lesion in rats.

Brain research 20100304

Manganese neurotoxic time course is not influenced by L-deprenyl systemic treatment: influence of L-deprenyl in manganese neurotoxic time course.

Brain research 20100304

Positron emission tomography kinetic modeling algorithms for small animal dopaminergic system imaging.

Synapse (New York, N.Y.) 20100301

Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.

Synapse (New York, N.Y.) 20100301

Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 20100301

Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease.

Neuroscience research 20100301

A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.

Neuropharmacology 20100301

L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.

Journal of neurochemistry 20100301

Involvement of induction and mitochondrial targeting of orphan nuclear receptor Nur77 in 6-OHDA-induced SH-SY5Y cell death.

Neurochemistry international 20100301

Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent.

Cell research 20100301

Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.

Current neuropharmacology 20100301

Role of locus coeruleus noradrenergic neurons in cardiorespiratory and thermal control during hypoxia.

Respiratory physiology & neurobiology 20100227

In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease.

Brain research 20100226

High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20100210

6-hydroxydopamine lesions enhance progesterone-facilitated lordosis of rats and hamsters, independent of effects on motor behavior.

Physiology & behavior 20100209

The rotational model and microdialysis: Significance for dopamine signalling, clinical studies, and beyond.

Progress in neurobiology 20100209

Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate.

Brain research 20100202

Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat.

Brain research 20100202

Evaluation of the importance of astrocytes when screening for acute toxicity in neuronal cell systems.

Neurotoxicity research 20100201

Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.

Journal of neuroscience research 20100201

The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats.

Neuropharmacology 20100201

The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Synapse (New York, N.Y.) 20100201

VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease.

Neurobiology of disease 20100201

Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease.

Free radical biology & medicine 20100201

The role of nucleus accumbens dopamine in outcome encoding in instrumental and Pavlovian conditioning.

Neurobiology of learning and memory 20100201

Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat.

Experimental neurology 20100201

Regulation of matrix metalloproteinase-9 gene expression in MPP+- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells.

Neurochemistry international 20100201

Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats.

The European journal of neuroscience 20100201

The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease.

Brain : a journal of neurology 20100201

Neuroprotective effects of zonisamide target astrocyte.

Annals of neurology 20100201

A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine.

Neuroscience letters 20100129

Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.

Brain research 20100122

Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20100120

Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.

Brain research 20100115

Exercise exerts neuroprotective effects on Parkinson's disease model of rats.

Brain research 20100115

Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease.

Free radical biology & medicine 20100115

Cortical oscillations scan using chirp-evoked potentials in 6-hydroxydopamine rat model of Parkinson's disease.

Brain research 20100115

Activation of the NMDA receptor involved in the alleviating after-effect of repeated stimulation of the subthalamic nucleus on motor deficits in hemiparkinsonian rats.

Brain research 20100108

Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via Akt and ERK signaling pathways.

Journal of ethnopharmacology 20100108

The neuroprotective role of tissue inhibitor of metalloproteinase-2 in MPP+- or 6-OHDA-treated SK-N-BE(2)C and SH-SY5Y human neuroblastoma cells.

Neuroscience letters 20100104

Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition.

Neuroscience and biobehavioral reviews 20100101

Genome-wide microarray analysis of the differential neuroprotective effects of antioxidants in neuroblastoma cells overexpressing the familial Parkinson's disease alpha-synuclein A53T mutation.

Neurochemical research 20100101

AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease.

Gene therapy 20100101

Repeated restraint stress increases IgA concentration in rat small intestine.

Brain, behavior, and immunity 20100101

Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells.

Toxicology and applied pharmacology 20100101

Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells.

Neurochemistry international 20100101

D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.

Pharmacology, biochemistry, and behavior 20100101

Expression of tyrosine hydroxylase increases the resistance of human neuroblastoma cells to oxidative insults.

Toxicological sciences : an official journal of the Society of Toxicology 20100101

WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.

The Journal of pharmacology and experimental therapeutics 20100101

The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.

Journal of neurochemistry 20100101

Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.

Cell transplantation 20100101

L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation.

Neurochemistry international 20100101

Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.

Experimental neurology 20100101

Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20100101

Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.

BMC neuroscience 20100101

Murine model for Parkinson's disease: from 6-OH dopamine lesion to behavioral test.

Journal of visualized experiments : JoVE 20100101

Amphetamine administration into the ventral striatum facilitates behavioral interaction with unconditioned visual signals in rats.

PloS one 20100101

Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole.

BMC pharmacology 20100101

Food seeking in spite of harmful consequences is under prefrontal cortical noradrenergic control.

BMC neuroscience 20100101

Quantitative evaluation of motor function before and after engraftment of dopaminergic neurons in a rat model of Parkinson's disease.

Journal of biomedical science 20100101

Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.

PloS one 20100101

Cellular stress responses: cell survival and cell death.

International journal of cell biology 20100101

Angiogenic factors stimulate growth of adult neural stem cells.

PloS one 20100101

Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.

BMC medical genetics 20100101

Effects of Pharmacological Block of GABA(A) Receptors on Pallidal Neurons in Normal and Parkinsonian State.

Frontiers in cellular neuroscience 20100101

Effects of UVB-induced oxidative stress on protein expression and specific protein oxidation in normal human epithelial keratinocytes: a proteomic approach.

Proteome science 20100101

Dopamine neuron stimulating actions of a GDNF propeptide.

PloS one 20100101

In utero exposure to a low concentration of diesel exhaust affects spontaneous locomotor activity and monoaminergic system in male mice.

Particle and fibre toxicology 20100101

Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells.

BMC neuroscience 20100101

Cell stress and cell death.

International journal of cell biology 20100101

Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study.

Chronobiology international 20100101

Lactotroph functional activity in hypothalamic dopaminergic system insufficiency.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20100101

Alterations in ZENK and glucagon RNA transcript expression during increased ocular growth in chickens.

Molecular vision 20100101

Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons.

Biochimica et biophysica acta 20100101

Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.

BMC neuroscience 20100101

Ropinirole in restless legs syndrome and periodic limb movement disorder.

Therapeutics and clinical risk management 20100101

GABAergic control of neurite outgrowth and remodeling during development and adult neurogenesis: general rules and differences in diverse systems.

Frontiers in cellular neuroscience 20100101

A translational approach to vocalization deficits and neural recovery after behavioral treatment in Parkinson disease.

Journal of communication disorders 20100101

Mitochondrial dysfunction in Parkinson's disease.

Journal of Alzheimer's disease : JAD 20100101

Animal models of neurological disease.

Advances in experimental medicine and biology 20100101

Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson's disease models.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20100101

Spirulina promotes stem cell genesis and protects against LPS induced declines in neural stem cell proliferation.

PloS one 20100101

Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats.

Pharmacological reports : PR 20100101

Evaluation of toxicological and antioxidant potential of Nardostachys jatamansi in reversing haloperidol-induced catalepsy in rats.

International journal of general medicine 20100101

GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neurons.

BMC neuroscience 20100101

The impact of dietary energy intake on cognitive aging.

Frontiers in aging neuroscience 20100101

Selective neuronal vulnerability to oxidative stress in the brain.

Frontiers in aging neuroscience 20100101

Different corticostriatal integration in spiny projection neurons from direct and indirect pathways.

Frontiers in systems neuroscience 20100101

Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide.

Redox report : communications in free radical research 20100101

6-hydroxydopamine-mediated release of norepinephrine increases faecal excretion of Salmonella enterica serovar Typhimurium in pigs.

Veterinary research 20100101

Prior treatment (priming) with caffeine sensitizes D2-dopamine-mediated contralateral rotational behavior in 6-hydroxydopamine-lesioned rats.

Pharmacology 20100101

Adult zebrafish as a model organism for behavioural genetics.

BMC neuroscience 20100101

Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord.

PloS one 20100101

Automated quantitative gait analysis in animal models of movement disorders.

BMC neuroscience 20100101

Effects of GPi and STN inactivation on physiological, motor, cognitive and motivational processes in animal models of Parkinson's disease.

Progress in brain research 20100101

Evidence of D-phenylglycine as delivering tool for improving L-dopa absorption.

Journal of biomedical science 20100101

Protective role of taurine against arsenic-induced mitochondria-dependent hepatic apoptosis via the inhibition of PKCdelta-JNK pathway.

PloS one 20100101

Mitochondrial preconditioning: a potential neuroprotective strategy.

Frontiers in aging neuroscience 20100101

From the bench to the bedside: Emerging science in Parkinson's disease, cholesterol metabolism, and neuroprotection.

Surgical neurology international 20100101

Levodopa in the treatment of Parkinson's disease: an old drug still going strong.

Clinical interventions in aging 20100101

Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity.

PloS one 20100101

Neurotoxic in vivo models of Parkinson's disease recent advances.

Progress in brain research 20100101

Behavioral analysis of motor and non-motor symptoms in rodent models of Parkinson's disease.

Progress in brain research 20100101

Modeling neuroinflammatory pathogenesis of Parkinson's disease.

Progress in brain research 20100101

Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease.

Frontiers in aging neuroscience 20100101

Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.

Frontiers in neuroanatomy 20100101

Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease.

Parkinson's disease 20100101

What is the Degree of Segregation between Striatonigral and Striatopallidal Projections?

Frontiers in neuroanatomy 20100101

Electrophysiological effects of SKF83959 on hippocampal CA1 pyramidal neurons: potential mechanisms for the drug's neuroprotective effects.

PloS one 20100101

Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate.

PloS one 20100101

Effects of SR141716A on Cognitive and Depression-Related Behavior in an Animal Model of Premotor Parkinson's Disease.

Parkinson's disease 20100101

Subtle cardiovascular dysfunction in the unilateral 6-hydroxydopamine-lesioned rat.

Parkinson's disease 20100101

Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease.

Molecular neurodegeneration 20100101

Forebrain ischemia triggers GABAergic system degeneration in substantia nigra at chronic stages in rats.

Cardiovascular psychiatry and neurology 20100101

Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan.

BMC neurology 20100101

Protein aggregation containing β-amyloid, α-synuclein and hyperphosphorylated τ in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure.

BMC neuroscience 20100101

Static magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385.

PloS one 20100101

Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Frontiers in neuroanatomy 20100101

Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.

PloS one 20100101

Catechol-O-methyltransferase inhibitors in preclinical models as adjuncts of L-dopa treatment.

International review of neurobiology 20100101

Extrastriatal dopaminergic circuits of the Basal Ganglia.

Frontiers in neuroanatomy 20100101

Neurotransplantation of stem cells genetically modified to express human dopamine transporter reduces alcohol consumption.

Stem cell research & therapy 20100101

Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys.

PloS one 20100101

Stem cells for the treatment of neurodegenerative diseases.

Stem cell research & therapy 20100101

Histone H3 Acetylation is Asymmetrically Induced Upon Learning in Identified Neurons of the Food Aversion Network in the Mollusk Helix Lucorum.

Frontiers in behavioral neuroscience 20100101

Role of Basal Ganglia in sleep-wake regulation: neural circuitry and clinical significance.

Frontiers in neuroanatomy 20100101

Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson's disease.

International journal of molecular sciences 20100101

The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review.

International journal of inflammation 20100101

The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.

International journal of molecular sciences 20100101

Acetaminophen induces apoptosis in rat cortical neurons.

PloS one 20100101

Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.

PloS one 20100101

The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.

PloS one 20100101

Striatal spine plasticity in Parkinson's disease.

Frontiers in neuroanatomy 20100101

The effect of chemical sympathectomy and stress on bone remodeling in adult rats.

Neuro endocrinology letters 20100101

Modulation of excessive neuronal activity by fibroblasts: potential use in treatment of Parkinson's disease.

Restorative neurology and neuroscience 20100101

Heterogeneity and diversity of striatal GABAergic interneurons.

Frontiers in neuroanatomy 20100101

Effects of low doses of intracerebroventricular 6-OHDA on the levels of monoaminergic neurotransmitters in rat brain structures.

Pharmacological reports : PR 20100101

Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.

Oxidative medicine and cellular longevity 20100101

Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.

International journal of tryptophan research : IJTR 20100101

Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT(1A) recaptors.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

About a snail, a toad, and rodents: animal models for adaptation research.

Frontiers in endocrinology 20100101

Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease.

Neuroscience letters 20091231

Application of Fluoro-Jade C in acute and chronic neurodegeneration models: utilities and staining differences.

Acta histochemica et cytochemica 20091229

The dual dopamine-glutamate phenotype of growing mesencephalic neurons regresses in mature rat brain.

The Journal of comparative neurology 20091220

Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection.

Brain research bulletin 20091216

Necdin and TrkA contribute to modulation by p75NTR of resistance to oxidant stress.

Experimental cell research 20091210

Effect of intranigral injection of GDNF and EGF on the survival and possible differentiation fate of progenitors and immature neurons in 6-OHDA-lesioned rats.

Neurochemical research 20091201

Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus.

Neuroscience 20091201

Dopamine D(2)-class receptor supersensitivity as reflected in Ca2+ current modulation in neostriatal neurons.

Neuroscience 20091201

The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway.

Neuroscience 20091201

C-terminal mechano growth factor protects dopamine neurons: a novel peptide that induces heme oxygenase-1.

Experimental neurology 20091201

The sympathetic nervous system modulates CD4(+)FoxP3(+) regulatory T cells via a TGF-beta-dependent mechanism.

Journal of leukocyte biology 20091201

Perisurgical amitriptyline produces a preventive effect on afferent hypersensitivity following spared nerve injury.

Pain 20091201

Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line.

Journal of neurochemistry 20091201

Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: relationship to invasive insulitis.

Diabetologia 20091201

Effect of exercise on dopamine neuron survival in prenatally stressed rats.

Metabolic brain disease 20091201

Biochemical alteration in cerebrospinal fluid precedes behavioral deficits in Parkinsonian rats induced by 6-hydroxydopamine.

Surgical neurology 20091201

Editorial: regulation of the regulator: sympathetic nervous system control of regulatory T cells.

Journal of leukocyte biology 20091201

Iron transport in Parkinson's disease.

Parkinsonism & related disorders 20091201

Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency.

Parkinsonism & related disorders 20091201

Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Current neuropharmacology 20091201

Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.

Journal of ethnopharmacology 20091112

Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.

Neuroscience 20091110

The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease.

Behavioural brain research 20091105

Cruciferous nutraceutical 3H-1,2-dithiole-3-thione protects human primary astrocytes against neurocytotoxicity elicited by MPTP, MPP(+), 6-OHDA, HNE and acrolein.

Neurochemical research 20091101

Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.

Neurochemistry international 20091101

Ascorbic acid and tetrahydrobiopterin potentiate the EDHF phenomenon by generating hydrogen peroxide.

Cardiovascular research 20091101

Reward-seeking and discrimination deficits displayed by hypodopaminergic mice are prevented in mice lacking dopamine D4 receptors.

Synapse (New York, N.Y.) 20091101

Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20091101

Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism.

Experimental neurology 20091101

Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents.

Journal of pineal research 20091101

Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing 'deprivation-amplification relapse therapy' (DART).

Postgraduate medicine 20091101

Oxidative neurodegeneration is prevented by UCP0045037, an allosteric modulator for the reduced form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.

International journal of molecular sciences 20091101

Effect of neuroleptic haloperidol, L-DOPA precursor dopamine, and neurotoxic dopamine analog 6-OHDA on acquisition of conditioned defensive reflex in edible snail.

Bulletin of experimental biology and medicine 20091101

Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats.

Neuroscience letters 20091025

Therapeutic effect of human amniotic epithelial cell transplantation into the lateral ventricle of hemiparkinsonian rats.

Chinese medical journal 20091020

Oxidative status of DJ-1-dependent activation of dopamine synthesis through interaction of tyrosine hydroxylase and 4-dihydroxy-L-phenylalanine (L-DOPA) decarboxylase with DJ-1.

The Journal of biological chemistry 20091016

In vivo multimodal imaging of stem cell transplantation in a rodent model of Parkinson's disease.

Journal of neuroscience methods 20091015

TRK-820, a selective kappa opioid receptor agonist, could effectively ameliorate L-DOPA-induced dyskinesia symptoms in a rat model of Parkinson's disease.

European journal of pharmacology 20091012

Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease.

Stem cells and development 20091001

Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness.

The international journal of neuropsychopharmacology 20091001

Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons.

Experimental neurology 20091001

Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies.

Neurobiology of disease 20091001

Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model.

Experimental neurology 20091001

Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats.

Psychopharmacology 20091001

Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.

The journal of gene medicine 20091001

The role of the neural sympathetic and parasympathetic systems in diurnal and sleep state-related cardiovascular rhythms in the late-gestation ovine fetus.

American journal of physiology. Regulatory, integrative and comparative physiology 20091001

Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats.

Journal of neurochemistry 20091001

Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway.

British journal of pharmacology 20091001

Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances.

Journal of neural transmission (Vienna, Austria : 1996) 20091001

Interaction between renin-angiotensin and sympathetic nervous systems in a rat model of pressure overload cardiac hypertrophy.

Autonomic & autacoid pharmacology 20091001

Effects of chemical sympathectomy on contralateral testicular histology and fertility in unilateral vasectomy.

Journal of Korean medical science 20091001

Kinetics of microglial activation and degeneration of dopamine-containing neurons in a rat model of Parkinson disease induced by 6-hydroxydopamine.

Journal of neuropathology and experimental neurology 20091001

Marked behavioral activation from inhibitory stimulation of locus coeruleus alpha1-adrenoceptors by a full agonist.

Brain research 20090929

Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia.

Neuroreport 20090923

The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson's disease.

Neuroscience 20090915

Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.

Biological psychiatry 20090915

Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study.

Biological psychiatry 20090915

Co-administration of the partial dopamine D2 agonist terguride with L-dopa attenuates L-dopa-induced locomotor sensitization in hemiparkinsonian mice.

Behavioural brain research 20090914

Bilateral high frequency stimulation of the subthalamic nucleus normalizes COX activity in the substantia nigra of Parkinsonian rats.

Brain research 20090908

Modified Wendan Decoction can Attenuate Neurotoxic Action Associated with Alzheimer's Disease.

Evidence-based complementary and alternative medicine : eCAM 20090901

Response of neural precursor cells in the brain of Parkinson's disease mouse model after LIF administration.

Neurological research 20090901

Rosmarinic acid inhibits 6-OHDA-induced neurotoxicity by anti-oxidation in MES23.5 cells.

Journal of molecular neuroscience : MN 20090901

Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.

Experimental neurology 20090901

In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease.

Experimental neurology 20090901

Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model.

Experimental neurology 20090901

Facing the lack of anti-phase oscillation in the parafascicular nucleus after dopamine depletion.

Experimental neurology 20090901

D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.

Neurobiology of disease 20090901

Generation of dopamine neurons with improved cell survival and phenotype maintenance using a degradation-resistant nurr1 mutant.

Stem cells (Dayton, Ohio) 20090901

Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles.

The journal of gene medicine 20090901

The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide.

Journal of neurochemistry 20090901

The electrocorticogram signal can be modulated with deep brain stimulation of the subthalamic nucleus in the hemiparkinsonian rat.

Journal of neurophysiology 20090901

Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling.

The FEBS journal 20090901

Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats.

The European journal of neuroscience 20090901

Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.

Brain research 20090825

Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease.

Brain research 20090825

[Dual effects of different concentrations of alpha-synuclein on the neurotoxicity of 6-hydroxydopamine in SH-SY5Y cells].

Sheng li xue bao : [Acta physiologica Sinica] 20090825

Effect of nigrostriatal damage induced by 6-hydroxydopamine on the expression of glial cell line-derived neurotrophic factor in the striatum of the rat.

Neuroscience 20090804

Deep brain stimulation of the posterior hypothalamic nucleus reverses akinesia in bilaterally 6-hydroxydopamine-lesioned rats.

Neuroscience 20090804

Effects of intranasally applied dopamine on behavioral asymmetries in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal tract.

Neuroscience 20090804

Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.

Neurobiology of disease 20090801

Comparative effects of acute or chronic administration of levodopa to 6-OHDA-lesioned rats on the expression and phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in the striatum.

Neurochemical research 20090801

NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.

Journal of neuroscience research 20090801

Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract.

NMR in biomedicine 20090801

Acute effects of morphine on distinct forms of impulsive behavior in rats.

Psychopharmacology 20090801

Not lost in translation Sensing the loss and filling the gap during regeneration.

Seminars in cell & developmental biology 20090801

Effects of dopamine depletion on network entropy in the external globus pallidus.

Journal of neurophysiology 20090801

Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.

Journal of neurochemistry 20090801

Rottlerin protected dopaminergic cell line from cytotoxicity of 6-hydroxydopamine by inhibiting PKCdelta phosphorylation.

Neuroscience bulletin 20090801

Dual-isotope single-photon emission computed tomography for dopamine and serotonin transporters in normal and Parkinsonian monkey brains.

Nuclear medicine and biology 20090801

Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain.

The European journal of neuroscience 20090801

Persistent short-term memory defects following sleep deprivation in a drosophila model of Parkinson disease.

Sleep 20090801

[The neuroprotective effects of lesion and high frequency stimulation of the subthalamic nucleus on the substantia nigra neurons].

Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20090801

Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by l-carnosine in SH-SY5Y cells.

Neuroscience letters 20090731

Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20090729

Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.

Neuroscience letters 20090717

Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells.

Biochemical pharmacology 20090715

Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum.

Neurochemical research 20090701

Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.

Journal of neuroscience research 20090701

Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model.

Journal of neuroscience research 20090701

The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.

Psychopharmacology 20090701

The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.

Synapse (New York, N.Y.) 20090701

Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression.

The Journal of pharmacology and experimental therapeutics 20090701

Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling.

The Journal of pharmacology and experimental therapeutics 20090701

Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.

Neurobiology of disease 20090701

Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats.

The Journal of comparative neurology 20090701

Transplantation of subventricular zone neural precursors induces an endogenous precursor cell response in a rat model of Parkinson's disease.

The Journal of comparative neurology 20090701

Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2.

Journal of neurochemistry 20090701

Noradrenergic modulation of the motor response induced by long-term levodopa administration in Parkinsonian rats.

Journal of neural transmission (Vienna, Austria : 1996) 20090701

Investigation of neuroprotective effects of cyclooxygenase inhibitors in the 6-hydroxydopamine induced rat Parkinson model.

Turkish neurosurgery 20090701

Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.

Brain research bulletin 20090630

Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.

Brain research 20090618

Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats.

Brain research 20090618

Optical imaging of rat prefrontal neuronal activity evoked by stimulation of the ventral tegmental area.

Neuroreport 20090617

Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20090617

Amphetamine-evoked rotation requires newly synthesized dopamine at 14 days but not 1 day after intranigral 6-OHDA and is consistently dissociated from sensorimotor behavior.

Behavioural brain research 20090608

Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum.

Neuroscience 20090602

Neuroprotective effects of chalcones from Myracrodruon urundeuva on 6-hydroxydopamine-induced cytotoxicity in rat mesencephalic cells.

Neurochemical research 20090601

Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats.

Psychopharmacology 20090601

The role of noradrenaline and 5-hydroxytryptamine in yohimbine-induced increases in alcohol-seeking in rats.

Psychopharmacology 20090601

Parafascicular thalamic nucleus activity in a rat model of Parkinson's disease.

Experimental neurology 20090601

Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review.

CNS neuroscience & therapeutics 20090601

Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro.

Pharmacology, biochemistry, and behavior 20090601

Changes to interneuron-driven striatal microcircuits in a rat model of Parkinson's disease.

Neurobiology of disease 20090601

Estrogen promotes sympathetic nerve regeneration in rat proximal urethra.

Urology 20090601

Involvement of P2Y receptors in pyridoxal-5'-phosphate-induced cardiac preconditioning.

Fundamental & clinical pharmacology 20090601

Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.

Journal of neurochemistry 20090601

Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways.

Journal of neurochemistry 20090601

Scoliosis in patients with Parkinson's disease.

Journal of clinical neurology (Seoul, Korea) 20090601

Neural cell protective compounds isolated from Phoenix hanceana var. formosana.

Phytochemistry 20090601

Adenosine and adenosine receptors: Newer therapeutic perspective.

Indian journal of pharmacology 20090601

Neurogenesis in Neurotoxin-induced Animal Models for Parkinson's Disease-A Review of the Current Status.

Journal of toxicologic pathology 20090601

Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum.

Neuroreport 20090527

Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20090527

A role for medial prefrontal dopaminergic innervation in instrumental conditioning.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20090520

Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.

Brain research 20090519

Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats.

Behavioural brain research 20090516

Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats.

Journal of neuroscience research 20090515

Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures.

Journal of neuroscience research 20090515

Near complete rescue of experimental Parkinson's disease with intravenous, non-viral GDNF gene therapy.

Pharmaceutical research 20090501

Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease.

Molecular & cellular proteomics : MCP 20090501

Mobilization of neural stem cells and generation of new neurons in 6-OHDA-lesioned rats by intracerebroventricular infusion of liver growth factor.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20090501

Synchronisation in the beta frequency-band--the bad boy of parkinsonism or an innocent bystander?

Experimental neurology 20090501

De novo and long-term l-Dopa induce both common and distinct striatal gene profiles in the hemiparkinsonian rat.

Neurobiology of disease 20090501

Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease.

Journal of neurochemistry 20090501

Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.

Journal of neurochemistry 20090501

Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats.

Neurotoxicity research 20090501

Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease.

Journal of neurochemistry 20090501

Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration.

Neurotoxicology 20090501

Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.

Brain, behavior, and immunity 20090501

Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment.

Journal of neurochemistry 20090501

Mitochondria and energetic depression in cell pathophysiology.

International journal of molecular sciences 20090501

Basolateral amygdala D1- and D2-dopaminergic system promotes the formation of long-term potentiation in the dentate gyrus of anesthetized rats.

Progress in neuro-psychopharmacology & biological psychiatry 20090430

Extracellular dopamine and norepinephrine in the developing rat prefrontal cortex: transient effects of early partial loss of dopamine.

Brain research bulletin 20090429

Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20090415

Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine.

Brain research 20090406

Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.

Neuroscience letters 20090403

Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.

The Journal of pharmacology and experimental therapeutics 20090401

Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study.

Journal of neurochemistry 20090401

Dopamine depletion induced up-regulation of HCN3 enhances rebound excitability of basal ganglia output neurons.

Neurobiology of disease 20090401

Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats.

Behavioral neuroscience 20090401

[Pharmacologic treatment of Parkinson disease].

Brain and nerve = Shinkei kenkyu no shinpo 20090401

Histaminergic activity in a rodent model of Parkinson's disease.

Neurotoxicity research 20090401

Comparing the role of the anterior cingulate cortex and 6-hydroxydopamine nucleus accumbens lesions on operant effort-based decision making.

The European journal of neuroscience 20090401

Quantitative autoradiographic study on receptor regulation in the basal ganglia in rat model of levodopa-induced motor complications.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20090401

Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: necessity of immunosuppressive treatment for sustained improvement.

Neurological research 20090401

[Study on the mechanism of electroacupuncture scalp point penetration therapy in action on apoptosis in the Parkinson's disease rat model].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20090401

Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease.

Neuroscience 20090331

Spinal cord stimulation restores locomotion in animal models of Parkinson's disease.

Science (New York, N.Y.) 20090320

Modeling operant behavior in the Parkinsonian rat.

Behavioural brain research 20090317

Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.

Neuroscience 20090317

Descending pathways from activated locus coeruleus/subcoeruleus following unilateral hindpaw inflammation in the rat.

Brain research bulletin 20090316

Genetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA model.

Brain research bulletin 20090316

Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia.

Biological psychiatry 20090315

The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease.

Journal of neuroscience methods 20090315

PET imaging in rats to discern temporal onset differences between 6-hydroxydopamine and tau gene vector neurodegeneration models.

Brain research 20090309

Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.

Neuroscience 20090303

Asymmetrical response of aminopeptidase A and nitric oxide in plasma of normotensive and hypertensive rats with experimental hemiparkinsonism.

Neuropharmacology 20090301

Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons.

Neuropharmacology 20090301

Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity.

Neurobiology of disease 20090301

Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats.

Neuropharmacology 20090301

Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.

Biological & pharmaceutical bulletin 20090301

Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.

International journal of molecular sciences 20090301

Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy.

Journal of clinical neurology (Seoul, Korea) 20090301

Targeting the progression of Parkinson's disease.

Current neuropharmacology 20090301

Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.

Brain research 20090227

Dopamine-dependent periadolescent maturation of corticostriatal functional connectivity in mouse.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20090225

Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy.

Proceedings of the National Academy of Sciences of the United States of America 20090224

Subthalamic neurons show increased firing to 5-HT2C receptor activation in 6-hydroxydopamine-lesioned rats.

Brain research 20090223

Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction.

Neuroscience 20090218

L-dopa-induced desensitization depends on 5-hydroxytryptamine imbalance in hemiparkinsonian rats.

Neuroreport 20090218

Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease.

Brain research bulletin 20090216

Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.

Brain research bulletin 20090216

Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.

Brain research bulletin 20090216

1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.

Journal of neuroscience research 20090215

The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF(1) receptors.

European journal of pharmacology 20090214

Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism.

Brain research 20090213

Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis.

Brain research 20090213

6-Hydroxydopamine lesion in thalamic reticular nucleus reduces anxiety behaviour in the rat.

Behavioural brain research 20090211

Natural and lesion-induced apoptosis in the rat striatum during development.

Brain research 20090203

Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090201

DJ-1 protects against dopamine toxicity.

Journal of neural transmission (Vienna, Austria : 1996) 20090201

Differences in the injury/sprouting response of splenic noradrenergic nerves in Lewis rats with adjuvant-induced arthritis compared with rats treated with 6-hydroxydopamine.

Brain, behavior, and immunity 20090201

Central or peripheral norepinephrine depletion enhances MK-801-induced plasma corticosterone level in mice.

Progress in neuro-psychopharmacology & biological psychiatry 20090201

Subthalamic nucleus stimulation and lesioning have distinct state-dependent effects upon striatal dopamine metabolism.

Synapse (New York, N.Y.) 20090201

Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.

Brain : a journal of neurology 20090201

A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA-induced motor deficit in rats.

British journal of pharmacology 20090201

L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice.

Journal of neurochemistry 20090201

Firing activity of locus coeruleus noradrenergic neurons increases in a rodent model of Parkinsonism.

Neuroscience bulletin 20090201

6-OHDA induces cycle reentry and apoptosis of PC12 cells through activation of ERK1/2 signaling pathway.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20090201

Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study .

Annals of the New York Academy of Sciences 20090201

Modulation of behavior by expected reward magnitude depends on dopamine in the dorsomedial striatum.

Neurotoxicity research 20090201

Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease.

Neurotoxicity research 20090201

[Research progress on pharmacological activities of echinacoside].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20090201

Oral creatine supplementation attenuates L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats.

Behavioural brain research 20090130

Inhibitory effect of dimethylthiourea on rat urinary bladder inflammation produced by 6-hydroxydopamine application.

Autonomic neuroscience : basic & clinical 20090128

Effects of calpain inhibition on dopaminergic markers and motor function following intrastriatal 6-hydroxydopamine administration in rats.

Neuroscience 20090123

Both pre- and post-lesion experiential therapy is beneficial in 6-hydroxydopamine dopamine-depleted female rats.

Neuroscience 20090123

Retrograde adenoviral vector targeting of nociresponsive pontospinal noradrenergic neurons in the rat in vivo.

The Journal of comparative neurology 20090110

Oxidative and inflammatory pathways in Parkinson's disease.

Neurochemical research 20090101

Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model.

Phytotherapy research : PTR 20090101

The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat.

Psychopharmacology 20090101

Human embryonic stem cell differentiation toward regional specific neural precursors.

Stem cells (Dayton, Ohio) 20090101

The neuroprotective effect of dental pulp cells in models of Alzheimer's and Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996) 20090101

Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.

Neurochemistry international 20090101

Low frequency stimulation of the pedunculopontine nucleus modulates electrical activity of subthalamic neurons in the rat.

Journal of neural transmission (Vienna, Austria : 1996) 20090101

Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.

Neurotoxicology 20090101

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

BMC medical genomics 20090101

Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration.

BMC neuroscience 20090101

Evolution of neurotoxins: from research modalities to clinical realities.

Current protocols in neuroscience 20090101

Electrophysiological effects of neurotensin on globus pallidus neurons of 6-hydroxydopamine-lesioned rats.

Neuro-Signals 20090101

(-)-Epigallocatechin-3-Gallate protects SH-SY5Y cells against 6-OHDA-induced cell death through STAT3 activation.

Journal of Alzheimer's disease : JAD 20090101

Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains.

Molecular neurodegeneration 20090101

Elevated P75NTR expression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression.

Neural development 20090101

Acetaminophen inhibits neuronal inflammation and protects neurons from oxidative stress.

Journal of neuroinflammation 20090101

All-you-can-eat: autophagy in neurodegeneration and neuroprotection.

Molecular neurodegeneration 20090101

Supplementary health benefits of soy aglycons of isoflavone by improvement of serum biochemical attributes, enhancement of liver antioxidative capacities and protection of vaginal epithelium of ovariectomized rats.

Nutrition & metabolism 20090101

[Synthesis of monoamines by non-monoaminergic neurons: illusion or reality?].

Journal de la Societe de biologie 20090101

Astaxanthin protects neuronal cells against oxidative damage and is a potent candidate for brain food.

Forum of nutrition 20090101

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interaction with 3' ends of Japanese encephalitis virus RNA and colocalization with the viral NS5 protein.

Journal of biomedical science 20090101

Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.

Neuropharmacology 20090101

The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons.

Neurotoxicity research 20090101

Nonenzymatic role of acetylcholinesterase in neuritic sprouting: regional changes in acetylcholinesterase and choline acetyltransferase after neonatal 6-hydroxydopamine lesions.

Neurotoxicology and teratology 20090101

The posttraumatic stress disorder project in Brazil: neuropsychological, structural and molecular neuroimaging studies in victims of urban violence.

BMC psychiatry 20090101

Identification and characterization of inhibitors of human apurinic/apyrimidinic endonuclease APE1.

PloS one 20090101

Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.

PloS one 20090101

Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients.

Molecular neurodegeneration 20090101

Microtransplantation of dopaminergic cell suspensions: further characterization and optimization of grafting parameters.

Cell transplantation 20090101

Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle.

Molecular neurodegeneration 20090101

Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease.

Journal of neuroinflammation 20090101

Arylbenzazepines are potent modulators for the delayed rectifier K+ channel: a potential mechanism for their neuroprotective effects.

PloS one 20090101

Restless legs syndrome: differential diagnosis and management with rotigotine.

Neuropsychiatric disease and treatment 20090101

Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease.

Journal of translational medicine 20090101

Involvement of Basal Ganglia network in motor disabilities induced by typical antipsychotics.

PloS one 20090101

Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them.

PloS one 20090101

Effect of prenatal manganese intoxication on [(3)H]glucose uptake in the brain of rats lesioned as neonates with 6-hydroxydopamine.

Pharmacological reports : PR 20090101

Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice.

Journal of neuroinflammation 20090101

Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10.

BMC neuroscience 20090101

Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons.

Cell transplantation 20090101

Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task.

Journal of biomedical science 20090101

rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex.

PloS one 20090101

Organotypic cultures as a model of Parkinson s disease. A twist to an old model.

TheScientificWorldJournal 20090101

Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells.

Biologics : targets & therapy 20090101

Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease.

BMC neuroscience 20090101

Homeostatic plasticity of striatal neurons intrinsic excitability following dopamine depletion.

PloS one 20090101

Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons.

PloS one 20090101

Resveratrol inhibits prostaglandin formation in IL-1beta-stimulated SK-N-SH neuronal cells.

Journal of neuroinflammation 20090101

Sympathetic nervous system overactivity in the Wistar rat with proliferative lesions of ventral prostate induced by chronic stress.

Urologia internationalis 20090101

Dopamine in motor cortex is necessary for skill learning and synaptic plasticity.

PloS one 20090101

Novel mitochondrial substrates of omi indicate a new regulatory role in neurodegenerative disorders.

PloS one 20090101

Slowly progressive dopamine cell loss--a model on which to test neuroprotective strategies for Parkinson's disease?

Reviews in the neurosciences 20090101

Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.

Cell transplantation 20090101

Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration.

PloS one 20090101

Dopamine, behavioral economics, and effort.

Frontiers in behavioral neuroscience 20090101

[Oxidative stress in the cardiovascular system of rats with chronic deficiency of cerebral dopamine].

Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20090101

Analysis of knockout mice suggests a role for VGF in the control of fat storage and energy expenditure.

BMC physiology 20090101

Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum.

PloS one 20090101

Does neuroinflammation fan the flame in neurodegenerative diseases?

Molecular neurodegeneration 20090101

Dissociable effects of dopamine on neuronal firing rate and synchrony in the dorsal striatum.

Frontiers in integrative neuroscience 20090101

Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease.

BMC neuroscience 20090101

Capturing dopaminergic modulation and bimodal membrane behaviour of striatal medium spiny neurons in accurate, reduced models.

Frontiers in computational neuroscience 20090101

Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation.

PloS one 20090101

Dopamine receptor loss of function is not protective of rd1 rod photoreceptors in vivo.

Molecular vision 20090101

Effects of chronic low dose rotenone treatment on human microglial cells.

Molecular neurodegeneration 20090101

Erythropoietin: a multimodal neuroprotective agent.

Experimental & translational stroke medicine 20090101

The neurobiology of the substantia nigra pars compacta: from motor to sleep regulation.

Journal of neural transmission. Supplementum 20090101

Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.

Journal of neural transmission. Supplementum 20090101

In vivo microdialysis in Parkinson's research.

Journal of neural transmission. Supplementum 20090101

Intake of tomato-enriched diet protects from 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons.

Journal of neural transmission. Supplementum 20090101

Neurokinin-1 receptor activation in globus pallidus.

Frontiers in neuroscience 20090101

Role of tyrosine phosphorylation in the antioxidant effects of the p75 neurotrophin receptor.

Oxidative medicine and cellular longevity 20090101

New strategies for Alzheimer's disease and cognitive impairment.

Oxidative medicine and cellular longevity 20090101

RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20081231

Parkinsonian beta oscillations in the external globus pallidus and their relationship with subthalamic nucleus activity.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20081224

Instability of superoxide dismutase 1 of Drosophila in mutants deficient for its cognate copper chaperone.

The Journal of biological chemistry 20081219

Preventive effects of genistein on motor dysfunction following 6-hydroxydopamine injection in ovariectomized rats.

Neuroscience letters 20081219

Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes).

Brain research 20081215

Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.

European journal of pharmacology 20081214

The firing activity of presumed cholinergic and non-cholinergic neurons of the pedunculopontine nucleus in 6-hydroxydopamine-lesioned rats: an in vivo electrophysiological study.

Brain research 20081203

Adenosine A(2A) receptors in Parkinson's disease treatment.

Purinergic signalling 20081201

Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism.

Behavioural brain research 20081201

Imaging serotonin transporters using [123I]ADAM SPECT in a parkinsonian primate model.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20081201

Lrrk2 and alpha-synuclein are co-regulated in rodent striatum.

Molecular and cellular neurosciences 20081201

Differential expression of Fos and Zif268 in the nigrostriatal system after methamphetamine administration in a rat model of Parkinson's disease.

Synapse (New York, N.Y.) 20081201

Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.

Neuropharmacology 20081201

Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease.

Neuroscience research 20081201

Time course changes of the striatum neuropil after unilateral dopamine depletion and the usefulness of the contralateral striatum as a control structure.

Neurological research 20081201

Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats.

The Journal of comparative neurology 20081201

Involvement of dopamine D2 receptors in the induction of long-term potentiation in the basolateral amygdala-dentate gyrus pathway of anesthetized rats.

Neuropharmacology 20081201

Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.

Brain : a journal of neurology 20081201

Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.

Brain : a journal of neurology 20081201

Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.

Journal of neurochemistry 20081201

The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA.

Journal of neurochemistry 20081201

JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration.

Journal of neurochemistry 20081201

Covalent arylation of metallothionein by oxidized dopamine products: a possible mechanism for zinc-mediated enhancement of dopaminergic neuron survival.

Neurotoxicity research 20081201

Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats: new insights into the role of delta receptors in parkinsonism.

Journal of neurochemistry 20081201

Future of cell and gene therapies for Parkinson's disease.

Annals of neurology 20081201

Frequency-dependent signal transmission and modulation by neuromodulators.

Frontiers in neuroscience 20081201

Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.

Current neuropharmacology 20081201

Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate.

Current neuropharmacology 20081201

Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat.

Brain research bulletin 20081125

Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20081119

Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

Brain research 20081113

The neuronal activity of thalamic parafascicular nucleus is conversely regulated by nigrostriatal pathway and pedunculopontine nucleus in the rat.

Brain research 20081113

Changes in apical dendritic structure correlate with sustained ERK1/2 phosphorylation in medial prefrontal cortex of a rat model of dopamine D1 receptor agonist sensitization.

The Journal of comparative neurology 20081110

Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.

Behavioural brain research 20081103

Dopamine as a potent inducer of cellular glutathione and NAD(P)H:quinone oxidoreductase 1 in PC12 neuronal cells: a potential adaptive mechanism for dopaminergic neuroprotection.

Neurochemical research 20081101

Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology.

Toxicological sciences : an official journal of the Society of Toxicology 20081101

Maternal separation exaggerates the toxic effects of 6-hydroxydopamine in rats: implications for neurodegenerative disorders.

Stress (Amsterdam, Netherlands) 20081101

The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors.

Neurobiology of disease 20081101

Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.

Neurobiology of disease 20081101

Apomorphine-induced differences in cortical and striatal EEG and their glutamatergic mediation in 6-hydroxydopamine-treated rats.

Experimental brain research 20081101

The rat heart contains a neural stem cell population; role in sympathetic sprouting and angiogenesis.

Journal of molecular and cellular cardiology 20081101

Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease.

Neuroscience research 20081101

Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's disease.

Clinical and experimental pharmacology & physiology 20081101

Rho-associated kinase inhibitor Y-27632 promotes survival of cynomolgus monkey embryonic stem cells.

Molecular human reproduction 20081101

Effects of neostriatal 6-OHDA lesion on performance in a rat sequential reaction time task.

Neuroscience letters 20081031

Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia.

Brain research 20081031

Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats.

Neuroreport 20081029

Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.

Neuroscience 20081028

Intermittent L-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats.

Brain research 20081021

Neurotrophin-3 reduces apoptosis induced by 6-OHDA in PC12 cells through Akt signaling pathway.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20081001

Generation of dopamine neurons from embryonic stem cells in the presence of the neuralizing activity of bone marrow stromal cells derived from adult mice.

Journal of neuroscience research 20081001

6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat.

Neuropharmacology 20081001

Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease.

Experimental neurology 20081001

Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 20081001

Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.

Journal of neurochemistry 20081001

Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.

Free radical biology & medicine 20081001

Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements.

Journal of neural transmission (Vienna, Austria : 1996) 20081001

Pleiotrophin receptor RPTP-zeta/beta expression is up-regulated by L-DOPA in striatal medium spiny neurons of parkinsonian rats.

Journal of neurochemistry 20081001

Dopaminergic but not glutamatergic neurotransmission is increased in the striatum after selective cyclooxygenase-2 inhibition in normal and hemiparkinsonian rats.

Basic & clinical pharmacology & toxicology 20081001

Chemical sympathetic denervation, suppression of myocardial transient outward potassium current, and ventricular fibrillation in the rat.

Canadian journal of physiology and pharmacology 20081001

[Effects of traditional Chinese herbal medicine on the neurobehavioral manifestations and the activity of dopamine D2 receptor in corpora striatum of rats with levodopa-induced dyskinesias].

Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20081001

Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine.

Free radical research 20081001

Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicability.

Neurotoxicity research 20081001

The protective effect of vitamin E on locus coeruleus in early model of Parkinson's disease in rat: immunoreactivity evidence.

Iranian biomedical journal 20081001

Potential cellular and regenerative approaches for the treatment of Parkinson's disease.

Neuropsychiatric disease and treatment 20081001

The role of duloxetine in the treatment of anxiety disorders.

Neuropsychiatric disease and treatment 20081001

Ependymal stem cells divide asymmetrically and transfer progeny into the subventricular zone when activated by injury.

Neuroscience 20080922

Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.

Neuroscience 20080922

Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.

Neuroscience 20080922

Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner.

Toxicology and applied pharmacology 20080915

A functional dissociation of the anterior and posterior pedunculopontine tegmental nucleus: excitotoxic lesions have differential effects on locomotion and the response to nicotine.

Brain structure & function 20080901

Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist.

Pharmacology, biochemistry, and behavior 20080901

Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content.

American journal of physiology. Regulatory, integrative and comparative physiology 20080901

Non-dopaminergic neurons in ventral mesencephalic transplants make widespread axonal connections in the host brain.

Experimental neurology 20080901

Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats.

Neuropharmacology 20080901

Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats.

Molecular therapy : the journal of the American Society of Gene Therapy 20080901

Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.

Brain structure & function 20080901

The basal ganglia and cerebellum interact in the expression of dystonic movement.

Brain : a journal of neurology 20080901

Development of a sialic acid-containing hydrogel of poly[N-(2-hydroxypropyl) methacrylamide]: characterization and implantation study.

Biomacromolecules 20080901

Immunohistochemical identification and quantitative analysis of cytoplasmic Cu/Zn superoxide dismutase in mouse organogenesis.

Journal of veterinary science 20080901

Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.

The European journal of neuroscience 20080901

Arterial baroreflex dysfunction fails to mimic Parkinson's disease in rats.

Journal of pharmacological sciences 20080901

Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disorders.

Current neuropharmacology 20080901

Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Current neuropharmacology 20080901

Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells.

Toxicology 20080819

Influence of acute progressive hypoxia on cardiovascular variability in conscious spontaneously hypertensive rats.

Autonomic neuroscience : basic & clinical 20080818

The CRF-like peptide urocortin produces a long-lasting recovery in rats made hemiparkinsonian by 6-hydroxydopamine or lipopolysaccharide.

Journal of the neurological sciences 20080815

Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress.

Neuroscience letters 20080815

Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic?

Psychopharmacology 20080801

Glutamate in dopamine neurons: synaptic versus diffuse transmission.

Brain research reviews 20080801

Neurotensin receptors as modulators of glutamatergic transmission.

Brain research reviews 20080801

Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.

The international journal of neuropsychopharmacology 20080801

Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease.

Experimental neurology 20080801

Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter.

Synapse (New York, N.Y.) 20080801

Involvement of NCAM in the effects of GDNF on the neurite outgrowth in the dopamine neurons.

Neuroscience research 20080801

Effect of locus coeruleus denervation on levodopa-induced motor fluctuations in hemiparkinsonian rats.

Journal of neural transmission (Vienna, Austria : 1996) 20080801

Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease.

Molecular therapy : the journal of the American Society of Gene Therapy 20080801

Sympathetic histamine exerts different pre- and post-synaptic functions according to the frequencies of nerve stimulation in guinea pig vas deferens.

Journal of neurochemistry 20080801

Patterns of FOS expression in the spinal cord and periaqueductal grey matter of 6OHDA-lesioned rats.

The International journal of neuroscience 20080801

Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease.

Brain : a journal of neurology 20080801

The involvement of NF-kappaB p65/p52 in the effects of GDNF on DA neurons in early PD rats.

Brain research bulletin 20080730

In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease.

European journal of pharmacology 20080728

Increased electrical and metabolic activity in the dorsal raphe nucleus of Parkinsonian rats.

Brain research 20080724

The coffee diterpene kahweol induces heme oxygenase-1 via the PI3K and p38/Nrf2 pathway to protect human dopaminergic neurons from 6-hydroxydopamine-derived oxidative stress.

FEBS letters 20080723

Substrate mediated reduction of copper-amyloid-beta complex in Alzheimer's disease.

Chemical communications (Cambridge, England) 20080721

Neuroprotective actions of leptin on central and peripheral neurons in vitro.

Neuroscience 20080717

Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.

Neuroscience letters 20080711

Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.

Brain research 20080707

Solid lipid nanoparticles as delivery systems for bromocriptine.

Pharmaceutical research 20080701

Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle.

Neurochemical research 20080701

Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model.

Journal of neuroscience research 20080701

Impaired activation of celiac ganglion neurons in vivo after damage to their sympathetic nerve terminals.

Journal of neuroscience research 20080701

Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.

Synapse (New York, N.Y.) 20080701

Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.

Journal of neurochemistry 20080701

Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease.

Journal of neuroscience research 20080701

Adaptation to chronic MG132 reduces oxidative toxicity by a CuZnSOD-dependent mechanism.

Journal of neurochemistry 20080701

Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection.

Journal of neuroimmunology 20080701

Dynamic changes in the cortex-basal ganglia network after dopamine depletion in the rat.

Journal of neurophysiology 20080701

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.

Neurobiology of disease 20080701

Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease.

Brain : a journal of neurology 20080701

Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins.

Neurotoxicology 20080701

Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.

Psychopharmacology 20080701

Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1.

Biological & pharmaceutical bulletin 20080701

Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells.

Free radical research 20080701

Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens.

The European journal of neuroscience 20080701

Contrasting effects of selective lesions of nucleus accumbens core or shell on inhibitory control and amphetamine-induced impulsive behaviour.

The European journal of neuroscience 20080701

Growth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20.

Frontiers in neuroscience 20080701

Quantitative evaluation of chaperone activity and neuroprotection by different preparations of a cell-penetrating Hsp70.

Journal of neuroscience methods 20080630

Behavioural effects of trishomocubanes in rats with unilateral 6-hydroxydopamine lesions.

Behavioural brain research 20080626

Postmenopausal effects of intrastriatal estrogen on catalepsy and pallidal electroencephalogram in an animal model of Parkinson's disease.

Neuroscience 20080626

Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion.

Neuroscience 20080626

Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration.

Neuroscience 20080626

Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats.

Neuroscience letters 20080613

Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease.

Brain research 20080612

Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine.

Brain research 20080605

Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission.

Behavioural brain research 20080603

Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats.

Neuroscience 20080602

Rats that differentially respond to cocaine differ in their dopaminergic storage capacity of the nucleus accumbens.

Journal of neurochemistry 20080601

In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway.

Synapse (New York, N.Y.) 20080601

Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.

Neurochemistry international 20080601

Role of endogenous sleep-wake and analgesic systems in anesthesia.

The Journal of comparative neurology 20080601

Increasing extracellular potassium results in subthalamic neuron activity resembling that seen in a 6-hydroxydopamine lesion.

Journal of neurophysiology 20080601

6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells.

Free radical biology & medicine 20080601

Enhanced function in the good forelimb of hemi-parkinson rats: compensatory adaptation for contralateral postural instability?

Experimental neurology 20080601

In vivo gene delivery to proliferating cells in the striatum generated in response to a 6-hydroxydopamine lesion of the nigro-striatal dopamine pathway.

Neurobiology of disease 20080601

Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease.

Neuropharmacology 20080601

Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.

Brain : a journal of neurology 20080601

Copper neurotoxicity in rat substantia nigra and striatum is dependent on DT-diaphorase inhibition.

Chemical research in toxicology 20080601

Expression of Cbl-interacting protein of 85 kDa in MPTP mouse model of Parkinson's disease and 1-methyl-4-phenyl-pyridinium ion-treated dopaminergic SH-SY5Y cells.

Acta biochimica et biophysica Sinica 20080601

GABAergic mechanism mediated via D receptors in the rat periaqueductal gray participates in the micturition reflex: an in vivo microdialysis study.

The European journal of neuroscience 20080601

Erythropoietin attenuates brain injury, subventricular zone expansion, and sensorimotor deficits in hypoxic-ischemic neonatal rats.

Journal of Korean medical science 20080601

Zebrafish: An in vivo model for the study of neurological diseases.

Neuropsychiatric disease and treatment 20080601

Water and ion channels: crucial in the initiation and progression of apoptosis in central nervous system?

Current neuropharmacology 20080601

The vermicelli handling test: a simple quantitative measure of dexterous forepaw function in rats.

Journal of neuroscience methods 20080530

Petroleum ether extract of Cnidium monnieri ameliorated scopolamine-induced amnesia through adrenal gland-mediated mechanism in male rats.

Journal of ethnopharmacology 20080522

Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity.

Journal of medicinal chemistry 20080522

Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20080521

6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex.

Journal of neuroscience research 20080515

Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.

Neuroscience 20080515

Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080501

Bilateral changes in neuronal activity of the basal ganglia in the unilateral 6-hydroxydopamine rat model.

Journal of neuroscience research 20080501

Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells.

Neurotoxicology 20080501

Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection.

Neurotoxicology 20080501

Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra.

Acta pharmacologica Sinica 20080501

Intratelencephalic corticostriatal neurons equally excite striatonigral and striatopallidal neurons and their discharge activity is selectively reduced in experimental parkinsonism.

The European journal of neuroscience 20080501

Low-level human equivalent gestational lead exposure produces supernormal scotopic electroretinograms, increased retinal neurogenesis, and decreased retinal dopamine utilization in rats.

Environmental health perspectives 20080501

Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20080430

The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review.

Yonsei medical journal 20080430

In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.

European journal of pharmacology 20080428

Alpha-lipoic acid suppresses 6-hydroxydopamine-induced ROS generation and apoptosis through the stimulation of glutathione synthesis but not by the expression of heme oxygenase-1.

Brain research 20080424

The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20080423

Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys.

Movement disorders : official journal of the Movement Disorder Society 20080415

Neuronal effects of 4-t-Butylcatechol: a model for catechol-containing antioxidants.

Toxicology and applied pharmacology 20080415

Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease.

The Journal of biological chemistry 20080411

A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.

Brain research 20080408

Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses.

Brain research 20080408

Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.

Brain research 20080408

Sensory (nociceptive) stimulation evokes Fos expression in the subthalamus of hemiparkinsonian rats.

Neurological research 20080401

The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.

Psychopharmacology 20080401

Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.

Synapse (New York, N.Y.) 20080401

Specific induction of PAG608 in cranial and spinal motor neurons of L-DOPA-treated parkinsonian rats.

Neuroscience research 20080401

Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats.

Experimental neurology 20080401

Inhibition of 6-hydroxydopamine-induced oxidative damage by 4,5-dihydro-3H-2-benzazepine N-oxides.

Biochemical pharmacology 20080401

Generation of a alpha-synuclein-based rat model of Parkinson's disease.

Neurobiology of disease 20080401

Antiallodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligation.

Anesthesia and analgesia 20080401

Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states.

The European journal of neuroscience 20080401

Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease.

The European journal of neuroscience 20080401

7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease.

Experimental and clinical psychopharmacology 20080401

Update on the use of pramipexole in the treatment of Parkinson's disease.

Neuropsychiatric disease and treatment 20080401

Survival and functional recovery of transplanted human dopaminergic neurons into hemiparkinsonian rats depend on the cannula size of the implantation instrument.

Journal of neuroscience methods 20080330

Low-frequency electroacupuncture suppresses carrageenan-induced paw inflammation in mice via sympathetic post-ganglionic neurons, while high-frequency EA suppression is mediated by the sympathoadrenal medullary axis.

Brain research bulletin 20080328

Exogenous l-DOPA induce no dopamine immuno-reactivity in striatal astroglias and microglias of adult rats with extensive nigro-striatal dopaminergic denervation.

Neuroscience letters 20080315

Neuritogenic effects of T cell-derived IL-3 on mouse splenic sympathetic neurons in vivo.

Journal of immunology (Baltimore, Md. : 1950) 20080315

Additive neuroprotection by metabotropic glutamate receptor subtype-selective ligands in a rat Parkinson's model.

Neuroreport 20080305

Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxy-2-nonenal, or hydrogen peroxide.

Brain research 20080304

Effects of development and dopamine depletion on striatal NMDA receptor-mediated calcium uptake.

Metabolic brain disease 20080301

Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?

Genes, brain, and behavior 20080301

Locus coeruleus noradrenergic neurons and CO2 drive to breathing.

Pflugers Archiv : European journal of physiology 20080301

Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.

Basic & clinical pharmacology & toxicology 20080301

Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment.

Journal of neurochemistry 20080301

6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA.

Journal of neurochemistry 20080301

Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.

Experimental neurology 20080301

Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease.

Experimental neurology 20080301

Effect and mechanisms underlying scorpion toxin action from Androctonus australis garzonii on atrial natriuretic peptide in rat atria: an in vitro study.

Peptides 20080301

Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease.

Brain : a journal of neurology 20080301

Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease.

Biochimica et biophysica acta 20080301

MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model animals of Parkinson disease for biomarker hunting.

Journal of proteome research 20080301

Differential activation of PKC delta in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesions.

The European journal of neuroscience 20080301

Mood disorder and epilepsy: a neurobiologic perspective of their relationship.

Dialogues in clinical neuroscience 20080301

Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20080227

Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.

Neuroscience letters 20080220

Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.

Neuroscience 20080219

Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines.

Toxicology in vitro : an international journal published in association with BIBRA 20080201

Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3.

Journal of neuroscience research 20080201

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.

Journal of neuroscience research 20080201

L-DOPA-induced activation of striatal p38MAPK and CREB in neonatal dopaminergic denervated rat: relevance to self-injurious behavior.

Journal of neuroscience research 20080201

Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.

Neurobiology of disease 20080201

c-Jun N-terminal kinases trigger both degeneration and neurite outgrowth in primary hippocampal and cortical neurons.

Journal of neurochemistry 20080201

l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation.

Neurobiology of disease 20080201

Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats.

Neuroscience research 20080201

Dopaminergic lesion enhances growth factor-induced striatal neuroblast migration.

Journal of neuropathology and experimental neurology 20080201

Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.

The European journal of neuroscience 20080201

[Evaluation of motor disorders in animal models of Parkinson's disease].

Revista de neurologia 20080201

Rasagiline in treatment of Parkinson's disease.

Neuropsychiatric disease and treatment 20080201

[The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease].

Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20080201

CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.

Brain research 20080129

Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.

Journal of medicinal chemistry 20080124

Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.

Brain research 20080123

Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20080116

Moderate degeneration of nigral neurons after repeated but not after single intrastriatal injections of low doses of 6-hydroxydopamine in mice.

Brain research 20080110

Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action.

Journal of medicinal chemistry 20080110

Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias.

Neuroreport 20080108

Depressed cardiac contractility and its postnatal development in rats after chemical sympathectomy.

Physiological research 20080101

Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells.

Journal of neuroscience research 20080101

Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells.

The international journal of biochemistry & cell biology 20080101

Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.

European journal of nuclear medicine and molecular imaging 20080101

Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease.

Neurobiology of disease 20080101

Interaction of dopamine and adenosine receptor function in behavior: studies with dopamine-deficient mice.

Frontiers in bioscience : a journal and virtual library 20080101

Does the cerebral cortex exacerbate dopaminergic cell death in the substantia nigra of 6OHDA-lesioned rats?

Parkinsonism & related disorders 20080101

Orthotopic transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the substantia nigra of hemiparkinsonian rats induces neuronal differentiation and motoric improvement.

Journal of anatomy 20080101

Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.

Experimental neurology 20080101

Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.

The European journal of neuroscience 20080101

Comparison of the therapeutic potential of adult and embryonic neural precursor cells in a rat model of Parkinson disease.

Journal of neurosurgery 20080101

Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.

The European journal of neuroscience 20080101

Alterations in serotonin signalling are involved in the hyperactivity of Pitx3-deficient mice.

The European journal of neuroscience 20080101

Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398.

Journal of neural transmission (Vienna, Austria : 1996) 20080101

Apoptosis of lactotrophs induced by D2 receptor activation is estrogen dependent.

Neuroendocrinology 20080101

Olfactory ensheathing cells conditioned medium prevented apoptosis induced by 6-OHDA in PC12 cells through modulation of intrinsic apoptotic pathways.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20080101

Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease.

Journal of neuroinflammation 20080101

Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment.

Journal of neuroinflammation 20080101

Similar pathological effects of sympathectomy and hypercholesterolemia on arterial smooth muscle cells and fibroblasts.

Acta histochemica 20080101

DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.

PloS one 20080101

Altered dopamine signaling in naturally occurring maternal neglect.

PloS one 20080101

[Compensatory reaction during degeneration of arcuate nucleus dopaminergic neurons in rats].

Zhurnal evoliutsionnoi biokhimii i fiziologii 20080101

[Compensatory effect of selank on the mnestic functions disturbed by neurotoxic damage of the noradrenergic system of the rat brain].

Eksperimental'naia i klinicheskaia farmakologiia 20080101

Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.

Journal of neuroinflammation 20080101

Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.

Neurotoxicity research 20080101

Mesencephalic human neural progenitor cells transplanted into the adult hemiparkinsonian rat striatum lack dopaminergic differentiation but improve motor behavior.

Cells, tissues, organs 20080101

Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence.

Parkinsonism & related disorders 20080101

Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training.

Parkinsonism & related disorders 20080101

Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease.

Autophagy 20080101

The 6-hydroxydopamine model: news from the past.

Parkinsonism & related disorders 20080101

The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response.

PloS one 20080101

Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease.

Parkinsonism & related disorders 20080101

Transgenic rodent models of Parkinson's disease.

Acta neurochirurgica. Supplement 20080101

Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons.

BMC neuroscience 20080101

Prefrontal norepinephrine determines attribution of 'high' motivational salience.

PloS one 20080101

[Antioxidants prevent experimental hemiparkinsonism in rats].

Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20080101

Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease.

BMC molecular biology 20080101

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.

Journal of neuroinflammation 20080101

Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): Implications for neurodegeneration in Parkinson's disease.

Molecular brain 20080101

Signaling pathways controlling neural stem cells slow progressive brain disease.

Cold Spring Harbor symposia on quantitative biology 20080101

Tremorgenesis: a new conceptual scheme using reciprocally innervated circuit of neurons.

Journal of translational medicine 20080101

Ascorbic acid increases the number of dopamine neurons in vitro and in transplants to the 6-OHDA-lesioned rat brain.

Cell transplantation 20080101

Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS.

BMC neuroscience 20080101

Use of rotorod as a method for the qualitative analysis of walking in rat.

Journal of visualized experiments : JoVE 20080101

Therapeutic promise and principles: metabotropic glutamate receptors.

Oxidative medicine and cellular longevity 20080101

Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT.

Autonomic neuroscience : basic & clinical 20071230

RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20071226

Activating transcription factor 3 induction in sympathetic neurons after axotomy: response to decreased neurotrophin availability.

Neuroscience 20071219

Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway.

Biological psychiatry 20071215

Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.

European journal of pharmacology 20071208

Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.

Behavioural brain research 20071203

Interactions among ovarian hormones and time of testing on behavioral sensitization and cocaine self-administration.

Behavioural brain research 20071203

Echinacoside prevents the striatal extracellular levels of monoamine neurotransmitters from diminution in 6-hydroxydopamine lesion rats.

Journal of ethnopharmacology 20071203

The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine.

Cerebral cortex (New York, N.Y. : 1991) 20071201

Cell stress induced by the parkinsonian mimetic, 6-hydroxydopamine, is concurrent with oxidation of the chaperone, ERp57, and aggresome formation.

Antioxidants & redox signaling 20071201

Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.

The Journal of pharmacology and experimental therapeutics 20071201

K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.

Molecular pharmacology 20071201

Treatment of Parkinson disease with C17.2 neural stem cells overexpressing NURR1 with a recombined republic-deficit adenovirus containing the NURR1 gene.

Synapse (New York, N.Y.) 20071201

Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model.

Neuropharmacology 20071201

Pael receptor is involved in dopamine metabolism in the nigrostriatal system.

Neuroscience research 20071201

Hydroxylated serotonin and dopamine as substrates and inhibitors for human cytosolic SULT1A3.

Journal of neurochemistry 20071201

A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress.

American journal of physiology. Cell physiology 20071201

Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.

Neuropharmacology 20071201

Resonant antidromic cortical circuit activation as a consequence of high-frequency subthalamic deep-brain stimulation.

Journal of neurophysiology 20071201

Activation of post-synaptic dopamine D₁ receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling.

Journal of neurochemistry 20071201

Aspartame decreases evoked extracellular dopamine levels in the rat brain: an in vivo voltammetry study.

Neuropharmacology 20071201

Effects of Ginkgolide B on 6-OHDA-induced apoptosis and calcium over load in cultured PC12.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20071201

Interactions between dopamine and melatonin organize circadian rhythmicity in the retina of the green iguana.

Journal of biological rhythms 20071201

Cannabinoids in health and disease.

Dialogues in clinical neuroscience 20071201

Lesion of subthalamic nucleus in parkinsonian rats : effects of dopamine d(1) and d(2) receptor agonists on the neuronal activities of the substantia nigra pars reticulata.

Journal of Korean Neurosurgical Society 20071201

The ERK 1 and 2 pathway in the nervous system: from basic aspects to possible clinical applications in pain and visceral dysfunction.

Current neuropharmacology 20071201

Endocannabinoid signaling in midbrain dopamine neurons: more than physiology?

Current neuropharmacology 20071201

Emerging synergisms between drugs and physiologically-patterned weak magnetic fields: implications for neuropharmacology and the human population in the twenty-first century.

Current neuropharmacology 20071201

The neuropharmacology of (-)-stepholidine and its potential applications.

Current neuropharmacology 20071201

Reprint of 'Neurobiology of animal models of attention-deficit hyperactivity disorder'.

Journal of neuroscience methods 20071130

Expression of FasL and its interaction with Fas are mediated by c-Jun N-terminal kinase (JNK) pathway in 6-OHDA-induced rat model of Parkinson disease.

Neuroscience letters 20071127

Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling.

The Journal of biological chemistry 20071123

Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism.

Behavioural brain research 20071122

Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20071121

The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing.

Behavioural brain research 20071102

Spatial deficits in a mouse model of Parkinson disease.

Psychopharmacology 20071101

Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx.

Journal of neuroscience research 20071101

The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.

Journal of neurochemistry 20071101

Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.

Journal of neurochemistry 20071101

NMDA-mediated release of glutamate and GABA in the subthalamic nucleus is mediated by dopamine: an in vivo microdialysis study in rats.

Journal of neurochemistry 20071101

Distribution and immunohistochemical localization of GDNF protein in selected neural and non-neural tissues of rats during development and changes in unilateral 6-hydroxydopamine lesions.

Neuroscience research 20071101

Neuroprotection and free radical scavenging effects of Osmanthus fragrans.

Journal of biomedical science 20071101

PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.

Journal of neuroscience research 20071101

Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.

Experimental neurology 20071101

Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons.

Nature neuroscience 20071101

Local effects of dexamethasone on immune reaction in neural transplantation.

Transplant immunology 20071101

Effect of selank on cognitive processes after damage inflicted to the cerebral catecholamine system during early ontogeny.

Bulletin of experimental biology and medicine 20071101

Dopamine induces TNFalpha and TNF-R1 expression in SH-SY5Y human neuroblastoma cells.

Neuroreport 20071029

Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease.

Brain research 20071024

Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity.

FEBS letters 20071016

Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.

Journal of neuroscience methods 20071015

Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease.

NeuroImage 20071015

Transforming growth factor-beta in the brain enhances fat oxidation via noradrenergic neurons in the ventromedial and paraventricular hypothalamic nucleus.

Brain research 20071010

Changes in the prodynorphin gene and DARPP-32 state in 6-OHDA-lesioned rats following long-term treatment with l-dopa.

Neuroscience letters 20071009

Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons.

Journal of neurochemistry 20071001

ANG II-induced attenuation of salt gland function in Pekin ducks is not catecholamine-dependent.

Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 20071001

Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats.

International journal of pharmaceutics 20071001

Effect of ventrolateral thalamic nucleus lesions in the unilateral 6-hydroxydopamine rat model.

Behavioural brain research 20071001

Experimental change on dopaminergic neurons in striatum of Parkinson disease rats.

Histology and histopathology 20071001

Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death.

Journal of neurochemistry 20071001

Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro.

Journal of neurochemistry 20071001

Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 20071001

Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.

Biological psychiatry 20071001

rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.

Experimental neurology 20071001

MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats.

Peptides 20071001

Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease.

Journal of pineal research 20071001

Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins.

Journal of proteome research 20071001

Manganese-enhanced MRI in a rat model of Parkinson's disease.

Journal of magnetic resonance imaging : JMRI 20071001

Dopamine lesion-induced changes in subthalamic nucleus activity are not associated with alterations in firing rate or pattern in layer V neurons of the anterior cingulate cortex in anesthetized rats.

The European journal of neuroscience 20071001

Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice.

Current protocols in neuroscience 20071001

Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model.

Physiology & behavior 20070910

High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats.

Neuroscience 20070907

Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20070905

Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study.

Behavioural brain research 20070904

Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models.

Proceedings of the National Academy of Sciences of the United States of America 20070904

Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070901

Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070901

A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation.

Journal of neurochemistry 20070901

Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.

Neuroscience research 20070901

Peripheral bee venom's anti-inflammatory effect involves activation of the coeruleospinal pathway and sympathetic preganglionic neurons.

Neuroscience research 20070901

Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.

Experimental neurology 20070901

NF-E2 related factor 2 activation and heme oxygenase-1 induction by tert-butylhydroquinone protect against deltamethrin-mediated oxidative stress in PC12 cells.

Chemical research in toxicology 20070901

Distinct changes in evoked and resting globus pallidus activity in early and late Parkinson's disease experimental models.

The European journal of neuroscience 20070901

High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.

The European journal of neuroscience 20070901

Evaluation of neuroprotective and anti-fatigue effects of sildenafil.

Life sciences 20070901

Behavioural supersensitivity following neonatal 6-hydroxydopamine: attenuation by MK-801.

Neurotoxicity research 20070901

Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease.

Neurotoxicity research 20070901

Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons.

Neurotoxicity research 20070901

Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study.

Purinergic signalling 20070901

Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.

Neuroscience letters 20070809

G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway.

Neurobiology of aging 20070801

Nicotine induces tyrosine hydroxylase plasticity in the neurodegenerating striatum.

Journal of neurochemistry 20070801

Mechanism of rapid-phase insulin response to elevation of portal glucose concentration.

American journal of physiology. Endocrinology and metabolism 20070801

Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.

Synapse (New York, N.Y.) 20070801

Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia.

Journal of neurochemistry 20070801

In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias.

Neurobiology of disease 20070801

6-Hydroxydopamine induces mitochondrial ERK activation.

Free radical biology & medicine 20070801

Midbrain dopaminergic neurogenesis and behavioural recovery in a salamander lesion-induced regeneration model.

Development (Cambridge, England) 20070801

Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum.

Journal of neurochemistry 20070801

An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20070801

The regulation of liver cytochrome p450 by the brain dopaminergic system.

Current drug metabolism 20070801

Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease.

CNS & neurological disorders drug targets 20070801

Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease.

Journal of the American College of Nutrition 20070801

Novel research translates to clinical cases of schizophrenic and cocaine psychosis.

Neuropsychiatric disease and treatment 20070801

D-beta-hydroxybutyrate inhibits the apoptosis of PC12 cells induced by 6-OHDA in relation to up-regulating the ratio of Bcl-2/Bax mRNA.

Autonomic neuroscience : basic & clinical 20070731

Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.

Brain research 20070730

Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20070725

Nicotine's attenuation of body weight involves the perifornical hypothalamus.

Life sciences 20070719

A comparison of dopaminergic cells from the human NTera2/D1 cell line transplanted into the hemiparkinsonian rat.

Life sciences 20070719

The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.

Brain research 20070716

Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats.

Neuroreport 20070716

Possible involvement of spinal noradrenergic mechanisms in the antiallodynic effect of intrathecally administered 5-HT2C receptor agonists in the rats with peripheral nerve injury.

European journal of pharmacology 20070712

Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.

Nature 20070705

Tyrosine hydroxylase (TH)- and aromatic-L-amino acid decarboxylase (AADC)-immunoreactive neurons of the common marmoset (Callithrix jacchus) brain: an immunohistochemical analysis.

Acta histochemica et cytochemica 20070703

Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.

European journal of pharmacology 20070702

In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070701

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

Brain : a journal of neurology 20070701

Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats.

NeuroImage 20070701

Differential effects on forelimb grasping behavior induced by fetal dopaminergic grafts in hemiparkinsonian rats.

Neurobiology of disease 20070701

AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease.

Neurobiology of disease 20070701

Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.

Neuropharmacology 20070701

Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20070701

Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of Parkinson disease.

Journal of neuropathology and experimental neurology 20070701

Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of Parkinson disease.

Journal of neuropathology and experimental neurology 20070701

The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease.

The European journal of neuroscience 20070701

[Effects of tetramethylpyrazine on brain oxidative damage induced by intracerebral perfusion of L-DOPA in rats with Parkinson's disease].

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070701

Therapeutic cloning: promises and issues.

McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students 20070701

Protective effects of fustin, a flavonoid from Rhus verniciflua Stokes, on 6-hydroxydopamine-induced neuronal cell death.

Experimental & molecular medicine 20070630

Neural plasticity maintained high by activation of cyclic AMP-dependent protein kinase: an age-independent, general mechanism in cat striate cortex.

Neuroscience 20070629

Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors.

Neuroscience letters 20070629

Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20070627

Determination of endogenous norepinephrine levels in different chambers of the rat heart by capillary electrophoresis coupled with amperometric detection.

Journal of neuroscience methods 20070615

Changes in the content of estrogen alpha and progesterone receptors during differentiation of mouse embryonic stem cells to dopamine neurons.

Brain research bulletin 20070615

Behavioral recovery following sub-chronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson's disease.

Journal of ethnopharmacology 20070613

Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease.

Neuroscience 20070608

Dopaminergic differentiation of grafted GFP transgenic neuroepithelial stem cells in the brain of a rat model of Parkinson's disease.

Neuroscience letters 20070608

Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells.

Neuroscience letters 20070604

Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons.

Journal of neurochemistry 20070601

Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease.

Synapse (New York, N.Y.) 20070601

Inotropic, chronotropic, and arrhythmogenic effects of dopamine on the isolated working heart of rabbit.

The journal of physiological sciences : JPS 20070601

Role of the midbrain dopaminergic system in modulation of vocal brain activation by social context.

The European journal of neuroscience 20070601

Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat.

The European journal of neuroscience 20070601

Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat.

The European journal of neuroscience 20070601

Assessing an eating disorder induced by 6-OHDA and the possibility of nerve regeneration therapy by transplantation of neural progenitor cells in rats.

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20070601

Frontal-subcortical circuitry and behavior.

Dialogues in clinical neuroscience 20070601

The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20070530

5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus alters neuronal activity of the subthalamic nucleus in normal and 6-hydroxydopamine-lesioned rats.

Brain research 20070529

Early inhibition of TNFalpha increases 6-hydroxydopamine-induced striatal degeneration.

Brain research 20070525

Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.

Neuroscience 20070525

Cis astaxanthin and especially 9-cis astaxanthin exhibits a higher antioxidant activity in vitro compared to the all-trans isomer.

Biochemical and biophysical research communications 20070525

Effects of engrafted neural stem cells derived from GFP transgenic mice in Parkinson's diseases rats.

Neuroscience letters 20070523

Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease.

Behavioural brain research 20070516

NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.

Brain research 20070511

[Proteolytic stress induced by environmental toxins in dopaminergic neurons: an experimental study].

Zhonghua yi xue za zhi 20070508

Low-frequency electroacupuncture suppresses zymosan-induced peripheral inflammation via activation of sympathetic post-ganglionic neurons.

Brain research 20070507

Nrf2-mediated protection against 6-hydroxydopamine.

Brain research 20070504

Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease.

Psychopharmacology 20070501

The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates.

Experimental neurology 20070501

Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.

Experimental neurology 20070501

Electroconvulsive shock enhances striatal dopamine D1 and D3 receptor binding and improves motor performance in 6-OHDA-lesioned rats.

Journal of psychiatry & neuroscience : JPN 20070501

Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome.

Journal of neuropathology and experimental neurology 20070501

Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats.

The European journal of neuroscience 20070501

Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.

The European journal of neuroscience 20070501

Therapeutic effect of microencapsulated porcine retinal pigmented epithelial cells transplantation on rat model of Parkinson's disease.

Neuroscience bulletin 20070501

The novel squamosamide derivative FLZ protects against 6-hydroxydopamine-induced apoptosis through inhibition of related signal transduction in SH-SY5Y cells.

European journal of pharmacology 20070430

Intracerebral co-transplantation of liposomal tacrolimus improves xenograft survival and reduces graft rejection in the hemiparkinsonian rat.

Neuroscience 20070425

Changes in the firing activity of serotonergic neurons in the dorsal raphe nucleus in a rat model of Parkinson's disease.

Sheng li xue bao : [Acta physiologica Sinica] 20070425

Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.

Brain research 20070420

Alpha-synuclein overexpression reduces gap junctional intercellular communication in dopaminergic neuroblastoma cells.

Neuroscience letters 20070418

[Effect of 6-hydroxydopamine on the levels of phosphorylation of signal transduction and transcription factor 1 and 3: experiment with dopaminergic neurons].

Zhonghua yi xue za zhi 20070417

Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model.

Behavioural brain research 20070416

Neural-tube-derived neuroepithelial stem cells: a new transplant resource for Parkinson's disease.

Neuroreport 20070416

Neurobiology of animal models of attention-deficit hyperactivity disorder.

Journal of neuroscience methods 20070415

Combination of bFGF, heparin and laminin induce the generation of dopaminergic neurons from rat neural stem cells both in vitro and in vivo.

Journal of the neurological sciences 20070415

Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.

Neurobiology of aging 20070401

TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice.

Neurobiology of disease 20070401

Protective effect of sulforaphane against dopaminergic cell death.

The Journal of pharmacology and experimental therapeutics 20070401

Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation.

Journal of neuroscience research 20070401

Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.

Journal of neurochemistry 20070401

Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.

Nuclear medicine and biology 20070401

Enhancement of dopaminergic properties and protection mediated by neuronal activation of Ras in mouse ventral mesencephalic neurones.

The European journal of neuroscience 20070401

The 6-hydroxydopamine model of Parkinson's disease.

Neurotoxicity research 20070401

Exploring neurocircuitries of the basal ganglia by intracerebral administration of selective neurotoxins.

Neurotoxicity research 20070401

The blood-brain barrier for catecholamines - revisited.

Neurotoxicity research 20070401

The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models.

Neurological research 20070401

Effects of desensitized nicotinic receptors on rotational behavior in a 6-hydroxydopamine model of Parkinson's disease.

Neuroscience letters 20070330

Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata.

Neuroscience 20070316

Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias.

Movement disorders : official journal of the Movement Disorder Society 20070315

Effects of 2,3-benzodiazepine AMPA receptor antagonists on dopamine turnover in the striatum of rats with experimental parkinsonism.

Brain research bulletin 20070315

Influence of autophagy genes on ion-channel-dependent neuronal degeneration in Caenorhabditis elegans.

Journal of cell science 20070315

The origin of the skewed amplitude distribution of spontaneous excitatory junction potentials in poorly coupled smooth muscle cells.

Neuroscience 20070302

Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons.

Brain research 20070302

Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease.

Parkinsonism & related disorders 20070301

Sympathetic and hyperthermic reactions by orexin A: role of cerebral catecholaminergic neurons.

Regulatory peptides 20070301

The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias.

Neurobiology of disease 20070301

Transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the neonatal parkinsonian rat caudate putamen.

Journal of neuroscience research 20070301

Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line--studies in vitro and after intracerebral grafting in vivo.

Molecular and cellular neurosciences 20070301

6-Hydroxydopamine induces cystatin C-mediated cysteine protease suppression and cathepsin D activation.

Neurochemistry international 20070301

Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity.

Neurochemical research 20070301

Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action.

Free radical biology & medicine 20070301

Rotation and immediate-early gene expression in rats treated with the atypical D1 dopamine agonist SKF 83822.

Pharmacology, biochemistry, and behavior 20070301

Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum.

Biological & pharmaceutical bulletin 20070301

Synergistic effects of adenosine A2A antagonist and L-DOPA on rotational behaviors in 6-hydroxydopamine-induced hemi-Parkinsonian mouse model.

Journal of pharmacological sciences 20070301

Signalling pathways underlying neural cell adhesion molecule-mediated survival of dopaminergic neurons.

The European journal of neuroscience 20070301

Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6-OHDA treated adult rats.

The European journal of neuroscience 20070301

Impact of 6-hydroxydopamine lesions and cocaine exposure on mu-opioid receptor expression and regulation of cholinergic transmission in the limbic-prefrontal territory of the rat dorsal striatum.

The European journal of neuroscience 20070301

Potential of adult neural stem cells for cellular therapy.

Biologics : targets & therapy 20070301

Sequential bilateral striatal lesions have additive effects on single skilled limb use in rats.

Behavioural brain research 20070227

High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20070227

[Effects of electrical stimulation of the parafascicular nucleus on the neuronal activities of the subthalamic nucleus and the ventromedial nucleus in rats].

Sheng li xue bao : [Acta physiologica Sinica] 20070225

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.

Brain research 20070223

Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease.

The Journal of biological chemistry 20070216

Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats.

Brain research 20070216

The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of l-dopa in unilaterally 6-OHDA-lesioned rats.

Brain research 20070216

Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy.

Movement disorders : official journal of the Movement Disorder Society 20070215

The 'motor complication syndrome' in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.

Behavioural brain research 20070212

Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease.

Neuroscience 20070209

Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection.

Neuroscience 20070209

Environmental enrichment brings a beneficial effect on beam walking and enhances the migration of doublecortin-positive cells following striatal lesions in rats.

Neuroscience 20070209

Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models.

Nature 20070208

The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20070207

GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease.

Neuroscience letters 20070202

The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice.

Journal of neural transmission (Vienna, Austria : 1996) 20070201

Effect of antidepressant drugs on 6-OHDA-treated mice in the FST.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070201

The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070201

Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.

Journal of neurochemistry 20070201

Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates.

Neuropharmacology 20070201

The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.

British journal of pharmacology 20070201

Does chemical sympathectomy alter the ontogeny of gubernacular migration in vivo?

Journal of pediatric surgery 20070201

Bilateral high-frequency stimulation of the subthalamic nucleus on attentional performance: transient deleterious effects and enhanced motivation in both intact and parkinsonian rats.

The European journal of neuroscience 20070201

Neonatal dopamine depletion induces changes in morphogenesis and gene expression in the developing cortex.

Neurotoxicity research 20070201

Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.

Neurotoxicity research 20070201

Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease.

Journal of neuroscience methods 20070130

Role of sympathetic nerves on early embryonic development and immune modulation of uterus in pregnant mice.

Autonomic neuroscience : basic & clinical 20070130

Quantitative measurement of neurological deficit after mild (30 min) transient middle cerebral artery occlusion in rats.

Brain research 20070126

Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine.

Neuroscience 20070119

Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20070117

Proapoptotic Nix activates the JNK pathway by interacting with POSH and mediates death in a Parkinson disease model.

The Journal of biological chemistry 20070112

Expression pattern of JunD after acute or chronic L-DOPA treatment: comparison with deltaFosB.

Neuroscience 20070105

A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo.

Brain research 20070105

Neurotoxicity assessment using zebrafish.

Journal of pharmacological and toxicological methods 20070101

Protective activities of Vaccinium antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity.

Neurotoxicology 20070101

Selective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.

The Journal of pharmacology and experimental therapeutics 20070101

Nifedipine suppresses self-injurious behaviors in animals.

Developmental neuroscience 20070101

Forward chemical genetic approach identifies new role for GAPDH in insulin signaling.

Nature chemical biology 20070101

Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.

Brain : a journal of neurology 20070101

Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease.

Neurochemical research 20070101

Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease.

Molecular therapy : the journal of the American Society of Gene Therapy 20070101

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra.

Molecular neurodegeneration 20070101

Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson's disease.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20070101

Deep brain stimulation in a rat model modulates TH, CaMKIIa and Homer1 gene expression.

The European journal of neuroscience 20070101

Concomitant short- and long-duration response to levodopa in the 6-OHDA-lesioned rat: a behavioural and molecular study.

The European journal of neuroscience 20070101

Sustained improvement of motor function in hemiparkinsonian rats chronically treated with low doses of caffeine or trihexyphenidyl.

Pharmacology, biochemistry, and behavior 20070101

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.

The European journal of neuroscience 20070101

TGF-beta dependent regulation of oxygen radicals during transdifferentiation of activated hepatic stellate cells to myofibroblastoid cells.

Comparative hepatology 20070101

Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.

Neuroscience and biobehavioral reviews 20070101

Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung.

BMC developmental biology 20070101

Implantation of pure cultured olfactory ensheathing cells in an animal model of parkinsonism.

Acta neurochirurgica 20070101

Modification of L-DOPA pharmacological activity by MAO inhibitors.

Journal of neural transmission (Vienna, Austria : 1996) 20070101

Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells.

Cancer cell international 20070101

Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment.

Neurotoxicity research 20070101

Food-associated cues alter forebrain functional connectivity as assessed with immediate early gene and proenkephalin expression.

BMC biology 20070101

Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.

Journal of molecular neuroscience : MN 20070101

Global and regional brain metabolic scaling and its functional consequences.

BMC biology 20070101

Differential development of neuronal physiological responsiveness in two human neural stem cell lines.

BMC neuroscience 20070101

The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.

Pharmacology, biochemistry, and behavior 20070101

The responses of HT22 cells to the blockade of mitochondrial complexes and potential protective effect of selenium supplementation.

International journal of biological sciences 20070101

Urocortin, a CRF-like peptide, restores key indicators of damage in the substantia nigra in a neuroinflammatory model of Parkinson's disease.

Journal of neuroinflammation 20070101

Stress before puberty exerts a sex- and age-related impact on auditory and contextual fear conditioning in the rat.

Neural plasticity 20070101

Nonhuman primate models of Parkinson's disease.

ILAR journal 20070101

A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere.

Restorative neurology and neuroscience 20070101

Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease.

Molecular neurodegeneration 20070101

Reversible unilateral nigrostriatal pathway inhibition induced through expression of adenovirus-mediated clostridial light chain gene in the substantia nigra.

Neuromolecular medicine 20070101

Assessing the ability of sequence-based methods to provide functional insight within membrane integral proteins: a case study analyzing the neurotransmitter/Na+ symporter family.

BMC bioinformatics 20070101

Possible use of repeated cold stress for reducing fatigue in chronic fatigue syndrome: a hypothesis.

Behavioral and brain functions : BBF 20070101

Protective effect of (+/-) isoborneol against 6-OHDA-induced apoptosis in SH-SY5Y cells.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20070101

Role of the ubiquitin proteasome system in Parkinson's disease.

BMC biochemistry 20070101

[The experimental models of Parkinson's disease in animals].

Uspekhi fiziologicheskikh nauk 20070101

Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome.

Orphanet journal of rare diseases 20070101

Early pubertal female rats are more resistant than males to 6-hydroxydopamine neurotoxicity and behavioural deficits: a possible role for trophic factors.

Restorative neurology and neuroscience 20070101

Assessment of antioxidative activity of extract from fermented grain food mixture using chemical and cellular systems.

BioFactors (Oxford, England) 20070101

Functionality of NGF-protected PC12 cells following exposure to 6-hydroxydopamine.

Biochemical and biophysical research communications 20061229

Forebrain adenosine A2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20061227

Molecular basis of 6-hydroxydopamine-induced caspase activations due to increases in oxidative stress in the mouse striatum.

Neuroscience letters 20061220

Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model.

Journal of neuroscience methods 20061215

Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels.

European journal of pharmacology 20061215

Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.

European journal of pharmacology 20061215

Subchronic administration of L-DOPA to adult rats with a unilateral 6-hydroxydopamine lesion of dopamine neurons results in a sensitization of enhanced GABA release in the substantia nigra, pars reticulata.

Brain research 20061206

[Phosphorylation of PKCdelta participates in the toxicity of 6-hydroxydopamine on dopaminergic neuroblastoma cell].

Zhonghua yi xue za zhi 20061205

L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors.

Journal of neural transmission (Vienna, Austria : 1996) 20061201

Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease.

Gene therapy 20061201

Sympathetic but not sensory denervation stimulates white adipocyte proliferation.

American journal of physiology. Regulatory, integrative and comparative physiology 20061201

Nucleofection is the most efficient nonviral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate.

Stem cells (Dayton, Ohio) 20061201

A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine.

Toxicology in vitro : an international journal published in association with BIBRA 20061201

Evaluation of the role of sympathetic denervation on hepatic function.

Hepatology research : the official journal of the Japan Society of Hepatology 20061201

Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: implications for abnormal motor behavior.

Neuroscience 20061201

Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats.

Molecular therapy : the journal of the American Society of Gene Therapy 20061201

Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease.

Neurobiology of disease 20061201

Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour.

Journal of anatomy 20061201

Modulation by 6-hydroxydopamine of expression of the phenylethanolamine N-methyltransferase (PNMT) gene in the rat heart during immobilization stress.

Stress (Amsterdam, Netherlands) 20061201

Unilateral ibotenic acid lesions of the prefrontal cortex reduce rotational behavior in 6-hydroxydopamine-lesioned rats.

Acta medica Okayama 20061201

Restless leg syndrome: is it a real problem?

Therapeutics and clinical risk management 20061201

Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder.

Neuropsychiatric disease and treatment 20061201

Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20061129

Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex.

Neuroreport 20061127

Ondamtanggamibang protects neurons from oxidative stress with induction of heme oxygenase-1.

Journal of ethnopharmacology 20061124

Improvements in motor behavioral tests during deep brain stimulation of the subthalamic nucleus in rats with different degrees of unilateral parkinsonism.

Brain research 20061120

Protection of nigral cell death by bilateral subthalamic nucleus stimulation.

Brain research 20061120

A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity.

Neuroscience 20061117

Neuronal precursors within the adult rat subventricular zone differentiate into dopaminergic neurons after substantia nigra lesion and chromaffin cell transplant.

Journal of neuroscience research 20061115

A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models.

Free radical biology & medicine 20061115

Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A) receptor antagonists.

Experimental neurology 20061101

White adipose tissue lacks significant vagal innervation and immunohistochemical evidence of parasympathetic innervation.

American journal of physiology. Regulatory, integrative and comparative physiology 20061101

Potentiation of in vivo neuroprotection by BclX(L) and GDNF co-expression depends on post-lesion time in deafferentiated CNS neurons.

Gene therapy 20061101

Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats.

Amino acids 20061101

Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease.

Molecular therapy : the journal of the American Society of Gene Therapy 20061101

Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease.

Behavioural brain research 20061101

Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress.

Journal of neuroscience research 20061101

Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning.

Journal of neurochemistry 20061101

Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression.

Neurobiology of disease 20061101

Fos immunoreactivity in some locomotor neural centres of 6OHDA-lesioned rats.

Anatomy and embryology 20061101

Catha edulis extract and its active principle cathinone induce ipsilateral rotation in unilaterally lesioned rats.

Behavioural pharmacology 20061101

Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats.

Neurochemical research 20061101

Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

Nature medicine 20061101

Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20061101

R-apomorphine protects against 6-hydroxydopamine-induced nigrostriatal damage in rat.

Neuroscience bulletin 20061101

Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias.

Journal of the neurological sciences 20061025

Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease.

Brain research 20061020

Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20061018

A method for a more complete in vitro Parkinson's model: slice culture bioassay for modeling maintenance and repair of the nigrostriatal circuit.

Journal of neuroscience methods 20061015

Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway.

Brain research 20061003

CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.

Neuroscience letters 20061002

Effects of direct intravitreal dopamine injections on the development of lid-suture induced myopia in rabbits.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20061001

Locus coeruleus is a central chemoreceptive site in toads.

American journal of physiology. Regulatory, integrative and comparative physiology 20061001

Behavioral models of Parkinson's disease in rodents: a new look at an old problem.

Movement disorders : official journal of the Movement Disorder Society 20061001

PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.

Neurobiology of disease 20061001

Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics.

Journal of neurochemistry 20061001

Distribution of DJ-1, Parkinson's disease-related protein PARK7, and its alteration in 6-hydroxydopamine-treated hemiparkinsonian rat brain.

Journal of pharmacological sciences 20061001

Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.

The European journal of neuroscience 20061001

Behavioural sensitization in addiction, schizophrenia, Parkinson's disease and dyskinesia.

Neurotoxicity research 20061001

Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft.

The European journal of neuroscience 20061001

Neuroprotection of the nigrostriatal dopaminergic neurons by melatonin in hemiparkinsonium rat.

The Indian journal of medical research 20061001

Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.

European journal of pharmacology 20060928

Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.

Brain research 20060927

RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20060927

Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway.

The Journal of comparative neurology 20060920

Neuroanatomical localization of an internal clock: a functional link between mesolimbic, nigrostriatal, and mesocortical dopaminergic systems.

Brain research 20060913

Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20060913

Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20060913

Differential involvement of mitochondrial permeability transition in cytotoxicity of 1-methyl-4-phenylpyridinium and 6-hydroxydopamine.

Molecular and cellular biochemistry 20060901

Simultaneous in vivo measurement of dopamine, serotonin and ascorbate in the striatum of experimental rats using voltammetric microprobe.

Frontiers in bioscience : a journal and virtual library 20060901

Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats.

Neuroscience 20060901

Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk.

Neurobiology of disease 20060901

Quebrachitol (2-O-methyl-L-inositol) attenuates 6-hydroxydopamine-induced cytotoxicity in rat fetal mesencephalic cell cultures.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20060901

Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway.

Journal of neuroscience research 20060901

On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease.

Experimental neurology 20060901

Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle.

Neuropharmacology 20060901

Intrathecal clonidine suppresses zymosan-induced peripheral leukocyte migration in a mouse air pouch model via activation of spinal muscarinic type 2 receptors and sympathoadrenal medullary activity.

Neuropharmacology 20060901

Phosphoproteomic profiling of human SH-SY5Y neuroblastoma cells during response to 6-hydroxydopamine-induced oxidative stress.

Biochimica et biophysica acta 20060901

Dependence of cardiac 11C-meta-hydroxyephedrine retention on norepinephrine transporter density.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20060901

Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease.

Indian journal of experimental biology 20060901

Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission.

The European journal of neuroscience 20060901

Proliferation of neural precursors in the subventricular zone after chemical lesions of the nigrostriatal pathway in rat brain.

Brain research 20060823

Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity.

Life sciences 20060822

KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.

Journal of neuroscience research 20060815

[Adenovirus mediated vascular endothelial growth factor gene transfer protects dopaminergic neurons in Parkinson's disease: experiment with rats].

Zhonghua yi xue za zhi 20060808

Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat.

Brain research 20060802

Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies.

Clinical psychology review 20060801

Quantitation of cardiac sympathetic innervation in rabbits using 11C-hydroxyephedrine PET: relation to 123I-MIBG uptake.

European journal of nuclear medicine and molecular imaging 20060801

The stepping test and its learning process in different degrees of unilateral striatal lesions by 6-hydroxydopamine in rats.

Neuroscience research 20060801

Field potential recording in the ventral tegmental area: pharmacological and toxicological evaluations of postsynaptic dopaminergic neuron activity.

Neuroscience research 20060801

Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.

Acta neuropathologica 20060801

Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats.

Neuropeptides 20060801

Neurochemical and behavioural characterisation of alkoxyamphetamine derivatives in rats.

Neurotoxicity research 20060801

Dopamine stimulation via infusion in the lateral ventricle.

Annals of the New York Academy of Sciences 20060801

Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures.

Annals of the New York Academy of Sciences 20060801

Effect of subthalamic nucleus lesions in a 6-hydroxydopamine-induced rat parkinsonian model: behavioral and biochemical studies.

Journal of neurosurgery 20060801

Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats.

Brain research 20060726

Enriched environment improves motor function in intact and unilateral dopamine-depleted rats.

Neuroscience 20060721

A novel therapeutic approach to 6-OHDA-induced Parkinson's disease in rats via supplementation of PTD-conjugated tyrosine hydroxylase.

Biochemical and biophysical research communications 20060721

Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment.

Behavioural brain research 20060715

FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.

Journal of medicinal chemistry 20060713

Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters.

Neuroscience letters 20060710

Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation.

Neuroscience letters 20060710

Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20060705

Role for dopamine neurons of the rostral linear nucleus and periaqueductal gray in the rewarding and sensitizing properties of heroin.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060701

Evidence for histamine as a neurotransmitter in the cardiac sympathetic nervous system.

American journal of physiology. Heart and circulatory physiology 20060701

Intravenous 6-hydroxydopamine attenuates vasopressin and oxytocin secretion stimulated by hemorrhage and hypotension but not hyperosmolality in rats.

American journal of physiology. Regulatory, integrative and comparative physiology 20060701

Subthalamic nucleus lesioning inhibits expression and phosphorylation of c-Jun in nigral neurons in the rat's 6-OHDA model of Parkinson's disease.

Synapse (New York, N.Y.) 20060701

Evidence for disease-regulated transgene expression in the brain with use of lentiviral vectors.

Journal of neuroscience research 20060701

Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure.

Hypertension (Dallas, Tex. : 1979) 20060701

Intranigral dopamine toxicity and alpha-synuclein response in rats.

Neurochemical research 20060701

Differential involvement of intracellular Ca2+ in 1-methyl-4-phenylpyridinium- or 6-hydroxydopamine-induced cell viability loss in PC12 cells.

Neurochemical research 20060701

Structure-specific patterns of neural stem cell engraftment after transplantation in the adult mouse brain.

Human gene therapy 20060701

Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats.

Pharmacology, biochemistry, and behavior 20060701

Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease.

Annals of the New York Academy of Sciences 20060701

Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease.

Human & experimental toxicology 20060701

Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.

The European journal of neuroscience 20060701

Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon?

Behavioural brain research 20060630

Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells.

The Journal of biological chemistry 20060630

Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study.

Brain research 20060620

Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease.

Brain research 20060620

Nigral injection of antisense oligonucleotides to synaptotagmin I using HVJ-liposome vectors causes disruption of dopamine release in the striatum and impaired skill learning.

Brain research 20060620

Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions.

Synapse (New York, N.Y.) 20060615

Colour-coded pellets increase the sensitivity of the staircase test to differentiate skilled forelimb performances of control and 6-hydroxydopamine lesioned rats.

Brain research bulletin 20060615

Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease.

Brain research 20060606

Oxidation and cytotoxicity of 6-OHDA are mediated by reactive intermediates of COX-2 overexpressed in PC12 cells.

Brain research 20060606

Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease.

Experimental neurology 20060601

Neural responses in multiple basal ganglia regions following unilateral dopamine depletion in behaving rats performing a treadmill locomotion task.

Experimental brain research 20060601

Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats.

Synapse (New York, N.Y.) 20060601

L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.

Neuropharmacology 20060601

Evidence for multiple sites within rat ventral striatum mediating cocaine-conditioned place preference and locomotor activation.

The Journal of pharmacology and experimental therapeutics 20060601

Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.

Synapse (New York, N.Y.) 20060601

Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.

Neurobiology of disease 20060601

Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease.

Apoptosis : an international journal on programmed cell death 20060601

Substantial role of locus coeruleus-noradrenergic activation and capsaicin-insensitive primary afferent fibers in bee venom's anti-inflammatory effect.

Neuroscience research 20060601

Transplantation of human neural precursor cells in the 6-OHDA lesioned rats: effect of immunosuppression with cyclosporine A.

Parkinsonism & related disorders 20060601

Electrolytic lesions of the nucleus accumbens enhance locomotor sensitization to nicotine in rats.

Behavioral neuroscience 20060601

Selective prefrontal serotonin depletion impairs acquisition of a detour-reaching task.

The European journal of neuroscience 20060601

Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.

Pharmacology, biochemistry, and behavior 20060601

Compensatory increase in extracellular dopamine in the nucleus accumbens of adult rats with neonatal 6-hydroxydopamine treatment.

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20060601

Further validation of the corridor task for assessing deficit and recovery in the hemi-Parkinsonian rat: restoration of bilateral food retrieval by dopamine receptor agonism.

Behavioural brain research 20060515

L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases.

Neuroscience letters 20060508

On the retention of neurotensin in the ventral tegmental area (VTA) despite destruction of the main neurotensinergic afferents of the VTA--implications for the organization of forebrain projections to the VTA.

Brain research 20060504

Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats.

Journal of neural transmission (Vienna, Austria : 1996) 20060501

Effects of systemic administration of iptakalim on extracellular neurotransmitter levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060501

The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.

Neurobiology of disease 20060501

Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.

Neuroscience letters 20060501

Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat.

Neuropharmacology 20060501

Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats.

Movement disorders : official journal of the Movement Disorder Society 20060501

6-Hydroxydopamine lesions of nucleus accumbens core abolish amphetamine-induced conditioned activity.

Synapse (New York, N.Y.) 20060501

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Neurobiology of disease 20060501

L-DOPA-induced dyskinesia in adult rats with a unilateral 6-OHDA lesion of dopamine neurons is paralleled by increased c-fos gene expression in the subthalamic nucleus.

The European journal of neuroscience 20060501

Involvement of endoplasmic reticulum stress on the cell death induced by 6-hydroxydopamine in human neuroblastoma SH-SY5Y cells.

Neurochemical research 20060501

MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation.

The European journal of neuroscience 20060501

Caspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway.

The Journal of biological chemistry 20060428

Effects of pallidotomy on motor symptoms in an animal model of Parkinson's disease.

Behavioural brain research 20060425

Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions.

Behavioural brain research 20060425

Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.

Brain research 20060421

Sleep induction and temperature lowering by medial preoptic alpha(1) adrenergic receptors.

Physiology & behavior 20060415

Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.

Brain research bulletin 20060414

6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation.

The Journal of biological chemistry 20060407

Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20060405

Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease.

Neurobiology of disease 20060401

Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease.

Neurobiology of disease 20060401

Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt.

American journal of physiology. Gastrointestinal and liver physiology 20060401

Intrastriatal infusion of liver growth factor stimulates dopamine terminal sprouting and partially restores motor function in 6-hydroxydopamine-lesioned rats.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20060401

Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.

Neurochemistry international 20060401

Calculating molar absorptivities for quinones: application to the measurement of tyrosinase activity.

Analytical biochemistry 20060401

Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.

Journal of neurochemistry 20060401

Norepinephrine modulates the inflammatory and proliferative phases of wound healing.

The Journal of trauma 20060401

Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats.

The European journal of neuroscience 20060401

[Effects of Shuanggu Yitong needling method on proliferation and differentiation of nerve stem cells in the Parkinson's disease model rat].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20060401

Neuroprotective bibenzyl glycosides of Stemona tuberosa roots.

Journal of natural products 20060401

Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine.

Neurochemical research 20060401

Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Endocrine 20060401

On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?

Current neuropharmacology 20060401

Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.

Life sciences 20060320

Modulation of torsinA expression in the globus pallidus internus is associated with levodopa-induced dyskinesia in hemiparkinsonian rats.

Neuroscience letters 20060320

A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20060315

Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents.

Neuroscience letters 20060306

6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta.

The Journal of biological chemistry 20060303

A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters.

Biological psychiatry 20060301

Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives.

Neurochemistry international 20060301

Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat.

Molecular pharmacology 20060301

Enhanced cystatin C and lysosomal protease expression following 6-hydroxydopamine exposure.

Neurotoxicology 20060301

Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.

Journal of neurochemistry 20060301

[Effect of prepared radix Polygoni multiflori on the elevation of extracellular hydroxyl radical in striatum of rats induced by intracerebral perfusion of 6-hydroxy dopamine].

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20060301

Trichopus zeylanicus combats fatigue without amphetamine-mimetic activity.

Phytotherapy research : PTR 20060301

Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats.

Brain research 20060223

Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.

Brain research 20060216

Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems.

Brain research 20060216

Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?

Experimental neurology 20060201

The signal transduction pathway for the dopamine D1 receptor in the guinea-pig cochlea.

Neuroscience 20060201

Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?

Experimental neurology 20060201

Circadian distribution of motor-activity in unilaterally 6-hydroxy-dopamine lesioned rats.

Experimental brain research 20060201

Increased galanin expression in the celiac ganglion of BB diabetic rats.

Neuropeptides 20060201

Functional investigations into the role of dopamine and serotonin in partial bilateral striatal 6-hydroxydopamine lesioned rats.

Pharmacology, biochemistry, and behavior 20060201

Neglect of memory after dopaminergic lesions in monkeys.

Behavioural brain research 20060130

Differing influence of sympathectomy on smooth muscle cells and fibroblasts in cerebral and peripheral muscular arteries.

Autonomic neuroscience : basic & clinical 20060130

Cross-sensitization between caffeine- and L-dopa-induced behaviors in hemiparkinsonian mice.

Neuroscience letters 20060123

Adaptive response induced by lipid peroxidation products in cell cultures.

FEBS letters 20060123

Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein.

Experimental cell research 20060115

Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease.

Brain research 20060112

Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease.

Brain research 20060112

Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20060111

Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20060104

UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060101

Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease.

Neurobiology of disease 20060101

Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.

Neurobiology of disease 20060101

Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.

Neurobiology of disease 20060101

Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism.

Stem cells (Dayton, Ohio) 20060101

Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats.

Molecular therapy : the journal of the American Society of Gene Therapy 20060101

ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.

Biological psychiatry 20060101

Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat.

Neuropharmacology 20060101

Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals.

Synapse (New York, N.Y.) 20060101

Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease.

Experimental neurology 20060101

Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb.

Experimental neurology 20060101

Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.

Experimental neurology 20060101

Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.

Neuroscience 20060101

Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex.

Psychopharmacology 20060101

Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death.

Journal of neurochemistry 20060101

Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity.

Neuroscience 20060101

Adrenergic modulation of the type 1 IP3 receptors in the rat heart.

Biochimica et biophysica acta 20060101

Influence of methylphenidate on brain development--an update of recent animal experiments.

Behavioral and brain functions : BBF 20060101

Blockade of mGluR glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson's disease.

The European journal of neuroscience 20060101

A new neuroprotective compound of Ligustrum japonicum leaves.

Planta medica 20060101

Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.

Pharmacology, biochemistry, and behavior 20060101

N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease.

BMC medical genetics 20060101

Sympathectomy causes aggravated lesions and dedifferentiation in large rabbit atherosclerotic arteries without involving nitric oxide.

Journal of vascular research 20060101

Melatonin in Alzheimer's disease and other neurodegenerative disorders.

Behavioral and brain functions : BBF 20060101

Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis.

Cell transplantation 20060101

Neural repair strategies for Parkinson's disease: insights from primate models.

Cell transplantation 20060101

Histochemical study of cardiac mast cells degranulation and collagen deposition: interaction with the cathecolaminergic system in the rat.

European journal of histochemistry : EJH 20060101

Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography.

Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20060101

[Inhibitors of mitochondrial permeability transition pore prevent apoptosis of dopaminergic neurons in the mesencephalon].

Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20060101

Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).

Journal of neural transmission. Supplementum 20060101

Proposed animal model of severe Parkinson's disease: neonatal 6-hydroxydopamine lesion of dopaminergic innervation of striatum.

Journal of neural transmission. Supplementum 20060101

Triggering endogenous neuroprotective mechanisms in Parkinson's disease: studies with a cellular model.

Journal of neural transmission. Supplementum 20060101

Anti-apoptotic gene therapy in Parkinson's disease.

Journal of neural transmission. Supplementum 20060101

Bridging nigrostriatal pathway with fibroblast growth factor-primed peripheral nerves and fetal ventral mesencephalon transplant recuperates from deficits in parkinsonian rats.

Cell transplantation 20060101

Sound sequence discrimination learning motivated by reward requires dopaminergic D2 receptor activation in the rat auditory cortex.

Learning & memory (Cold Spring Harbor, N.Y.) 20060101

Transplanted human neural precursor cells migrate widely but show no lesion-specific tropism in the 6-hydroxydopamine rat model of Parkinson's disease.

Cell transplantation 20060101

Effect of antisense FosB and CREB on the expression of prodynorphin gene in rats with levodopa-induced dyskinesias.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101

Intrastriatal gene transfer of vascular endothelial growth factor rescues dopaminergic neurons in a rat Parkinson's disease model.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101

Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases.

Journal of neural transmission. Supplementum 20060101

Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions.

Drug target insights 20060101

DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.

The Journal of biological chemistry 20051230

Marmoset monkey models of Parkinson's disease: which model, when and why?

Brain research bulletin 20051230

The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.

European journal of pharmacology 20051228

4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2.

The Journal of biological chemistry 20051223

Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.

Human molecular genetics 20051215

Validation of the l-dopa-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists.

Brain research bulletin 20051215

The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum.

Brain research bulletin 20051215

Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age.

Brain research bulletin 20051215

Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy.

Brain research bulletin 20051215

Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in rats using a lateralised nose-poking task with low stimulus-response compatibility.

Behavioural brain research 20051207

Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.

Behavioural brain research 20051207

Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats.

Brain research 20051207

Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures.

Neurobiology of disease 20051201

Blueberry- and spirulina-enriched diets enhance striatal dopamine recovery and induce a rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system.

Experimental neurology 20051201

Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions.

Brain : a journal of neurology 20051201

Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists.

Behavioural pharmacology 20051201

A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area.

Brain research. Brain research protocols 20051201

Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice.

Journal of pharmacological sciences 20051201

Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.

The European journal of neuroscience 20051201

Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.

The European journal of neuroscience 20051201

Alterations in the development of rat cerebellum and impaired behavior of juvenile rats after neonatal 6-OHDA treatment.

Neurochemical research 20051201

Involvement of catecholamine neurotransmission in the rat anterior cingulate in effort-related decision making.

Behavioral neuroscience 20051201

Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture.

Molecular and cellular neurosciences 20051201

Reduction in parvalbumin expression in the zona incerta after 6OHDA lesion in rats.

Journal of neurocytology 20051201

l-DOPA administration enhances 6-hydroxydopamine generation.

Brain research 20051130

Alteration of striatal [11C]raclopride and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake precedes development of methamphetamine-induced rotation following unilateral 6-hydroxydopamine lesions of medial forebrain bundle in rats.

Neuroscience letters 20051125

Novel potential neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons.

Biochemical pharmacology 20051125

Deprenyl enhances the striatal neuronal damage produced by quinolinic acid.

Brain research. Molecular brain research 20051118

Amburoside A, a glucoside from Amburanacearensis, protects mesencephalic cells against 6-hydroxydopamine-induced neurotoxicity.

Neuroscience letters 20051111

Mice lacking the alpha4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function.

Molecular pharmacology 20051101

CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.

Journal of neurochemistry 20051101

Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats.

Journal of neurochemistry 20051101

Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease.

Biochemical pharmacology 20051101

Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.

Journal of neuroscience research 20051101

Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?

Anatomy and embryology 20051101

Gene expression profiles of reactive astrocytes cultured from dopamine-depleted striatum.

Neurobiology of disease 20051101

Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats.

Journal of neuropathology and experimental neurology 20051101

Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.

The European journal of neuroscience 20051101

Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesia.

The European journal of neuroscience 20051101

Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model.

The European journal of neuroscience 20051101

Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells.

European journal of cell biology 20051101

Neuroprotective effect of D-psicose on 6-hydroxydopamine-induced apoptosis in rat pheochromocytoma (PC12) cells.

Journal of bioscience and bioengineering 20051101

Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.

Neuroscience letters 20051028

The change of the neuron-glia differentiation rate in human neural precursor cells (HPCs) and Ad-BDNF-/-GDNF-infected HPCs following the administration of a neurotoxin.

Neuroscience letters 20051021

Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20051019

Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations.

Journal of neuroscience methods 20051015

Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro.

Neurotoxicology 20051001

Pathological synaptic plasticity in the striatum: implications for Parkinson's disease.

Neurotoxicology 20051001

Expanded mesencephalic precursors develop into grafts of densely packed dopaminergic neurons that reinnervate the surrounding striatum and induce functional responses in the striatal neurons.

Synapse (New York, N.Y.) 20051001

Increased nuclear factor-erythroid 2 p45-related factor 2 activity protects SH-SY5Y cells against oxidative damage.

Journal of neurochemistry 20051001

Anti-apoptotic activity of Bak Foong Pills and its ingredients on 6-hydroxydopamine-induced neurotoxicity in PC12 cells.

Cell biology international 20051001

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.

Journal of neurochemistry 20051001

Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease.

The European journal of neuroscience 20051001

Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease.

Free radical research 20051001

[Animal models of parkinsonism].

Revue neurologique 20051001

Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's.

Brain research 20050928

Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria.

The Journal of biological chemistry 20050916

Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism.

Journal of neuroscience research 20050915

Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.

Journal of neural transmission (Vienna, Austria : 1996) 20050901

Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.

The international journal of neuropsychopharmacology 20050901

Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct.

Experimental neurology 20050901

Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.

Experimental brain research 20050901

Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro.

Toxicological sciences : an official journal of the Society of Toxicology 20050901

Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.

Neuropharmacology 20050901

Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway.

Free radical biology & medicine 20050901

Central thyrotropin-releasing hormone increases hepatic cyclic AMP through vagal-cholinergic and prostaglandin-dependent pathways in rats.

Peptides 20050901

The antiallodynic and antihyperalgesic effects of neurotropin in mice with spinal nerve ligation.

Anesthesia and analgesia 20050901

Involvement of supraspinal imidazoline receptors and descending monoaminergic pathways in tizanidine-induced inhibition of rat spinal reflexes.

Journal of pharmacological sciences 20050901

Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats.

Analytical and bioanalytical chemistry 20050901

Differential survival patterns among midbrain dopaminergic cells of MPTP-treated monkeys and 6OHDA-lesioned rats.

Anatomy and embryology 20050901

6-Hydroxydopamine-induced alterations in blood-brain barrier permeability.

The European journal of neuroscience 20050901

Neurorescue effects of VEGF on a rat model of Parkinson's disease.

Brain research 20050816

Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.

Brain research 20050809

Adaptation to hydrogen peroxide enhances PC12 cell tolerance against oxidative damage.

Neuroscience letters 20050805

Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.

Brain research 20050802

Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy).

Journal of neural transmission (Vienna, Austria : 1996) 20050801

Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats.

Neuroscience letters 20050801

Neuronal markers expression of NGF-primed bone marrow cells (BMCs) transplanted in the brain of 6-hydroxydopamine and ibotenic acid lesioned littermate mice.

Neuroscience letters 20050801

Chemical sympathectomy inhibits periodontal disease in Fischer 344 rats.

Journal of periodontal research 20050801

Rewarding properties of the stereoisomers of 4-methylaminorex: involvement of the dopamine system.

Pharmacology, biochemistry, and behavior 20050801

A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking.

Journal of neurochemistry 20050801

Neuroprotection by crocetin in a hemi-parkinsonian rat model.

Pharmacology, biochemistry, and behavior 20050801

Aging and sympathetic modulation of immune function in Fischer 344 rats: effects of chemical sympathectomy on primary antibody response.

Journal of neuroimmunology 20050801

Pig xenografts to the immunocompetent rat brain: Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains.

Experimental neurology 20050801

Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.

Pharmacology, biochemistry, and behavior 20050801

Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease.

PLoS biology 20050801

In vivo models of multiple system atrophy.

Movement disorders : official journal of the Movement Disorder Society 20050801

The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.

The European journal of neuroscience 20050801

Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism.

Behavioural brain research 20050730

Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.

Brain research bulletin 20050730

Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.

Brain research 20050727

A proteomic approach in the study of an animal model of Parkinson's disease.

Clinica chimica acta; international journal of clinical chemistry 20050724

The anti-inflammatory effect of peripheral bee venom stimulation is mediated by central muscarinic type 2 receptors and activation of sympathetic preganglionic neurons.

Brain research 20050712

Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20050706

The effects of cocaine on CART expression in the rat nucleus accumbens: a possible role for corticosterone.

European journal of pharmacology 20050704

Sympathetic denervation does not prevent a reduction in fat pad size of rats or mice treated with peripherally administered leptin.

American journal of physiology. Regulatory, integrative and comparative physiology 20050701

Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases.

The Journal of biological chemistry 20050701

The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity.

Neuroscience letters 20050701

Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

Experimental neurology 20050701

Apoptosis and nestin expression in the cortex and cultured astrocytes following 6-OHDA administration.

Neuroscience letters 20050701

Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.

Behavioural brain research 20050701

Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.

Journal of neuroscience research 20050701

Degeneration of dopaminergic neurons triggers an expression of individual enzymes of dopamine synthesis in non-dopaminergic neurons of the arcuate nucleus in adult rats.

Journal of chemical neuroanatomy 20050701

6-Hydroxydopamine-induced glutathione alteration occurs via glutathione enzyme system in primary cultured astrocytes.

Acta pharmacologica Sinica 20050701

Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro.

Neurological research 20050701

Toxin-induced models of Parkinson's disease.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 20050701

Diminished serotonergic innervation of adult medial prefrontal cortex after 6-OHDA lesions in the newborn rat.

Brain research. Developmental brain research 20050630

Comparison of the effects of nicotine and epibatidine given in combination with nomifensine on rotational behaviour in rats.

Neuroscience letters 20050624

Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain.

The Journal of comparative neurology 20050613

In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system.

Brain research. Molecular brain research 20050613

Effects of phencyclidine on schedule-controlled responding following neurotoxic lesions of the striatum.

Life sciences 20050610

Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat.

Journal of neural transmission (Vienna, Austria : 1996) 20050601

Arachidonic acid incorporation and turnover is decreased in sympathetically denervated rat heart.

American journal of physiology. Heart and circulatory physiology 20050601

Increase of GAP-43 in the rat cerebellum following unilateral striatal 6-OHDA lesion.

Synapse (New York, N.Y.) 20050601

Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells.

Toxicology in vitro : an international journal published in association with BIBRA 20050601

Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: implications for treating Parkinson's disease?

Neuropharmacology 20050601

Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.

Experimental neurology 20050601

Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus.

Experimental neurology 20050601

Chronic treatment with the mGlu5R antagonist MPEP reduces the functional effects of the mGlu5R agonist CHPG in the striatum of 6-hydroxydopamine-lesioned rats: possible relevance to the effects of mGlu5R blockade in Parkinson's disease.

Journal of neuroscience research 20050601

A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to L-DOPA in a rodent model of Parkinson's disease.

Neuroscience research 20050601

PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning.

Cardiovascular research 20050601

The vulnerability of striatal projection neurons and interneurons to excitotoxicity is differentially regulated by dopamine during development.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20050601

Baicalein prevents 6-hydroxydopamine-induced dopaminergic dysfunction and lipid peroxidation in mice.

Journal of pharmacological sciences 20050601

Association of vitamin D receptor gene polymorphism and Parkinson's disease in Koreans.

Journal of Korean medical science 20050601

Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20050601

The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats.

Naunyn-Schmiedeberg's archives of pharmacology 20050601

The effects of neurochemical lesioning of dopaminergic terminals in early ontogenesis on behavior in adult rats.

Neuroscience and behavioral physiology 20050601

Receptor binding occurrence and plasma levels of natriuretic peptides in response to sympathectomy.

Microscopy research and technique 20050601

The mechanisms of 6-hydroxydopamine-induced astrocyte death.

Annals of the New York Academy of Sciences 20050601

Guanosine stimulates neurite outgrowth in PC12 cells via activation of heme oxygenase and cyclic GMP.

Purinergic signalling 20050601

Fate of pre-differentiated mouse embryonic stem cells transplanted in unilaterally 6-hydroxydopamine lesioned rats: histological characterization of the grafted cells.

Brain research 20050531

Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats.

Brain research 20050531

Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys.

Behavioural brain research 20050528

3,4-Methylenedioxymethamphetamine and naloxone in rat rotational behaviour and open field.

European journal of pharmacology 20050523

Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20050518

Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20050518

Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.

Journal of neuroscience methods 20050515

8-hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson's disease.

Neuroreport 20050512

Neonatal depletion of cortical dopamine: effects on dopamine turnover and motor behavior in juvenile and adult rats.

Brain research. Developmental brain research 20050512

The therapeutic effects of dopamine replacement therapy and its psychiatric side effects are mediated by pineal function.

Behavioural brain research 20050507

Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains.

The Journal of biological chemistry 20050506

Control of cellular pattern formation in the vertebrate inner retina by homotypic regulation of cell-fate decisions.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20050504

Unilateral lesions of mesostriatal dopaminergic pathway alters the withdrawal response of the rat hindpaw to mechanical stimulation.

Neuroscience research 20050501

Acute and separate modulation of motor and cognitive performance in parkinsonian rats by bilateral stimulation of the subthalamic nucleus.

Experimental neurology 20050501

Apomorphine-induced alterations in striatal and substantia nigra pars reticulata glutamate following unilateral loss of striatal dopamine.

Experimental neurology 20050501

Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-parkinsonian rats.

Experimental neurology 20050501

Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons.

Journal of neurochemistry 20050501

Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease.

Brain research. Brain research protocols 20050501

Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions.

The Journal of comparative neurology 20050418

Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry.

Journal of neuroscience methods 20050415

Electrophysiological alterations in subthalamic neurons after unilateral dopamine depletion in the rat.

Journal of neuroscience research 20050415

Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats.

Behavioural brain research 20050415

Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20050413

Role of amygdalo-nigral circuitry in conditioning of a visual stimulus paired with food.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20050413

Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.

Psychopharmacology 20050401

Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050401

Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats.

Synapse (New York, N.Y.) 20050401

Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesia.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20050401

Synaptosomal dopamine uptake in rat striatum following controlled cortical impact.

Journal of neuroscience research 20050401

Striatal synaptic plasticity: implications for motor learning and Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20050401

Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.

Journal of neurochemistry 20050401

Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.

Journal of neurochemistry 20050401

Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease.

Stem cells (Dayton, Ohio) 20050401

Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.

The International journal of neuroscience 20050401

Glial bFGF and S100 immunoreactivities increase in ascending dopamine pathways following striatal 6-OHDA-induced partial lesion of the nigrostriatal system: a sterological analysis.

The International journal of neuroscience 20050401

Iron protects astrocytes from 6-hydroxydopamine toxicity.

Neuropharmacology 20050401

The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959.

Pharmacology, biochemistry, and behavior 20050401

Selective effects of partial striatal 6-OHDA lesions on information processing in the rat.

The European journal of neuroscience 20050401

Reduced basal activity and increased functional homogeneity in sensorimotor and striatum of a Parkinson's disease rat model: a functional MRI study.

The European journal of neuroscience 20050401

Assessment of recovery in the hemiparkinson rat: drug-induced rotation is inadequate.

Physiology & behavior 20050331

Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats.

Behavioural brain research 20050330

Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw.

European journal of pharmacology 20050328

Protective effects of N-acetylserotonin against 6-hydroxydopamine-induced neurotoxicity.

Life sciences 20050325

Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.

Brain research. Molecular brain research 20050324

Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion.

Brain research 20050321

Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20050316

p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.

Journal of neuroscience research 20050315

The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model.

Brain research 20050315

Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells.

Brain research 20050315

Contribution of the sympathetic nervous system on the burn-associated impairment of CCL3 production.

Cytokine 20050307

Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson's disease.

Experimental brain research 20050301

Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors.

The Journal of pharmacology and experimental therapeutics 20050301

3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy.

Synapse (New York, N.Y.) 20050301

Glial overexpression of heme oxygenase-1: a histochemical marker for early stages of striatal damage.

Journal of chemical neuroanatomy 20050301

Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors.

Brain : a journal of neurology 20050301

Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse.

British journal of pharmacology 20050301

Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.

Experimental neurology 20050301

6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.

Experimental neurology 20050301

Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.

Experimental neurology 20050301

Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.

Neuroscience research 20050301

Catecholaminergic and cholinergic regulation of swimming motility development in free embryos of Cichlasoma Nigrofasciatum.

Journal of experimental zoology. Part A, Comparative experimental biology 20050301

Re-evaluation and quantification of the different sources of nerve fibres supplying the rat eye.

Journal of anatomy 20050301

Viral vector mediated overexpression of human alpha-synuclein in the nigrostriatal dopaminergic neurons: a new model for Parkinson's disease.

CNS spectrums 20050301

Does proteasome [corrected] inhibition decrease or accelerate toxin-induced dopaminergic neurodegeneration?

Journal of pharmacological sciences 20050301

Caffeine and the dopaminergic system.

Behavioural pharmacology 20050301

Proteasome function and pathological proteins in the pathogenesis of Parkinson's disease.

Journal of pharmacological sciences 20050301

Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.

The European journal of neuroscience 20050301

Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat.

The European journal of neuroscience 20050301

The effects of 6-hydroxydopamine on the electrical characteristics of snail neurons in long-term sensitization.

Neuroscience and behavioral physiology 20050301

Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats.

Human & experimental toxicology 20050301

Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum.

Neurochemical research 20050301

Dopamine manipulation alters immediate-early gene response of striatal parvalbumin interneurons to cortical stimulation.

Brain research 20050221

Hsp27 inhibits 6-hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells.

Biochemical and biophysical research communications 20050218

Carbidopa/levodopa-loaded biodegradable microspheres: in vivo evaluation on experimental Parkinsonism in rats.

Journal of controlled release : official journal of the Controlled Release Society 20050216

Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats.

Regulatory peptides 20050215

Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson's disease.

Brain research 20050209

Dopamine depletion alters responses to glutamate and GABA in the rat subthalamic nucleus.

Neuroreport 20050208

Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins.

Brain research 20050208

Heterologous expression of human {alpha}6{beta}4{beta}3{alpha}5 nicotinic acetylcholine receptors: binding properties consistent with their natural expression require quaternary subunit assembly including the {alpha}5 subunit.

The Journal of pharmacology and experimental therapeutics 20050201

Effects of repeated cocaine on the release and clearance of dopamine within the rat medial prefrontal cortex.

Synapse (New York, N.Y.) 20050201

Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy).

Acta neuropathologica 20050201

A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo.

Experimental neurology 20050201

Effect of central corticotropin releasing factor on hepatic circulation in rats: the role of the CRF2 receptor in the brain.

Gut 20050201

Cerebral glutamate metabolism in Parkinson's disease: an in vivo dynamic (13)C NMS study in the rat.

Experimental neurology 20050201

Testing forelimb placing 'across the midline' reveals distinct, lesion-dependent patterns of recovery in rats.

Experimental neurology 20050201

Analysis of gene expression changes in a cellular model of Parkinson disease.

Neurobiology of disease 20050201

RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells.

Neurobiology of disease 20050201

Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.

Neurobiology of disease 20050201

Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.

Bioorganic & medicinal chemistry 20050201

Effects of intrathecal 6-hydroxydopamine, alpha1 and alpha2 adrenergic receptor antagonists on antinociception of propofol in mice.

Acta pharmacologica Sinica 20050201

Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists.

Bioorganic & medicinal chemistry letters 20050201

Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats.

Journal of pharmacological sciences 20050201

A potassium channel blocker induces a long-lasting enhancement of corticostriatal responses.

Neuropharmacology 20050201

Altered extracellular striatal in vivo biotransformation of the opioid neuropeptide dynorphin A(1-17) in the unilateral 6-OHDA rat model of Parkinson's disease.

Journal of mass spectrometry : JMS 20050201

The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles.

Brain research. Brain research reviews 20050201

6-Hydroxydopamine lesions in female hamsters (Mesocricetus auratus) abolish the sensitized effects of sexual experience on copulatory interactions with males.

Behavioral neuroscience 20050201

A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease.

The European journal of neuroscience 20050201

An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.

Behavioural brain research 20050130

Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20050126

Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline.

Brain research 20050125

Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model.

Neuroscience letters 20050120

Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures.

Biochemical pharmacology 20050115

Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20050112

Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat.

Synapse (New York, N.Y.) 20050101

Inhibitory effects of cigarette smoke on glial inducible nitric oxide synthase and lack of protective properties against oxidative neurotoxins in vitro.

Neurotoxicology 20050101

The conditioned enhancement of neutrophil activity is catecholamine dependent.

Journal of neuroimmunology 20050101

Bilateral nigral 6-hydroxydopamine lesions increase the amount of extracellular dopamine in the nucleus accumbens.

Experimental neurology 20050101

The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neurons.

Experimental neurology 20050101

Morphology and distribution of dopaminergic neurons intrinsic to the human striatum.

Journal of chemical neuroanatomy 20050101

Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice.

Neuroscience research 20050101

Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behaviours.

The European journal of neuroscience 20050101

Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease.

Journal of neurosurgery 20050101

Specific pathophysiological functions of JNK isoforms in the brain.

The European journal of neuroscience 20050101

[The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus].

Revista de neurologia 20050101

Aminopeptidase activity in the nigrostriatal system and prefrontal cortex of rats with experimental hemiparkinsonism.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20050101

Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's.

BMC biology 20050101

Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 20050101

Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions.

Neuroscience 20050101

Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog.

Neuroscience 20050101

Bilateral increase of perforated synapses after unilateral dopamine depletion.

The International journal of neuroscience 20050101

Transient and widespread astroglial activation in the brain after a striatal 6-OHDA-induced partial lesion of the nigrostriatal system.

The International journal of neuroscience 20050101

Increased levels of ubiquitin in the 6-OHDA-lesioned striatum of rats.

Journal of proteome research 20050101

Coherent spike-wave oscillations in the cortex and subthalamic nucleus of the freely moving rat.

Neuroscience 20050101

Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions.

Neuroscience 20050101

Comparative effects of acute or chronic administration of levodopa to 6-hydroxydopamine-lesioned rats on the expression of glutamic acid decarboxylase in the neostriatum and GABAA receptors subunits in the substantia nigra, pars reticulata.

Neuroscience 20050101

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.

Neurobiology of disease 20050101

Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.

Neuroscience 20050101

Increased splenocyte mitogenesis following sympathetic denervation in Xenopus laevis.

Developmental and comparative immunology 20050101

Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes.

Neuroscience 20050101

Dopaminergic reinnervation of the globus pallidus by fetal nigral grafts in the rodent model of Parkinson's disease.

Cell transplantation 20050101

Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death.

Antioxidants & redox signaling 20050101

Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease.

Antioxidants & redox signaling 20050101

Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.

Neuroscience 20050101

Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism.

Neuroscience 20050101

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition.

Journal of neuroinflammation 20050101

Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease.

Redox report : communications in free radical research 20050101

Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions.

Neuroscience 20050101

Bilateral control of brain activity by dopamine D1 receptors: evidence from induction patterns of regulator of G protein signaling 2 and c-fos mRNA in D1-challenged hemiparkinsonian rats.

Neuroscience 20050101

Alterations in the proportions of skeletal muscle proteins following a unilateral lesion to the substantia nigra pars compacta of rats.

Journal of muscle research and cell motility 20050101

Animal models of attention-deficit hyperactivity disorder.

Behavioral and brain functions : BBF 20050101

Dopamine agonist pergolide prevents levodopa-induced quinoprotein formation in parkinsonian striatum and shows quenching effects on dopamine-semiquinone generated in vitro.

Clinical neuropharmacology 20050101

Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.

Neuroscience 20050101

Differential regulation of the growth-associated proteins GAP-43 and superior cervical ganglion 10 in response to lesions of the cortex and substantia nigra in the adult rat.

Neuroscience 20050101

Sympathetic denervation accelerates wound contraction but delays reepithelialization in rats.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 20050101

Harm reduction--the cannabis paradox.

Harm reduction journal 20050101

Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease.

Neurochemical research 20050101

Selective acetylcholine and dopamine lesions in neonatal rats produce distinct patterns of cortical dendritic atrophy in adulthood.

Neuroscience 20050101

Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model.

Surgical neurology 20050101

Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.

Methods in enzymology 20050101

Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity.

BMC neuroscience 20050101

In vivo PET measurements with [11C]PE2I to evaluate fetal mesencephalic transplantations to unilateral 6-OHDA-lesioned rats.

Cell transplantation 20050101

[Fundamentals of modern treatment of myopia].

Annales Academiae Medicae Stetinensis 20050101

Effect of PD I administration on dopamine receptors mRNAs expression in the lesioned striatum of PD rat model.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20050101

JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine.

The Journal of biological chemistry 20041231

Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.

Journal of neuroscience methods 20041230

Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats.

Regulatory peptides 20041215

Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord.

Regulatory peptides 20041215

Motor hyperactivity caused by a deficit in dopaminergic neurons and the effects of endocrine disruptors: a study inspired by the physiological roles of PACAP in the brain.

Regulatory peptides 20041215

Biphasic effects of oxotremorine-M on turning behavior induced by caffeine in 6-OHDA-lesioned rats.

European journal of pharmacology 20041203

Partial bilateral mesencephalic lesions affect D1 but not D2 binding in both the striatum and cortex.

Neurochemistry international 20041201

The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity.

Toxicology letters 20041201

Locomotor effects of imidazoline I2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway.

British journal of pharmacology 20041201

Neuronal expression of the transcription factor Gli1 using the Talpha1 alpha-tubulin promoter is neuroprotective in an experimental model of Parkinson's disease.

Gene therapy 20041201

The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20041201

Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.

The European journal of neuroscience 20041201

Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures.

Journal of neurochemistry 20041201

Malfunction of vascular control in lifestyle-related diseases: distribution of adrenomedullin-containing perivascular nerves and its alteration in hypertension.

Journal of pharmacological sciences 20041201

Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation-induced cellular defects in the rat striatum and globus pallidus.

The European journal of neuroscience 20041201

Hypertrophy of medial globus pallidus and substantia nigra reticulata in 6-hydroxydopamine-lesioned rats treated with L-DOPA: implication for L-DOPA-induced dyskinesia in Parkinson's disease.

Neuropathology : official journal of the Japanese Society of Neuropathology 20041201

Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system.

Neurochemical research 20041201

[Iptakalim enhances astrocytic glutamate uptake activity].

Yao xue xue bao = Acta pharmaceutica Sinica 20041201

The neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine on SK-N-SH cells.

Neuroscience letters 20041123

Release of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder.

The Journal of biological chemistry 20041119

Effect of 17-beta-estradiol on dopamine, serotonine and GABA striatal levels in 6-hydroxydopamine-treated rats.

Toxicology 20041115

Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.

Brain research 20041105

Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease.

Brain research 20041105

Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20041101

Sympathectomy reveals alpha 1A- and alpha 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens.

British journal of pharmacology 20041101

Purinergic modulation of extracellular glutamate levels in the nucleus accumbens in vivo.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20041101

Transplantation of pig stem cells into rat brain: proliferation during the first 8 weeks.

Experimental neurology 20041101

Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.

Neurobiology of disease 20041101

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia.

Neurobiology of disease 20041101

Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism.

PLoS biology 20041101

Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned rat.

Naunyn-Schmiedeberg's archives of pharmacology 20041101

Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor.

Pharmacology, biochemistry, and behavior 20041101

HSV vector-delivery of GDNF in a rat model of PD: partial efficacy obscured by vector toxicity.

Brain research 20041022

Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.

Journal of neuroscience research 20041015

Role of catecholaminergic inputs to the medial prefrontal cortex in local and subcortical expression of Fos after psychological stress.

Journal of neuroscience research 20041015

Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis.

Journal of neuroscience research 20041015

Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20041013

Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence.

Behavioural brain research 20041005

Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats.

Behavioural brain research 20041005

Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20041001

Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease.

Brain research 20041001

Motor activity and gene expression in rats with neonatal 6-hydroxydopamine lesions.

Journal of neurochemistry 20041001

Deficits in a lateralized associative learning task in dopamine-depleted rats with functional recovery by dopamine-rich transplants.

The European journal of neuroscience 20041001

Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease.

Journal of neurochemistry 20041001

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

Cell and tissue research 20041001

Involvement of signal transduction cascade via dopamine-D1 receptors in phencyclidine dependence.

Annals of the New York Academy of Sciences 20041001

Activation of NF-kappaB is involved in 6-hydroxydopamine-but not MPP+ -induced dopaminergic neuronal cell death: its potential role as a survival determinant.

Biochemical and biophysical research communications 20040924

Effect of central thyrotropin-releasing hormone on pancreatic blood flow in rats.

Regulatory peptides 20040915

Evaluation of functional asymmetry in rats with dose-dependent lesions of dopaminergic nigrostriatal system using elevated body swing test.

Physiology & behavior 20040915

6-hydroxydopamine lesions in anuran amphibians: a new model system for Parkinson's disease?

Journal of neurobiology 20040915

Co-treatment with ethanol enhances the toxicity of 6-hydroxydopamine.

Neuroscience letters 20040902

Effects of orbital prefrontal cortex dopamine depletion on inter-temporal choice: a quantitative analysis.

Psychopharmacology 20040901

NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats.

Psychopharmacology 20040901

Protective effect of resveratrol against 6-hydroxydopamine-induced impairment of renal p-aminohippurate transport.

Archives of toxicology 20040901

SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.

The Journal of pharmacology and experimental therapeutics 20040901

Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.

Experimental neurology 20040901

Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration.

Molecular therapy : the journal of the American Society of Gene Therapy 20040901

Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system.

Journal of neurochemistry 20040901

6-Hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression.

Journal of neuroscience research 20040901

Cholecystokinin tetrapeptide improves water maze performance of neonatally 6-hydroxydopamine-lesioned young rats.

Pharmacology, biochemistry, and behavior 20040901

Neuroprotective effects of the antiparkinson drug Mucuna pruriens.

Phytotherapy research : PTR 20040901

Effect of 6-hydroxydopamine on the gene expression of Na+/Ca2+ exchanger in the rat heart.

General physiology and biophysics 20040901

Serial induction of mutations by ethylnitrosourea in PC12 cells: a new model for a phenotypical characterization of the neurotoxic response to 6-hydroxydopamine.

Journal of neuroscience methods 20040830

Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.

Brain research bulletin 20040830

New insights into iron release from ferritin: direct observation of the neurotoxin 6-hydroxydopamine entering ferritin and reaching redox equilibrium with the iron core.

Organic & biomolecular chemistry 20040821

Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage.

Regulatory peptides 20040815

Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.

Human molecular genetics 20040815

Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis.

Cancer research 20040815

Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat.

Brain research 20040806

Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20040804

A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 20040801

Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040801

Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.

The Journal of pharmacology and experimental therapeutics 20040801

Immobilization induces acute nitric oxide production in the rat hypothalamus: a role of ionotropic glutamate receptors in the paraventricular nucleus.

Endocrinology 20040801

NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats.

Neuropharmacology 20040801

Increased dopamine release in vivo by estradiol benzoate from the central amygdaloid nucleus of Parkinson's disease model rats.

Journal of neurochemistry 20040801

Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells.

Neurobiology of disease 20040801

The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous system.

Journal of neuroimmunology 20040801

Functional improvement with low-dose dopaminergic grafts in hemiparkinsonian rats.

Neurosurgery 20040801

Bystin as a novel marker for reactive astrocytes in the adult rat brain following injury.

The European journal of neuroscience 20040801

Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation.

The European journal of neuroscience 20040801

[Stromal cell transplant in the 6-OHDA lesion model].

Revista de neurologia 20040801

Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson's disease.

Phytotherapy research : PTR 20040801

Opposite morphological responses of partially denervated cortical serotonergic and noradrenergic axons to repeated stress in adult rats.

Brain research bulletin 20040730

N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats.

Neuroreport 20040719

Lesions of the dorsal noradrenergic bundle augment the renin response to blood loss but do not alter hypothalamic Fos expression.

Brain research bulletin 20040715

Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias.

Behavioural brain research 20040709

High-frequency stimulation of the subthalamic nucleus reverses limb-use asymmetry in rats with unilateral 6-hydroxydopamine lesions.

Brain research 20040702

The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.

Molecular psychiatry 20040701

Loss-of-function mutation of the galanin gene is associated with perturbed islet function in mice.

Endocrinology 20040701

Selective knockdown of gene expression of N-methyl-D-aspartate receptor one ameliorates parkinsonian motor symptom in 6-hydroxydopamine-lesioned rats.

Neurochemistry international 20040701

Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040701

Thermoeffector neuronal pathways in fever: a study in rats showing a new role of the locus coeruleus.

The Journal of physiology 20040701

Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism.

Brain : a journal of neurology 20040701

Rasagiline enhances L-DOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea-pig.

Neuropharmacology 20040701

The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.

Experimental neurology 20040701

Dopamine depletion impairs precursor cell proliferation in Parkinson disease.

Nature neuroscience 20040701

In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats.

Journal of neurochemistry 20040701

Bone marrow norepinephrine mediates development of functionally different macrophages after thermal injury and sepsis.

Annals of surgery 20040701

Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone.

The European journal of neuroscience 20040701

Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo.

Molecular therapy : the journal of the American Society of Gene Therapy 20040701

Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease.

Pharmacology, biochemistry, and behavior 20040701

Recent failures of new potential symptomatic treatments for Parkinson's disease: causes and solutions.

Movement disorders : official journal of the Movement Disorder Society 20040701

Peripheral P2X receptors and nociception: interactions with biogenic amine systems.

Pain 20040701

Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors.

Pain 20040701

Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies.

Naunyn-Schmiedeberg's archives of pharmacology 20040701

Gene expression profiles of reactive astrocytes in dopamine-depleted striatum.

Brain pathology (Zurich, Switzerland) 20040701

Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20040630

Prevention of catecholaminergic oxidative toxicity by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and its recycling complex with polynitroxylated albumin, TEMPOL/PNA.

Brain research 20040625

Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation.

The Journal of clinical investigation 20040615

Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20040609

Beneficial effects of intraventricularly administered BMP-7 following a striatal 6-hydroxydopamine lesion.

Brain research 20040604

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole.

The Journal of pharmacology and experimental therapeutics 20040601

Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040601

Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA.

Synapse (New York, N.Y.) 20040601

The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?

Naunyn-Schmiedeberg's archives of pharmacology 20040601

Change in phase synchronization of local field potentials in anesthetized rats after chronic dopamine depletion.

Neuroscience research 20040601

The role of NF-kappaB in 6-hydroxydopamine- and TNFalpha-induced apoptosis of PC12 cells.

Naunyn-Schmiedeberg's archives of pharmacology 20040601

Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease.

Experimental neurology 20040601

Increased norepinephrine production associated with burn injuries results in CCL2 production and type 2 T cell generation.

Burns : journal of the International Society for Burn Injuries 20040601

Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity.

Journal of neural transmission (Vienna, Austria : 1996) 20040601

A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.

Neurobiology of disease 20040601

Voluntary running provides neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle.

Metabolic brain disease 20040601

Continuous light exposure and sympathectomy suppress circadian rhythm of blood pressure in rats.

Journal of cardiovascular pharmacology and therapeutics 20040601

Striatal tyrosine hydroxylase immunoreactive neurons are induced by L-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats.

Neuroscience letters 20040520

Extracellular taurine in the substantia nigra: taurine-glutamate interaction.

Journal of neuroscience research 20040515

Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration.

Journal of neuroscience research 20040515

Clozapine prolongs hypotonic immobility in rats with bilateral 6-hydroxydopamine lesions of the striatum.

Neuroscience letters 20040513

Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons.

The Journal of biological chemistry 20040507

Cognitive inflexibility after prefrontal serotonin depletion.

Science (New York, N.Y.) 20040507

Accumbens dopamine and the regulation of effort in food-seeking behavior: modulation of work output by different ratio or force requirements.

Behavioural brain research 20040505

Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.

Behavioural brain research 20040505

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.

Behavioural brain research 20040505

Dopaminergic agonists and muscarinic antagonists improve lateralization in hemiparkinsonian rats in a novel exploratory Y-maze.

The Journal of pharmacology and experimental therapeutics 20040501

L-DOPA-induced modulation of GABA and glutamate release in substantia nigra pars reticulata in a rodent model of Parkinson's disease.

Synapse (New York, N.Y.) 20040501

An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.

Experimental neurology 20040501

Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease.

Experimental neurology 20040501

Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease.

Experimental neurology 20040501

Slow N-acetyltransferase 2 status leads to enhanced intrastriatal dopamine depletion in 6-hydroxydopamine-lesioned rats.

Experimental neurology 20040501

Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.

Journal of neurochemistry 20040501

Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system.

The European journal of neuroscience 20040501

Pedunculopontine nucleus.

Journal of neurosurgery 20040501

The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.

The Journal of pharmacy and pharmacology 20040501

Survival and migration of transplanted neural stem cell-derived dopamine cells in the brain of parkinsonian rat.

The International journal of neuroscience 20040501

Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease.

Neuroscience letters 20040429

The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.

Brain research 20040409

Dissociation of hemi-spatial and hemi-motor impairments in a unilateral primate model of Parkinson's disease.

Behavioural brain research 20040402

Delayed stress-induced colonic hypersensitivity in male Wistar rats: role of neurokinin-1 and corticotropin-releasing factor-1 receptors.

American journal of physiology. Gastrointestinal and liver physiology 20040401

A hypothalamic-testicular neural pathway is influenced by brain catecholamines, but not testicular blood flow.

Endocrinology 20040401

Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease.

The international journal of biochemistry & cell biology 20040401

Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.

Experimental neurology 20040401

Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells.

Journal of neurochemistry 20040401

Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.

Human gene therapy 20040401

Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy).

Neurobiology of disease 20040401

Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons.

Journal of neurosurgery 20040401

[Effects of neurotensin microinjected into ventral tegmental area on spontaneous motor activity in neonatal 6-hydroxydopamine-treated rats].

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20040401

Distribution of adrenomedullin-containing perivascular nerves in the rat mesenteric artery.

Peptides 20040401

Glutamic acid decarboxylase 67 mRNA regulation in two globus pallidus neuron populations by dopamine and the subthalamic nucleus.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20040324

Sympathetic nervous system mediates cold stress-induced suppression of natural killer cytotoxicity in rats.

Neuroscience letters 20040318

Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice.

Synapse (New York, N.Y.) 20040315

Lesion of subthalamic or motor thalamic nucleus in 6-hydroxydopamine-treated rats: effects on striatal glutamate and apomorphine-induced contralateral rotations.

Synapse (New York, N.Y.) 20040315

Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion.

Synapse (New York, N.Y.) 20040301

High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonism.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040301

Participation of the substantia nigra dopaminergic neurons in the occurrence of gastric mucosal erosions.

Physiology & behavior 20040301

Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.

The European journal of neuroscience 20040301

Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease.

Neuroreport 20040301

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

Annals of the New York Academy of Sciences 20040301

Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions.

Journal of neurocytology 20040301

Sympathetic nervous system mediates cold stress-induced suppression of natural killer cytotoxicity in rats.

Neuroscience letters 20040226

Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.

European journal of pharmacology 20040220

Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease.

Neuroscience letters 20040219

Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease.

Current biology : CB 20040217

[Therapeutic study of autologous Schwann cells' bridge graft into the brain of hemiparkinsonian monkey].

Zhonghua yi xue za zhi 20040217

Time-dependent recovery from the effects of 6-hydroxydopamine lesions of the rat nucleus accumbens on cocaine self-administration and the levels of dopamine in microdialysates.

Psychopharmacology 20040201

Locally released norepinephrine in the oxygen-dependent regulation of vascular tone of human umbilical vein.

Pediatric research 20040201

Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease.

Biomaterials 20040201

Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.

Synapse (New York, N.Y.) 20040201

Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.

Synapse (New York, N.Y.) 20040201

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats.

Neuropharmacology 20040201

Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine.

The International journal of neuroscience 20040201

Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease.

Experimental neurology 20040201

Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson's disease.

Experimental neurology 20040201

Sympathetic nervous system regulation of immunity.

Journal of neuroimmunology 20040201

Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor.

Pharmacology, biochemistry, and behavior 20040201

Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine.

Journal of neurochemistry 20040201

[Effect of high-frequency stimulation to subthalamic nucleus on STR neuronal firing rates in Parkinson disease rats].

Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20040201

Preclinical models of Parkinson's disease.

Current protocols in toxicology 20040201

Vulnerabilities of ventral mesencephalic neurons projecting to the nucleus accumbens following infusions of 6-hydroxydopamine into the medial forebrain bundle in the rat.

Brain research 20040130

6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats.

Brain research 20040123

Ventral striatopallidal oxytocin and vasopressin V1a receptors in the monogamous prairie vole (Microtus ochrogaster).

The Journal of comparative neurology 20040119

Beta-adrenoceptor modulation of transiently overexpressed alpha 2-adrenoceptors in brain and peripheral tissues: cellular mechanisms underlying the developmental toxicity of terbutaline.

Brain research bulletin 20040115

Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment.

Neurology 20040113

Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040101

Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry.

Experimental brain research 20040101

'Hydrocephalus-parkinsonism complex': progressive hydrocephalus as a factor affecting extrapyramidal tract disorder-an experimental study.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20040101

Normalization of glutamate decarboxylase gene expression in the entopeduncular nucleus of rats with a unilateral 6-hydroxydopamine lesion correlates with increased GABAergic input following intermittent but not continuous levodopa.

Neuroscience 20040101

Neuritogenic and survival-promoting effects of the P2 peptide derived from a homophilic binding site in the neural cell adhesion molecule.

Journal of neuroscience research 20040101

Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions.

Journal of neuroscience research 20040101

Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Journal of neurochemistry 20040101

CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamine.

Journal of neurochemistry 20040101

Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.

Experimental neurology 20040101

Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.

Molecular pharmacology 20040101

Intralaminar thalamic nuclei lesions: widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia.

Journal of neuropathology and experimental neurology 20040101

[Modeling Parkinson's disease and objectifying the nigro-striatum system dysfunction].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20040101

Minocycline: neuroprotective mechanisms in Parkinson's disease.

Current pharmaceutical design 20040101

Exploiting oxidative stress and signaling in chemotherapy of resistant neoplasms.

Biochemistry. Biokhimiia 20040101

Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain.

Neuroscience 20040101

Heparin-binding epidermal growth factor-like growth factor: a component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo.

Neuroscience 20040101

The implementation of acute versus chronic animal models for treatment discovery in Parkinson's disease.

Reviews in the neurosciences 20040101

P2Y receptors present in the native and isolated rat glomerulus.

Nephron. Physiology 20040101

Dopamine D2 receptors mediate two-odor discrimination and reversal learning in C57BL/6 mice.

BMC neuroscience 20040101

Inhibition of DT-diaphorase potentiates the in vivo neurotoxic effect of intranigral injection of salsolinol in rats.

Neurotoxicity research 20040101

Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry.

Journal of proteome research 20040101

Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration.

Stem cells (Dayton, Ohio) 20040101

Liposomal formulations of tacrolimus and rapamycin increase graft survival and fiber outgrowth of dopaminergic grafts.

Cell transplantation 20040101

Comparison of embryonic stem cell-derived dopamine neuron grafts and fetal ventral mesencephalic tissue grafts: morphology and function.

Cell transplantation 20040101

Fate of (D-Ala2)-deltorphin-I-like immunoreactive neurons in 6-hydroxydopamine lesioned rat brain.

European journal of histochemistry : EJH 20040101

Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.

Neuroscience 20040101

Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson disease.

Clinical neuropharmacology 20040101

Effects of neonatal treatment with 6-hydroxydopamine and endocrine disruptors on motor activity and gene expression in rats.

Neural plasticity 20040101

Effects of moxibustion to zusanli (ST36) on alteration of natural killer cell activity in rats.

The American journal of Chinese medicine 20040101

Genome wide analysis of common and specific stress responses in adult drosophila melanogaster.

BMC genomics 20040101

The potential role of vascular endothelial growth factor in the central nervous system.

Reviews in the neurosciences 20040101

Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity.

Neurotoxicity research 20040101

Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo.

Cell transplantation 20040101

FGF-2 and S100beta immunoreactivities increase in reactive astrocytes, but not in microglia, in ascending dopamine pathways following a striatal 6-OHDA-induced partial lesion of the nigrostriatal system.

Cell biology international 20040101

Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture.

Stem cells (Dayton, Ohio) 20040101

AMPA receptor blockade potentiates the stimulatory effect of L-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation.

Critical reviews in neurobiology 20040101

Plasma aminopeptidase activities in rats after left and right intrastriatal administration of 6-hydroxydopamine.

Neuroendocrinology 20040101

Serotonin neurotoxins--past and present.

Neurotoxicity research 20040101

Neurotoxins and neurotoxic species implicated in neurodegeneration.

Neurotoxicity research 20040101

Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease.

Journal of molecular neuroscience : MN 20040101

[Comparative study of the effects of amphetamine and dimethoxymethamphetamine on brain self-stimulation in rats after perinatal administration of 6-hydroxydopamine].

Eksperimental'naia i klinicheskaia farmakologiia 20040101

Origin and mediation of secretion induced by oral phytohaemagglutinin (PHA) in rats.

Acta physiologica Hungarica 20040101

Changes in dopamine D2 receptors and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake in the brain of 6-hydroxydopamine-lesioned rats.

Neuro-degenerative diseases 20040101

Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals.

Brain research 20031219

Genetically modified human embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease.

Neuroscience letters 20031219

Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice.

Synapse (New York, N.Y.) 20031215

Baculovirus p35 gene greatly enhances PC12 cell's resistance against oxidative stress.

Journal of the neurological sciences 20031215

Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase.

Brain research bulletin 20031215

Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats.

Neurology 20031209

Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease.

Neurology 20031209

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.

Neurology 20031209

Gene expression of glutamate receptors GluR1 and NR1 is differentially modulated in striatal neurons in rats after 6-hydroxydopamine lesion.

Neurochemistry international 20031201

Cardiovascular regulation after destruction of the C1 cell group of the rostral ventrolateral medulla in rats.

American journal of physiology. Heart and circulatory physiology 20031201

'Passive stabilization' of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat.

Journal of neurochemistry 20031201

Effects of orally administered levodopa on mesencephalic dopaminergic neurons undergoing a degenerative process.

Neuroscience research 20031201

cDNA microarray analysis of changes in gene expression associated with MPP+ toxicity in SH-SY5Y cells.

Neurochemical research 20031201

Dopamine receptor supersensitivity in rat subthalamus after 6-hydroxydopamine lesions.

The European journal of neuroscience 20031201

Neuroprotection by flavonoids.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20031201

Long term gene therapy of Parkinson's disease using immortalized rat glial cell line with tyrosine hydroxylase gene.

Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica 20031201

Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats.

Movement disorders : official journal of the Movement Disorder Society 20031201

Neurochemical correlates of sparing from motor deficits in rats depleted of striatal dopamine as weanlings.

Developmental psychobiology 20031201

[Relationship between neurotoxicity of 6-hydroxydopamine and glutamate transport].

Yao xue xue bao = Acta pharmaceutica Sinica 20031201

The role of metallothionein II in neuronal differentiation and survival.

Brain research 20031128

Proteomic analysis reveals upregulation of calreticulin in murine dopaminergic neuronal cells after treatment with 6-hydroxydopamine.

Neuroscience letters 20031127

Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells.

Brain research. Molecular brain research 20031126

A unilateral 6-hydroxydopamine lesion decreases the expression of metabotropic glutamate receptors in rat substantia nigra.

Neuroscience letters 20031120

Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells.

Journal of the neurological sciences 20031115

Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons.

Brain research 20031107

The importance of the prolonged postnatal period in determination of heart atrial muscarinic receptor and beta-adrenoceptor densities.

Life sciences 20031107

Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy.

American journal of physiology. Endocrinology and metabolism 20031101

Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats.

Synapse (New York, N.Y.) 20031101

Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats.

Synapse (New York, N.Y.) 20031101

Role of brain dopaminergic system in the adrenomedullin-induced diuresis and natriuresis.

Pharmacological research 20031101

The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.

Naunyn-Schmiedeberg's archives of pharmacology 20031101

The sympathomimetic actions of l-ephedrine and d-pseudoephedrine: direct receptor activation or norepinephrine release?

Anesthesia and analgesia 20031101

Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regeneration.

Experimental neurology 20031101

mGluRs: a target for pharmacotherapy in Parkinson disease.

Experimental neurology 20031101

Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20031101

Chemical sympathectomy by 6-OH dopamine during fetal life results in inguinal testis through altering cremasteric contractility in rats.

Journal of pediatric surgery 20031101

Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats.

The European journal of neuroscience 20031101

[Protective effect of exogenous superoxide dismutase against rat midbrain dopaminergic neuron apoptosis induced by 6-hydroxydopamine].

Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20031101

Can the brain be protected through exercise? Lessons from an animal model of parkinsonism.

Experimental neurology 20031101

Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers.

Experimental neurology 20031101

Interaction between serotonergic and noradrenergic axons during axonal regeneration.

Experimental neurology 20031101

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease.

Experimental neurology 20031101

The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations.

Experimental neurology 20031101

Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus).

Experimental neurology 20031101

Intrathecal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine blocks the antinociception induced by endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse.

Journal of pharmacological sciences 20031101

[Wakefulness and central basal nuclei: experimental observations and possible implications in Parkinson's disease].

Revue neurologique 20031101

Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease.

The European journal of neuroscience 20031101

Experimental therapeutics of Parkinson's disease.

Clinical and experimental pharmacology & physiology 20031101

[The effect of neurochemical damage of dopaminergic terminals in early ontogenesis on the behavior of adult rats].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20031101

[Effect of Chinese and western medicine integration on spinning behavior of rats with Parkinson disease].

Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20031101

Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception.

Brain research 20031017

Minocycline enhances MPTP toxicity to dopaminergic neurons.

Journal of neuroscience research 20031015

Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat.

Brain research. Molecular brain research 20031007

Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine.

Brain research 20031003

Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031001

Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.

The Journal of pharmacology and experimental therapeutics 20031001

Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons.

Neurobiology of disease 20031001

Denervation and repeated L-DOPA induce a coordinate expression of the transcription factor NGFI-B in striatal projection pathways in hemi-parkinsonian rats.

Neurobiology of disease 20031001

Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease.

Parkinsonism & related disorders 20031001

Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion.

Biochemical pharmacology 20031001

Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells.

Cellular and molecular neurobiology 20031001

Dopaminergic trophism after intrastriatal injection of lentivirus-transferred GDNF in Parkinson rat model.

Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica 20031001

Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20031001

Primate models of Parkinson's disease.

Experimental neurology 20031001

Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra.

Experimental neurology 20031001

Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection.

Experimental neurology 20031001

Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys.

Experimental neurology 20031001

Survival and differentiation of adult rat-derived neural progenitor cells transplanted to the striatum of hemiparkinsonian rats.

Experimental neurology 20031001

Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells.

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20031001

Effect of ipsilateral subthalamic nucleus lesioning in a rat parkinsonian model: study of behavior correlated with neuronal activity in the pedunculopontine nucleus.

Journal of neurosurgery 20031001

Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences.

Journal of chemical neuroanatomy 20031001

Effect of 6-OHDA lesions of the dopaminergic mesolimbic system on drug priming induced reinstatement of extinguished morphine CPP in rats.

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20031001

Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases.

Brain pathology (Zurich, Switzerland) 20031001

Physiological release of striatal acetylcholine (in vivo): effect of somatostatin on dopaminergic-cholinergic interaction.

Brain research bulletin 20030930

Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease.

The Journal of biological chemistry 20030926

Dual effects of intermittent or continuous L-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion.

Synapse (New York, N.Y.) 20030915

Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity.

Journal of medicinal chemistry 20030911

Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20030910

High frequency stimulation of the subthalamic nucleus improves treadmill locomotion in unilateral 6-hydroxydopamine lesioned rats.

Brain research 20030905

Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 20030901

The meningeal sheath of the regenerating spinal cord of the eel, Anguilla.

Anatomy and embryology 20030901

In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria.

American journal of physiology. Endocrinology and metabolism 20030901

Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.

Journal of neurochemistry 20030901

Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat.

Journal of neuroscience research 20030901

Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury.

Hepatology (Baltimore, Md.) 20030901

Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.

Journal of neurochemistry 20030901

Transfer of the von Hippel-Lindau gene to neuronal progenitor cells in treatment for Parkinson's disease.

Annals of neurology 20030901

Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat.

The European journal of neuroscience 20030901

Effect of acute and chronic administration of U50,488, a kappa opioid receptor agonist, in 6-OHDA-lesioned rats chronically treated with levodopa.

Experimental neurology 20030901

Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole.

Experimental neurology 20030901

Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias.

The European journal of neuroscience 20030901

[Effect of 6-hydroxydopamine on the electrical characteristics of snail neurons in long-term sensitization].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20030901

Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20030827

[Correlation between iron levels and degeneration of dopaminergic neurons in rat nigrostriatal system during the early 6-OHDA lesions in medial forebrain bundle].

Sheng li xue bao : [Acta physiologica Sinica] 20030825

Role of the mesotelencephalic dopamine system in learning and memory processes in the rat.

European journal of pharmacology 20030815

In vivo delivery of glial cell-derived neurotrophic factor across the blood-brain barrier by gene transfer into brain capillary endothelial cells.

Human gene therapy 20030810

Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.

British journal of pharmacology 20030802

LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 20030801

Toluene-induced locomotor activity is blocked by 6-hydroxydopamine lesions of the nucleus accumbens and the mGluR2/3 agonist LY379268.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030801

Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions.

Brain research 20030801

Central catecholamine depletion inhibits peripheral lymphocyte responsiveness in spleen and blood.

Journal of neurochemistry 20030801

The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats.

Pharmacology & toxicology 20030801

Behavioral correction of Parkinsonian rats following the transplantation of immortalized fibroblasts genetically modified with TH and GCH genes.

Parkinsonism & related disorders 20030801

Intraaccumbens dopaminergic lesion suppresses desipramine effects in the forced swim test but not in the neuronal activity of lateral septal nucleus.

Progress in neuro-psychopharmacology & biological psychiatry 20030801

The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis.

The European journal of neuroscience 20030801

High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task.

The European journal of neuroscience 20030801

Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20030716

Neurotrophic factor in the treatment of Parkinson disease.

Neurosurgical focus 20030715

Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease.

Experimental brain research 20030701

Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity.

Journal of neurochemistry 20030701

Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?

Journal of neural transmission (Vienna, Austria : 1996) 20030701

Models of Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20030701

Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK.

Journal of neuroscience research 20030701

Protective effect of central thyrotropin-releasing hormone on carbon tetrachloride-induced acute hepatocellular necrosis in rats.

Journal of hepatology 20030701

Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned rats.

Pharmacology & toxicology 20030701

Degeneration of the nigrostriatal pathway and induction of motor deficit by tetrahydrobiopterin: an in vivo model relevant to Parkinson's disease.

Neurobiology of disease 20030701

Group I mGluR ligands fail to affect 6-hydroxydopamine- induced death and glutamate release of PC12 cells.

Acta pharmacologica Sinica 20030701

Firing regulation in dopaminergic cells: effect of the partial degeneration of nigrostriatal system in surviving neurons.

The European journal of neuroscience 20030701

The role of the sympathetic nervous system in moxibustion-induced immunomodulation in rats.

Journal of neuroimmunology 20030701

Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc.

Journal of neurochemistry 20030701

Adult neural stem/progenitor cells in neurodegenerative repair.

Sheng li xue bao : [Acta physiologica Sinica] 20030625

Acute alcohol administration improves skilled reaching success in intact but not 6-OHDA dopamine depleted rats: a subsystems analysis of the motoric and anxiolytic effects of alcohol.

Behavioural brain research 20030616

Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats.

Journal of neuroscience research 20030615

Distinct forelimb and hind limb stepping impairments in unilateral dopamine-depleted rats: use of the rotorod as a method for the qualitative analysis of skilled walking.

Journal of neuroscience methods 20030615

Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20030615

Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20030601

Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.

The European journal of neuroscience 20030601

Cellular models to study dopaminergic injury responses.

Annals of the New York Academy of Sciences 20030601

Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.

Antioxidants & redox signaling 20030601

The dopaminergic system in attention deficit/hyperactivity disorder.

Congenital anomalies 20030601

Increased p53 levels without caspase-3 activity and change of cell viability in 6-hydroxydopamine-treated CV1-P cells.

Cell biology and toxicology 20030601

Dopamine effect on the stimulus pattern related changes in response characteristics of R/G horizontal cells in carp retina.

Brain research 20030530

Rapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation.

Neuroscience letters 20030529

Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons.

The Journal of biological chemistry 20030523

EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease.

Brain research 20030516

Amantadine increases L-DOPA-derived extracellular dopamine in the striatum of 6-hydroxydopamine-lesioned rats.

Brain research 20030516

Behavioral and subthalamic effects of combining a fetal ventral mesencephalic transplant in striatum with an electrolytic lesion of the entopeduncular nucleus in the rat with a unilateral 6-OHDA lesion of substantia nigra.

Synapse (New York, N.Y.) 20030501

A distinct death mechanism is induced by 1-methyl-4-phenylpyridinium or by 6-hydroxydopamine in cultured rat cortical neurons: degradation and dephosphorylation of tau.

Neuroscience letters 20030501

Role of specific adrenergic receptors in mediating the adrenocorticotropic hormone response to increased nitric oxide levels.

Journal of neuroendocrinology 20030501

Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity.

Journal of neurochemistry 20030501

Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism.

Journal of neurochemistry 20030501

Striatal formation of 6-hydroxydopamine in mice treated with pargyline, pyrogallol and methamphetamine.

Journal of neural transmission (Vienna, Austria : 1996) 20030501

Impairment of the renal p-aminohippurate transport induced by 6-hydroxydopamine.

The Journal of pharmacy and pharmacology 20030501

Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner.

The Journal of biological chemistry 20030418

Both pineal and lateral eyes are needed to sustain daily circulating melatonin rhythms in sea bass.

Brain research 20030418

Convulsive and postural effects of lesioning the mid-substantia nigra pars reticulata in naïve and 6-hydroxydopamine lesioned rats.

Brain research bulletin 20030415

Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists.

Bioorganic & medicinal chemistry 20030403

Uptake and release of [3H]adenosine in human dental pulp.

Archives of oral biology 20030401

Animal models of attention-deficit hyperactivity disorder.

Brain research. Brain research reviews 20030401

Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF.

Journal of neurochemistry 20030401

Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector.

Human gene therapy 20030320

Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats.

European journal of pharmacology 20030307

Effect of experimenter-delivered and self-administered cocaine on extracellular beta-endorphin levels in the nucleus accumbens.

Journal of neurochemistry 20030301

Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation.

Journal of neurochemistry 20030301

Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia.

Journal of neurochemistry 20030301

Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: different action on GABA cell subpopulations.

Movement disorders : official journal of the Movement Disorder Society 20030301

Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20030301

Prefrontocortical dopamine loss in rats delays long-term extinction of contextual conditioned fear, and reduces social interaction without affecting short-term social interaction memory.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030301

Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET.

European journal of nuclear medicine and molecular imaging 20030301

D2 Dopamine receptor blockade results in sprouting of DA axons in the intact animal but prevents sprouting following nigral lesions.

The European journal of neuroscience 20030301

Spreading of slow cortical rhythms to the basal ganglia output nuclei in rats with nigrostriatal lesions.

The European journal of neuroscience 20030301

Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.

Experimental neurology 20030301

Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats.

The Tohoku journal of experimental medicine 20030301

Neural stem cells. Biological features and therapeutic potential in Parkinson's disease.

Journal of neurosurgical sciences 20030301

[Effects of sympathectomy on the blood pressure of young Wistar rats fed with high-sucrose diet].

Zhonghua er ke za zhi = Chinese journal of pediatrics 20030301

Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons.

Life sciences 20030221

Activation of the peripheral sympathetic nervous system increased the expression of cyclooxygenase-2 (COX-2) mRNA in mouse calvaria.

Neuroscience letters 20030220

Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat.

Behavioural brain research 20030217

Protein 4.1N is required for translocation of inositol 1,4,5-trisphosphate receptor type 1 to the basolateral membrane domain in polarized Madin-Darby canine kidney cells.

The Journal of biological chemistry 20030207

Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro.

Neuroscience letters 20030206

Pathogenic role of glial cells in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20030201

Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences.

Journal of neurochemistry 20030201

Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors.

Journal of neurochemistry 20030201

Catalepsy intensifies context-dependently irrespective of whether it is induced by intermittent or chronic dopamine deficiency.

Behavioural pharmacology 20030201

Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment.

The European journal of neuroscience 20030201

Role of reactive oxygen species in extracellular signal-regulated protein kinase phosphorylation and 6-hydroxydopamine cytotoxicity.

Journal of biosciences 20030201

Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle.

Neuroreport 20030120

Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatments.

European journal of pharmacology 20030117

Motor effects of a dopamine stabilizer (GMC1111) in primate models of Parkinson and hemiparkinsonism.

European journal of pharmacology 20030117

A novel skilled-reaching impairment in paw supination on the 'good' side of the hemi-Parkinson rat improved with rehabilitation.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20030115

Effects of sex and estrogen on behavioral sensitization to cocaine in rats.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20030115

The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration.

Annual review of pharmacology and toxicology 20030101

99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET.

Nuclear medicine communications 20030101

Comparison of the visceral antinociceptive effects of spinally administered MPV-2426 (fadolmidine) and clonidine in the rat.

Anesthesiology 20030101

Ectopic expression of cell cycle markers in models of induced programmed cell death in dopamine neurons of the rat substantia nigra pars compacta.

Experimental neurology 20030101

Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.

Neuroscience 20030101

Effects of basolateral amygdala dopamine depletion on the nucleus accumbens and medial prefrontal cortical dopamine responses to stress.

Neuroscience 20030101

Effects of oligonucleotide antisense to dopamine D3 receptor mRNA in a rodent model of behavioural sensitization to levodopa.

Neuroscience 20030101

Effect of 6-hydroxydopamine on gluconeogenesis in the rat renal cortex.

Clinical and experimental pharmacology & physiology 20030101

Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease.

Journal of neurosurgery 20030101

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.

Human gene therapy 20030101

Effects of 6-hydroxydopamine on the development of the immune system in chickens.

The Journal of veterinary medical science 20030101

Distribution and regulation of galanin receptor 1 messenger RNA in the forebrain of wild type and galanin-transgenic mice.

Neuroscience 20030101

Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells.

Stem cells (Dayton, Ohio) 20030101

Effects of sex and hormonal status on astrocytic basic fibroblast growth factor-2 and tyrosine hydroxylase immunoreactivity after medial forebrain bundle 6-hydroxydopamine lesions of the midbrain dopamine neurons.

Neuroscience 20030101

Regulation of neuropeptide mRNA expression in the basal ganglia by intrastriatal and intranigral transplants in the rat Parkinson model.

Neuroscience 20030101

Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats.

Neuroscience 20030101

Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease.

Neuroscience 20030101

Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study.

Neuroscience 20030101

Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment.

Neurotoxicity research 20030101

Dopamine receptor supersensitivity: an outcome and index of neurotoxicity.

Neurotoxicity research 20030101

Neurotrophic factors for the investigation and treatment of movement disorders.

Neurotoxicity research 20030101

Neuroprotective strategies in Parkinson's disease : an update on progress.

CNS drugs 20030101

Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain.

Neuroscience 20030101

Changes in GABA(B) receptor mRNA expression in the rodent basal ganglia and thalamus following lesion of the nigrostriatal pathway.

Neuroscience 20030101

Attenuation of neuropathic manifestations by local block of the activities of the ventrolateral orbito-frontal area in the rat.

Neuroscience 20030101

What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?

Journal of neural transmission. Supplementum 20030101

Animal models of Parkinson's disease in rodents induced by toxins: an update.

Journal of neural transmission. Supplementum 20030101

Growth/differentiation factor-15 (GDF-15), a novel member of the TGF-beta superfamily, promotes survival of lesioned mesencephalic dopaminergic neurons in vitro and in vivo and is induced in neurons following cortical lesioning.

Journal of neural transmission. Supplementum 20030101

Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20030101

Effect of subthalamic lesion with kainic acid on the neuronal activities of the basal ganglia of rat parkinsonian models with 6-hydroxydopamine.

Acta neurochirurgica. Supplement 20030101

Ampakines reduce methamphetamine-driven rotation and activate neocortex in a regionally selective fashion.

Neuroscience 20030101

Effect of levodopa chronic administration on behavioral changes and fos expression in basal ganglia in rat model of PD.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20030101

Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats.

Neuroscience 20030101

Apomorphine attenuates 6-hydroxydopamine-induced apoptotic cell death in SH-SY5Y cells.

Redox report : communications in free radical research 20030101

A6 noradrenergic cell group modulates the hypoxic ventilatory response.

Advances in experimental medicine and biology 20030101

Neural immune pathways and their connection to inflammatory diseases.

Arthritis research & therapy 20030101

Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway.

Neurotoxicity research 20030101

Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.

Neurotoxicity research 20030101

Co-localization of histamine and dopamine-beta-hydroxylase in sympathetic ganglion and release of histamine from cardiac sympathetic terminals of guinea-pig.

Autonomic & autacoid pharmacology 20030101

Cardiac myosin phenotype remodelling following adrenodemedullectomy and chronic 6-hydroxydopamine in male Sprague-Dawley rats.

Experimental and clinical cardiology 20030101

Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease.

The Journal of biological chemistry 20021227

Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats.

Neuroscience letters 20021225

Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat.

Brain research 20021220

Systemic administration of dizocilpine maleate (MK-801) or L-dopa reverses the increases in GAD65 and GAD67 mRNA expression in the globus pallidus in a rat hemiparkinsonian model.

Synapse (New York, N.Y.) 20021215

Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20021215

The acquisition and maintenance of voluntary ethanol drinking in the rat: effects of dopaminergic lesions and naloxone.

Behavioural brain research 20021202

Nucleus accumbens dopamine depletion impairs both acquisition and performance of appetitive Pavlovian approach behaviour: implications for mesoaccumbens dopamine function.

Behavioural brain research 20021202

Nucleus accumbens dopamine and work requirements on interval schedules.

Behavioural brain research 20021202

Fixed ratio discrimination training increases in vivo striatal dopamine in neonatal 6-OHDA-lesioned rats.

Pharmacology, biochemistry, and behavior 20021201

Locomotor stimulant effects of nornicotine: role of dopamine.

Pharmacology, biochemistry, and behavior 20021201

Diffusion parameters in the striatum of rats with 6-hydroxydopamine-induced lesions and with fetal mesencephalic grafts.

Journal of neuroscience research 20021201

Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment.

Brain : a journal of neurology 20021201

Activation of tyrosine hydroxylase in the lateral efferent terminals by sound conditioning.

Hearing research 20021201

Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's disease.

Molecular pharmacology 20021201

Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20021201

Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases.

The American journal of pathology 20021201

Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors.

Stroke 20021201

AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa.

The European journal of neuroscience 20021201

Chemical sympathectomy increases numbers of inflammatory cells in the peritoneum early in murine listeriosis.

Brain, behavior, and immunity 20021201

Contrasting pattern of cytokines in antigen- versus mitogen-stimulated splenocyte cultures from chemically denervated mice.

Brain, behavior, and immunity 20021201

Intrastriatal grafting of glomus cells ameliorates behavioral defects of Parkinsonian rats.

Physiology & behavior 20021201

An inflammatory review of Parkinson's disease.

Progress in neurobiology 20021201

Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity.

Brain research 20021129

Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins.

Neuroscience letters 20021115

Acute and repeated treatment with L-DOPA increase c-jun expression in the 6-hydroxydopamine-lesioned forebrain of rats and common marmosets.

Brain research 20021115

Differential in vivo clearance of serotonin in rat dorsal raphe nucleus and CA3 region.

Brain research 20021115

[125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents.

Brain research 20021108

The p53-activated gene, PAG608, requires a zinc finger domain for nuclear localization and oxidative stress-induced apoptosis.

The Journal of biological chemistry 20021101

Behavioral effects of aminochrome and dopachrome injected in the rat substantia nigra.

Pharmacology, biochemistry, and behavior 20021101

Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.

Journal of neurochemistry 20021101

Compromised peripheral immunity of mice injected intrastriatally with six-hydroxydopamine.

Journal of neuroimmunology 20021101

Dopamine agonists and neuroprotection in Parkinson's disease.

European journal of neurology 20021101

Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats.

Movement disorders : official journal of the Movement Disorder Society 20021101

Bone morphogenetic proteins but not growth differentiation factors induce dopaminergic differentiation in mesencephalic precursors.

Molecular and cellular neurosciences 20021101

Distribution of adenosine A(2A) receptor antagonist KW-6002 and its effect on gene expression in the rat brain.

Brain research 20021025

Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20021015

FR143166 attenuates spinal pain transmission through activation of the serotonergic system.

European journal of pharmacology 20021011

Nerve growth factor levels in Parkinson disease and experimental parkinsonian rats.

Brain research 20021011

Subthalamic GAD gene therapy in a Parkinson's disease rat model.

Science (New York, N.Y.) 20021011

Dopamine depletion causes fragmented clustering of neurons in the sensorimotor striatum: evidence of lasting reorganization of corticostriatal input.

The Journal of comparative neurology 20021007

Rotational behaviour in AA and ANA rats after repeated administration of morphine and cocaine.

Pharmacology, biochemistry, and behavior 20021001

Effect of glutamatergic systems on in vivo binding of [(125)I]beta-CIT in the brain of a rat model of Parkinson's disease.

Synapse (New York, N.Y.) 20021001

Early, selective, and marked loss of sympathetic nerves from the islets of BioBreeder diabetic rats.

Diabetes 20021001

Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20021001

Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism.

Journal of neural transmission (Vienna, Austria : 1996) 20021001

Rat heart GDNF: effect of chemical sympathectomy.

Histochemistry and cell biology 20021001

PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's disease.

Neuropharmacology 20021001

Catecholaminergic neuronal degeneration in rainbow trout assessed by skin color change: a model system for identification of environmental risk factors.

Neurotoxicology 20021001

Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer.

Experimental neurology 20021001

Neonatal ablation of the nigrostriatal dopamine pathway does not influence limb development in rats.

Experimental neurology 20021001

Quetiapine attenuates levodopa-induced motor complications in rodent and primate parkinsonian models.

Experimental neurology 20021001

Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and beta-adrenoceptors.

Journal of neuroimmunology 20021001

Role of catecholaminergic terminals in the preoptic area in behavioural thermoregulation in rats.

Indian journal of physiology and pharmacology 20021001

The sympathetic nervous system is involved in the inhibitory effect of morphine on the colon motility in rats.

Autonomic neuroscience : basic & clinical 20020930

Optimal conditions for in vivo induction of dopaminergic neurons from embryonic stem cells through stromal cell-derived inducing activity.

Journal of neuroscience research 20020915

Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.

Journal of neuroscience research 20020915

Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.

Journal of neuroscience research 20020915

Regulation of c-Ret, GFRalpha1, and GFRalpha2 in the substantia nigra pars compacta in a rat model of Parkinson's disease.

Journal of neurobiology 20020915

The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20020915

Behavioral improvement and dopamine release in a Parkinsonian rat model.

Neuroscience letters 20020913

Induced expression of early response genes/oxidative injury in rat pheochromocytoma (PC12) cell line by 6-hydroxydopamine: implication for Parkinson's disease.

Neuroscience letters 20020913

Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease.

Pharmacology, biochemistry, and behavior 20020901

Effect of FK506 on neurotransmitter content and expression of GAP-43 in neurotoxin-lesioned peripheral sensory and sympathetic neurons.

Pharmacology 20020901

Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum.

The Journal of pharmacology and experimental therapeutics 20020901

Functional and histochemical characterization of a uterine adrenergic denervation process in pregnant rats.

Biology of reproduction 20020901

(123)I- or (125)I-metaiodobenzylguanidine visualization of brown adipose tissue.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20020901

alpha2-Adrenoceptors control the release of noradrenaline but not neuropeptide Y from perivascular nerve terminals.

Peptides 20020901

Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity?

Parkinsonism & related disorders 20020901

Selective destruction of dopaminergic neurons by low concentrations of 6-OHDA and MPP+: protection by acetylsalicylic acid aspirin.

Parkinsonism & related disorders 20020901

Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells.

Neuropharmacology 20020901

Identification and comparative analysis of differentially expressed proteins in rat striatum following 6-hydroxydopamine lesions of the nigrostriatal pathway: up-regulation of amyloid precursor-like protein 2 expression.

The European journal of neuroscience 20020901

Generation of dopaminergic neurons from embryonic stem cells.

Journal of neurology 20020901

Change in bi-directional plasticity at CA1 synapses in hippocampal slices taken from 6-hydroxydopamine-treated rats: the role of endogenous norepinephrine.

The European journal of neuroscience 20020901

Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat.

Experimental neurology 20020901

Behavioral and anatomical effects of long-term L-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesions of the nigrostriatal system.

Experimental neurology 20020901

Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT.

NeuroImage 20020901

The biology of fear- and anxiety-related behaviors.

Dialogues in clinical neuroscience 20020901

Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion.

Neuroscience letters 20020830

The spinal antinociceptive effect of kyotorphin in mice: involvement of the descending noradrenergic and serotonergic systems.

Neuroscience letters 20020830

Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.

Brain research 20020830

Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity.

Brain research. Developmental brain research 20020830

Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action.

The Journal of biological chemistry 20020823

Ventral tegmental lesions reduce overconsumption of normally preferred taste fluid in rats.

Behavioural brain research 20020821

Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20020815

Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure.

Circulation 20020813

Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats.

Neuroscience letters 20020809

A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis.

Brain research 20020802

Comparison of fresh and cryopreserved porcine ventral mesencephalon cells transplanted in A rat model of Parkinson's disease.

Journal of neuroscience research 20020801

Efficacy of elevated body swing test in the early model of Parkinson's disease in rat.

Physiology & behavior 20020801

Characterization of a novel tetrandrine-induced contraction in rat tail artery.

Acta pharmacologica Sinica 20020801

Lack of correlation between NF-kappaB activation and induction of programmed cell death in PC12 pheochromocytoma cells treated with 6-hydroxydopamine or the cannabinoid receptor 1-agonist CP55,940.

Biochemical pharmacology 20020801

The adult substantia nigra contains progenitor cells with neurogenic potential.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20020801

Forced nonuse in unilateral parkinsonian rats exacerbates injury.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20020801

Lack of daily rhythms major modifications despite continuous infusion of melatonin in the rat.

Journal of veterinary pharmacology and therapeutics 20020801

Effect of 6-hydroxydopamine treatment in the area postrema on morphine-induced emesis in ferrets.

Japanese journal of pharmacology 20020801

Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum.

Neurobiology of disease 20020801

A novel rotometer based on a RISC microcontroller.

Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc 20020801

[Participation of the brain catecholamines in changes in activity of the rat hypophyseal-adrenal system induced by hydrocortisone administration during neonatal ontogenesis].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20020801

Excitatory effects of dopamine on subthalamic nucleus neurons: in vitro study of rats pretreated with 6-hydroxydopamine and levodopa.

Brain research 20020726

Aggravation of 6-hydroxydopamine-induced dopaminergic lesions in metallothionein-I and -II knock-out mouse brain.

Neuroscience letters 20020712

Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys.

Nuclear medicine and biology 20020701

Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine.

Journal of neurochemistry 20020701

Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.

Journal of neurophysiology 20020701

Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20020701

Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease.

Biochemical pharmacology 20020701

L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.

Neurobiology of disease 20020701

7-Hydroxy-N,N'-di-n-propyl-2-aminotetraline, a preferential dopamine D3 agonist, induces c-fos mRNA expression in the rat cerebellum.

Japanese journal of pharmacology 20020701

Low 4-aminopyridine concentration-induced contraction is mediated by neuronal noradrenaline in canine saphenous vein.

Vascular pharmacology 20020701

Evidence for a mutual interaction between noradrenergic and serotonergic agonists in stimulation of ACTH and corticosterone secretion in the rat.

Brain research 20020621

Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation.

European journal of pharmacology 20020620

High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20020615

Specific up-regulation of GADD153/CHOP in 1-methyl-4-phenyl-pyridinium-treated SH-SY5Y cells.

Journal of neuroscience research 20020615

Morphological changes in immunopositive cells of ionotropic glutamate receptor subunits during the development of transplanted fetal ventral mesencephalic neurons.

Brain research 20020614

Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase.

Neuroscience letters 20020607

Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.

Synapse (New York, N.Y.) 20020601

Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020601

Involvement of endogenous CRF in carbon tetrachloride-induced acute liver injury in rats.

American journal of physiology. Regulatory, integrative and comparative physiology 20020601

Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.

The Journal of pharmacology and experimental therapeutics 20020601

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.

Experimental neurology 20020601

Neurturin is a neuritogenic but not a survival factor for developing and adult central noradrenergic neurons.

Journal of neurochemistry 20020601

Nucleus accumbens dopamine and discriminated approach learning: interactive effects of 6-hydroxydopamine lesions and systemic apomorphine administration.

Psychopharmacology 20020601

Dopamine has a critical role in photoreceptor degeneration in the rd mouse.

Neurobiology of disease 20020601

Abused inhalants and central reward pathways: electrophysiological and behavioral studies in the rat.

Annals of the New York Academy of Sciences 20020601

[Glia conditioned medium offers protection against the toxicity induced by 6-OH-dopamine in vivo].

Revista de neurologia 20020601

Intraperitoneal administration of choline increases serum glucose in rat: involvement of the sympathoadrenal system.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20020601

Comparison of the efficacy of cell preparations from embryonic ventral mesencephalon of various prenatal age transplanted intrastriatally to rats with 6-OHDA-induced Parkinsonism.

Bulletin of experimental biology and medicine 20020601

Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats.

Brain research 20020531

Induction of tyrosine hydroxylase expression in rat fetal striatal precursor cells following transplantation.

Neuroscience letters 20020510

Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020501

beta-Adrenergic modulation of muscarinic cholinergic receptor expression and function in developing heart.

American journal of physiology. Regulatory, integrative and comparative physiology 20020501

Brain structures mediating the suckling stimulus-induced release of prolactin.

Journal of neuroendocrinology 20020501

Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra.

Experimental neurology 20020501

The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease.

Experimental neurology 20020501

Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.

Experimental neurology 20020501

Involvement of dopaminergic system in the nucleus accumbens in the discriminative stimulus effects of phencyclidine.

Neuropharmacology 20020501

Phencyclidine supersensitivity in rats with neonatal dopamine loss.

Psychopharmacology 20020501

p38 MAP kinase is involved in lipopolysaccharide-induced dopaminergic neuronal cell death in rat mesencephalic neuron-glia cultures.

Annals of the New York Academy of Sciences 20020501

Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area -- model of the early beginning of Parkinson's symptomatology?

Journal of neural transmission (Vienna, Austria : 1996) 20020501

Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.

Movement disorders : official journal of the Movement Disorder Society 20020501

[Effects of simultaneous transplant of foetal mesencephalic cells in the striatum and the subthalamic nucleus of hemiparkinsonian rats].

Revista de neurologia 20020501

Low cumulative manganese exposure affects striatal GABA but not dopamine.

Neurotoxicology 20020501

The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585.

Brain research 20020426

Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors.

European journal of pharmacology 20020419

The rate of intravenous cocaine administration determines susceptibility to sensitization.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20020415

Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination.

Journal of neuroscience methods 20020415

Differential effect of catecholamines and MPP(+) on membrane permeability in brain mitochondria and cell viability in PC12 cells.

Neurochemistry international 20020401

In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020401

Alterations in responses of ventral pallidal neurons to excitatory amino acids after long-term dopamine depletion.

The Journal of pharmacology and experimental therapeutics 20020401

Chemical sympathectomy has no effect on the severity of murine AIDS: murine AIDS alone depletes norepinephrine levels in infected spleen.

Brain, behavior, and immunity 20020401

Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.

Experimental neurology 20020401

Animal models of Parkinson's disease.

BioEssays : news and reviews in molecular, cellular and developmental biology 20020401

Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens: commentary on Jackson and Cunnane.

British journal of pharmacology 20020401

Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens.

British journal of pharmacology 20020401

Modulation of dendritic release of dopamine by metabotropic glutamate receptors in rat substantia nigra.

Biochemical pharmacology 20020401

Sympathetic nervous system plays a major role in acute cold/restraint stress inhibition of host resistance to Listeria monocytogenes.

Journal of neuroimmunology 20020401

Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.

Psychopharmacology 20020401

Dopaminergic cells of the carotid body: physiological significance and possible therapeutic applications in Parkinson's disease.

Brain research bulletin 20020401

6-Hydroxydopamine lesioning differentially affects alpha-synuclein mRNA expression in the nucleus accumbens, striatum and substantia nigra of adult rats.

Neuroscience letters 20020329

Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems.

The Journal of comparative neurology 20020318

Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease.

Biochimica et biophysica acta 20020316

Glyceraldehyde-3-phospate dehydrogenase is translocated into nuclei through Golgi apparatus during apoptosis induced by 6-hydroxydopamine in human dopaminergic SH-SY5Y cells.

Neuroscience letters 20020315

GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum.

Neuroscience letters 20020315

Central noradrenergic blockade prevents autotomy in rat: implication for pharmacological prevention of postdenervation pain syndrome.

Brain research bulletin 20020315

Interactions of the neurotoxin 6-hydroxydopamine with glyceraldehyde-3-phosphate dehydrogenase.

Toxicology letters 20020310

Protective effect of serotonin on 6-hydroxydopamine- and dopamine-induced oxidative damage of brain mitochondria and synaptosomes and PC12 cells.

Neurochemistry international 20020301

Role of norepinephrine in the dorsomedial hypothalamic panic response: an in vivo microdialysis study.

Pharmacology, biochemistry, and behavior 20020301

Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20020301

D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation.

The European journal of neuroscience 20020301

Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

The European journal of neuroscience 20020301

Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum.

Journal of neural transmission (Vienna, Austria : 1996) 20020301

Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.

Gene therapy 20020301

Fos and nitric oxide synthase in rat brain with chronic mesostriatal dopamine deficiency: effects of nitroglycerin and hypoxia.

Parkinsonism & related disorders 20020301

Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.

Brain research. Developmental brain research 20020227

Neuroprotection and dopamine agonists.

Neurology 20020226

Mesolimbic dopaminergic system is involved in diurnal blood pressure regulation.

Brain research 20020222

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Proceedings of the National Academy of Sciences of the United States of America 20020219

Monoamine neurotoxins-induced apoptosis in lymphocytes by a common oxidative stress mechanism: involvement of hydrogen peroxide (H(2)O(2)), caspase-3, and nuclear factor kappa-B (NF-kappaB), p53, c-Jun transcription factors.

Biochemical pharmacology 20020215

Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.

European journal of pharmacology 20020202

Modulation of neuroleptic activity of 9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829) by D1 intrinsic activity in hemi-parkinsonian rats.

Molecular pharmacology 20020201

Neuroprotective actions of selegiline.

Journal of neuroscience research 20020201

MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats.

Brain research 20020201

Differential effects of a small, unilateral, 6-hydroxydopamine-induced nigral lesion on behavior in high and low responders to novelty.

Experimental neurology 20020201

Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20020201

Inhibition of rat liver fibrogenesis through noradrenergic antagonism.

Hepatology (Baltimore, Md.) 20020201

Intraplantar injection of glutamate evokes peripheral adenosine release in the rat hind paw: involvement of peripheral ionotropic glutamate receptors and capsaicin-sensitive sensory afferents.

Journal of neurochemistry 20020201

Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice.

Cell and tissue research 20020201

The effects of chemical sympathectomy on T-cell cytokine responses are not mediated by altered peritoneal exudate cell function or an inflammatory response.

Brain, behavior, and immunity 20020201

Chemical sympathectomy alters numbers of splenic and peritoneal leukocytes.

Brain, behavior, and immunity 20020201

Protective effect of boldine on dopamine-induced membrane permeability transition in brain mitochondria and viability loss in PC12 cells.

Biochemical pharmacology 20020201

Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.

Psychopharmacology 20020201

Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector.

Neuroreport 20020121

Effects of short- and long-acting dopamine agonists on sensitized dopaminergic neurotransmission in rats with unilateral 6-OHDA lesions.

Life sciences 20020118

Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum.

Life sciences 20020118

The reaction of nitric oxide with 6-hydroxydopamine: implications for Parkinson's disease.

Free radical biology & medicine 20020115

MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.

Synapse (New York, N.Y.) 20020101

Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells.

Archives of biochemistry and biophysics 20020101

Regulation of striatal neuropeptide mRNAs: effects of the 5-HT(2) antagonist SR46349B in adult rats with a neonatal 6-hydroxydopamine lesion.

Journal of neuroscience research 20020101

Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures.

Biochemical pharmacology 20020101

Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease.

Experimental neurology 20020101

Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.

Neurological research 20020101

D-amphetamine-induced behavioral sensitization: effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex.

Neuroscience 20020101

Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease - a functional magnetic resonance imaging study.

The European journal of neuroscience 20020101

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

The European journal of neuroscience 20020101

Study of the neurotransmitter dopamine and the neurotoxin 6-hydroxydopamine by electrospray ionization coupled with tandem mass spectrometry.

Rapid communications in mass spectrometry : RCM 20020101

Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease.

Journal of neurochemistry 20020101

Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture.

Journal of neurochemistry 20020101

Activation and differentiation of endogenous neural stem cell progeny in the rat Parkinson animal model.

Methods in molecular biology (Clifton, N.J.) 20020101

[Experimental models of Parkinson's disease].

Annales pharmaceutiques francaises 20020101

Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance.

Neuroscience 20020101

Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian rats.

Neuroscience 20020101

A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: implications for graft survival and targeting.

Cell transplantation 20020101

Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease.

Cell transplantation 20020101

Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response.

Cell transplantation 20020101

Adeno-associated viral delivery of GDNF promotes recovery of dopaminergic phenotype following a unilateral 6-hydroxydopamine lesion.

Cell transplantation 20020101

Xenografts of MHC-deficient mouse embryonic mesencephalon improve behavioral recovery in hemiparkinsonian rats.

Cell transplantation 20020101

Response of GABAergic cells in the deep mesencephalic nucleus to dopaminergic cell degeneration: an electrophysiological and in situ hybridization study.

Neuroscience 20020101

The effects of xenografts of dopamine-rich ganglia from the immature CNS of the mollusk Helix aspersa L. on learning time during acquisition of an operant food-procuring reflex in WAG/Rij rats.

Neuroscience and behavioral physiology 20020101

Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson's disease.

Neuroscience 20020101

Interocular effect of intravitreal injection of 6-hydroxydopamine and dopamine on spinule formation in teleost retina.

Histology and histopathology 20020101

Asymmetrical changes of excitatory synaptic transmission in dopamine-denervated striatum after transient forebrain ischemia.

Neuroscience 20020101

Enhanced release of adenosine in rat hind paw following spinal nerve ligation: involvement of capsaicin-sensitive sensory afferents.

Neuroscience 20020101

Detailed localization of regulator of G protein signaling 2 messenger ribonucleic acid and protein in the rat brain.

Neuroscience 20020101

The influence of chemical sympathectomy on pain responsivity and alpha 2-adrenergic antinociception in neuropathic animals.

Neuroscience 20020101

Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Amino acids 20020101

Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.

Amino acids 20020101

Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease.

Amino acids 20020101

Radiation and regeneration: behavioral improvement and GDNF expression after Gamma Knife radiosurgery in the 6-OHDA rodent model of hemi-parkinsonism.

Acta neurochirurgica. Supplement 20020101

A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis.

Neuroscience 20020101

Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral 'despair' in a mouse model of depression.

Neuroscience 20020101

Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia.

Neuroscience 20020101

[Criteria of efficiency of transplantation of embryonic nervous tissue preparations in rats with 6-OHDA-impaired dopaminergic nigrostriatal system].

Patologicheskaia fiziologiia i eksperimental'naia terapiia 20020101

Critical periods of the dopaminergic system formation in rat brain.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20020101

Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease.

Cell transplantation 20020101

Histochemical properties of intrastriatal mesencephalic grafts.

Advances in experimental medicine and biology 20020101

[Effect of bushen yanggan recipe on nigrostriatal function in parkinsonian model rats after long-term levodopa treatment].

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20020101

Protective effect of GSH on PD model induced by 6-OHDA in vitro.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20020101

D2-dopamine receptor blockade modulates temporal resolution in goldfish.

Visual neuroscience 20020101

Neonatal 6-hydroxydopamine administration to mice is fatal.

Developmental neuroscience 20020101

[Myoelectric function, metabolism, intestinal circulation and vagal activity after chemical sympathectomy].

Folia medica Cracoviensia 20020101

Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase.

Polish journal of pharmacology 20020101

Down-regulation of Bcl-2, activation of caspases, and involvement of reactive oxygen species in 6-hydroxydopamine-induced thymocyte apoptosis.

Neuroimmunomodulation 20020101

Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20011215

cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20011215

6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase.

Brain research 20011213

GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area.

The Journal of comparative neurology 20011210

Local capsaicin application to the stellate ganglion and stellatectomy attenuate neurogenic inflammation in rat bronchi.

Autonomic neuroscience : basic & clinical 20011210

Sustained unilateral blockade of rat striatal M(1) muscarinic receptors with m1-toxin1 in vivo.

Brain research 20011207

Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats.

European journal of pharmacology 20011207

Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease.

Neuroreport 20011204

Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.

Experimental neurology 20011201

Liposomal tacrolimus administered systemically and within the donor cell suspension improves xenograft survival in hemiparkinsonian rats.

Experimental neurology 20011201

Different effects of five catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells.

Journal of agricultural and food chemistry 20011201

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011201

Role of dopaminergic system in core part of nucleus accumbens in hyperlocomotion and rearing induced by MK-801 in rats: a behavioral and in vivo microdialysis study.

Japanese journal of pharmacology 20011201

Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat.

The European journal of neuroscience 20011201

6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease.

Cellular and molecular neurobiology 20011201

Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.

Brain research 20011130

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models.

Neurology 20011127

Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set.

Cerebral cortex (New York, N.Y. : 1991) 20011101

Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011101

Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation.

British journal of pharmacology 20011101

Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.

Clinical and experimental pharmacology & physiology 20011101

Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats.

Alcoholism, clinical and experimental research 20011101

The role of dopamine transporter imaging agent [99mTc]TRODAT-1 in hemi-parkinsonism rat brain.

Nuclear medicine and biology 20011101

Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine.

The European journal of neuroscience 20011101

Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum.

Journal of neurochemistry 20011101

Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain.

Movement disorders : official journal of the Movement Disorder Society 20011101

Nitric oxide-dependent vasodilation and the regulation of arterial blood pressure.

Journal of cardiovascular pharmacology 20011101

Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease.

Neurotoxicity research 20011101

Effects of isatin on rotational behavior and DA levels in caudate putamen in Parkinsonian rats.

Brain research 20011026

Peripheral effects of morphine in neuropathic rats: role of sympathetic postganglionic nerve fibers.

European journal of pharmacology 20011019

Involvement of primary sensory afferents, postganglionic sympathetic nerves and mast cells in the formalin-evoked peripheral release of adenosine.

European journal of pharmacology 20011019

Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20011015

Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: mediation of antioxidants.

Free radical biology & medicine 20011015

Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats.

European journal of pharmacology 20011005

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

Progress in neurobiology 20011001

Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice.

Parkinsonism & related disorders 20011001

Future of neuroprotection in Parkinson's disease.

Parkinsonism & related disorders 20011001

The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011001

Influence of alternating low frequency magnetic fields on reactivity of central dopamine receptors in neonatal 6-hydroxydopamine treated rats.

Bioelectromagnetics 20011001

Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions.

Experimental neurology 20011001

Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.

Molecular therapy : the journal of the American Society of Gene Therapy 20011001

Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.

Journal of neurochemistry 20011001

Increased burst firing in substantia nigra pars reticulata neurons and enhanced response to selective D2 agonist in hemiparkinsonian rats after repeated administration of apomorphine.

Journal of Korean medical science 20011001

LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats.

Synapse (New York, N.Y.) 20011001

Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.

Synapse (New York, N.Y.) 20011001

Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease.

The European journal of neuroscience 20011001

Effects of nerve growth factor on expression of GAP-43 in right atria after sympathectomy in diabetic rats.

Diabetes, obesity & metabolism 20011001

Unilateral striatal dopamine depletion: time-dependent effects on cortical function and behavioural correlates.

The European journal of neuroscience 20011001

[Relationship between dopamine and iron contents in the brain of parkinsonian rats].

Sheng li xue bao : [Acta physiologica Sinica] 20011001

Erectile dysfunction occurs following substantia nigra lesions in the rat.

International journal of impotence research 20011001

The spinal antinociceptive effect of FR140423 in mice involvement of the descending noradrenergic and serotonergic systems.

Life sciences 20010928

Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons.

Synapse (New York, N.Y.) 20010915

NMDA receptor antagonism modifies the synergistic regulation of striatal tachykinin gene expression induced by dopamine D(1) and serotonin(2) receptor stimulation following neonatal dopamine depletion.

Brain research. Molecular brain research 20010910

Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage.

The Journal of pharmacology and experimental therapeutics 20010901

Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.

Experimental neurology 20010901

In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions.

Experimental neurology 20010901

A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.

Experimental neurology 20010901

Dopamine D3 receptors are involved in amphetamine-induced contralateral rotation in 6-OHDA lesioned rats.

Pharmacology, biochemistry, and behavior 20010901

Effect of tail suspension on haemodynamics in intact and sympathectomized rats.

European journal of applied physiology 20010901

MPP(+) downregulates mitochondrially encoded gene transcripts and their activities in dopaminergic neuronal cells: protective role of Bcl-2.

Biochemical and biophysical research communications 20010824

6-hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells.

Biochemical pharmacology 20010815

Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.

Brain research. Molecular brain research 20010815

Restorative plasticity of dopamine neuronal transplants depends on the degree of hemispheric dominance.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010815

Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010815

In vitro generation and transplantation of precursor-derived human dopamine neurons.

Journal of neuroscience research 20010815

Hemorrhage activates catecholaminergic neurons sensitive to GABA in the nucleus of the solitary tract with ascending projections to the subfornical organ in rats.

Autonomic neuroscience : basic & clinical 20010813

Enhanced excitatory synaptic transmission in spiny neurons of rat striatum after unilateral dopamine denervation.

Neuroscience letters 20010810

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.

Brain research 20010803

Effect of olanzapine on functional responses from sensitized D1-dopamine receptors in rats with neonatal dopamine loss.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010801

Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010801

Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010801

Effects of lesioning noradrenergic neurones in the locus coeruleus on conditioned and unconditioned aversive behaviour in the rat.

Progress in neuro-psychopharmacology & biological psychiatry 20010801

6-hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation.

Journal of neurochemistry 20010801

Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.

Neurobiology of disease 20010801

[Influence of adrenergic denervation on uterine contractility of pregnant rats in vitro].

Acta pharmaceutica Hungarica 20010801

Validity of a quantitative technique to study striatal dopaminergic neurodegeneration by in vivo microdialysis.

Journal of neuroscience methods 20010730

A possible indirect sympathomimetic action of metformin in the arterial vessel wall of spontanously hypertensive rats.

Life sciences 20010720

Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion.

Neuron 20010719

The role of dopamine receptors in regulating the size of axonal arbors.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010715

Comparison of two independent aromatic hydroxylation assays in combination with intracerebral microdialysis to determine hydroxyl free radicals.

Journal of neuroscience methods 20010715

Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease.

Behavioural brain research 20010701

The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation.

Journal of neurochemistry 20010701

Chronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6-OHDA dopamine-depleted (hemi-Parkinson analogue) rats.

The European journal of neuroscience 20010701

Differential effects of unilateral striatal and nigrostriatal lesions on grip strength, skilled paw reaching and drug-induced rotation in the rat.

Brain research bulletin 20010701

Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway.

The European journal of neuroscience 20010701

NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease.

The European journal of neuroscience 20010701

Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine.

The International journal of neuroscience 20010701

Effects of sibutramine on the central dopaminergic system in rodents.

Neurotoxicity research 20010701

Increased expression of the transcription factor E2F1 during dopamine-evoked, caspase-3-mediated apoptosis in rat cortical neurons.

Neuroscience letters 20010629

Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.

Brain research 20010629

Peripheral target contact regulates Ca2+ channels in the cell bodies of bullfrog sympathetic ganglion B-neurons.

Autonomic neuroscience : basic & clinical 20010620

Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010615

2,4,5-Trichlorophenoxyacetic acid inhibits apoptosis in PC12 cells.

Life sciences 20010615

Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.

Brain research 20010615

Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.

Brain research 20010615

(-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release.

European journal of pharmacology 20010615

Cholecystokinin-8 promotes recovery of sympathectomy induced by 6-hydroxydopamine in adult mice.

Neuroreport 20010613

Entopeduncular lesions facilitate and thalamic lesions depress spontaneous and drug-evoked motor behavior in the hemiparkinsonian rat.

Synapse (New York, N.Y.) 20010601

The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010601

Free 3-nitrotyrosine causes striatal neurodegeneration in vivo.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010601

Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010601

Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.

Experimental neurology 20010601

Animal model of neuropathic tachycardia syndrome.

Hypertension (Dallas, Tex. : 1979) 20010601

Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo.

Journal of neurochemistry 20010601

Central and peripheral catecholamines regulate the exercise-induced elevation of plasma interleukin 6 in rats.

Life sciences 20010601

Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022.

Annals of the New York Academy of Sciences 20010601

A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor.

Journal of neuroscience methods 20010530

Microdialysates of amines and metabolites from core nucleus accumbens of freely moving rats are altered by dizocilpine.

Brain research 20010525

Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010515

Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine.

Brain research bulletin 20010515

Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats.

Neuroscience letters 20010511

Adrenergic nerves mediate acetylcholine-induced endothelium-independent vasodilation in the rat mesenteric resistance artery.

European journal of pharmacology 20010511

6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum.

Neuroreport 20010508

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.

Nature 20010503

Evidence for a direct action of Tityus serrulatus scorpion venom on the cardiac muscle.

Toxicon : official journal of the International Society on Toxinology 20010501

Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat.

Synapse (New York, N.Y.) 20010501

Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.

Experimental neurology 20010501

Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.

Experimental neurology 20010501

Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions.

Experimental neurology 20010501

Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease.

Experimental neurology 20010501

Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons.

The European journal of neuroscience 20010501

Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease.

Journal of neurochemistry 20010501

Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture.

Neuropharmacology 20010501

Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats.

Neuropharmacology 20010501

Reaction of oxygen with 6-hydroxydopamine catalyzed by Cu, Fe, Mn, and V complexes: identification of a thermodynamic window for effective metal catalysis.

Archives of biochemistry and biophysics 20010501

Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.

Movement disorders : official journal of the Movement Disorder Society 20010501

Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells.

The European journal of neuroscience 20010501

Convergent functional genomics: application to bipolar disorder.

Annals of medicine 20010501

Preclinical models of Parkinson's disease.

Current protocols in neuroscience 20010501

Ribozyme-mediated inhibition of caspase-3 activity reduces apoptosis induced by 6-hydroxydopamine in PC12 cells.

Brain research 20010427

Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats.

Brain research 20010427

Circadian rhythm of drinking and running-wheel activity in rats with 6-hydroxydopamine lesions of the ventral tegmental area.

Brain research 20010427

Effect of 6-hydroxydopamine or repeated amphetamine treatment on mesencephalic mRNA levels for AMPA glutamate receptor subunits in the rat.

Neuroscience letters 20010420

Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010415

Lesion of the bulbospinal noradrenergic pathways blocks desipramine-induced inhibition of the C-fiber evoked nociceptive reflex in rats.

Neuroscience letters 20010413

NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats.

Brain research 20010406

Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways.

The Journal of comparative neurology 20010402

Changes in the gene expression of GABA(A) receptor alpha1 and alpha2 subunits and metabotropic glutamate receptor 5 in the basal ganglia of the rats with unilateral 6-hydroxydopamine lesion and embryonic mesencephalic grafts.

Experimental neurology 20010401

Retrograde tracing techniques influence reported death rates of adult rat nigrostriatal neurons.

Experimental neurology 20010401

A nitric oxide-dopamine link pathway in organum vasculosum laminae terminalis of rat brain exerts control over blood pressure.

British journal of pharmacology 20010401

Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals.

Journal of neurochemistry 20010401

Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.

Neurobiology of disease 20010401

Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice.

British journal of pharmacology 20010401

Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease.

Annals of neurology 20010401

Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease.

The European journal of neuroscience 20010401

[3H]acetycholine release in rat striatal slices is not subject to dopamine heteroreceptor supersensitivity 30 months after 6-hydroxydopamine lesion of the substantia nigra.

Naunyn-Schmiedeberg's archives of pharmacology 20010401

Intracerebral administration of 2,4-diclorophenoxyacetic acid induces behavioral and neurochemical alterations in the rat brain.

Neurotoxicology 20010401

Postnatal inorganic lead exposure decreases the number of spontaneously active midbrain dopamine neurons in the rat.

Neurotoxicology 20010401

Central norepinephrine pathways are involved in cardiovascular response to intracerebroventricular substance P.

Acta pharmacologica Sinica 20010401

Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism.

Journal of neuroscience methods 20010330

The pasta matrix reaching task: a simple test for measuring skilled reaching distance, direction, and dexterity in rats.

Journal of neuroscience methods 20010330

Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.

Brain research 20010330

Modulation of visceral nociceptive responses of rat spinal dorsal horn neurons by sympathectomy.

Neuroreport 20010326

Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.

Brain research 20010302

6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins.

Experimental neurology 20010301

IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands.

Experimental neurology 20010301

Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 20010301

Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice.

Journal of neurochemistry 20010301

Chemical sympathectomy increases the innate immune response and decreases the specific immune response in the spleen to infection with Listeria monocytogenes.

Journal of neuroimmunology 20010301

Adrenergic hyperactivity and metanephrine excess in the nucleus accumbens after prefrontocortical dopamine depletion.

Journal of neurophysiology 20010301

Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.

Synapse (New York, N.Y.) 20010301

Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease.

The European journal of neuroscience 20010301

Effect of chemical sympathectomy with 6-hydroxydopamine on osteoclast activity in the gerbilline middle ear bulla.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20010301

Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum.

Pharmacopsychiatry 20010301

Effect of dopamine depletion on DARPP-32 protein in ischemic rat striatum.

Acta pharmacologica Sinica 20010301

[Effect of alpha-lipoic acid on the apoptosis of PC12 cells induced by 6-hydroxydopamine].

Shi yan sheng wu xue bao 20010301

[Preliminary experimental study on therapeutic mechanism of kangzhen zhijing capsule in treating Parkinson's disease].

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20010301

Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.

Brain research 20010216

Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion.

Brain research 20010209

Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism.

Journal of neuroimmunology 20010201

Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 20010201

Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase.

Molecular pharmacology 20010201

Norepinephrine modulates myelopoiesis after experimental thermal injury with sepsis.

Annals of surgery 20010201

Microglial response to the neurotoxicity of 6-hydroxydopamine in neonatal rat cerebellum.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20010201

The sympathetic nervous system promotes carbon tetrachloride-induced liver cirrhosis in rats by suppressing apoptosis and enhancing the growth kinetics of regenerating hepatocytes.

Journal of gastroenterology 20010201

Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1beta-induced hypothalamic pituitary adrenal axis responses.

Neuroendocrinology 20010201

Microencapsulated bovine chromaffin cell xenografts into hemiparkinsonian rats: a drug-induced rotational behavior and histological changes analysis.

Artificial organs 20010201

Blockade of subthalamic glutamatergic activity corrects changes in neuronal metabolism and motor behavior in rats with nigrostriatal lesions.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201

Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201

Role of striatal acetylcholine on dopamine D1 receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats: a microdialysis-behavioral study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201

Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201

Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats.

Brain research 20010126

Role of corticostriatal and nigrostriatal inputs in malonate-induced striatal toxicity.

Neuroreport 20010122

Fetal intra-nigral ventral mesencephalon and kidney tissue bridge transplantation restores the nigrostriatal dopamine pathway in hemi-parkinsonian rats.

Brain research 20010119

Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010115

Alteration of spontaneous firing rate of primary myelinated afferents by ATP in adjuvant-induced inflamed rats.

Brain research bulletin 20010115

The small molecule FKBP ligand GPI 1046 induces partial striatal re-innervation after intranigral 6-hydroxydopamine lesion in rats.

Neuroscience letters 20010112

Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.

Brain research 20010112

Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.

Synapse (New York, N.Y.) 20010101

Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor.

The European journal of neuroscience 20010101

The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.

The European journal of neuroscience 20010101

Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010101

Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration.

Experimental neurology 20010101

Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.

Experimental neurology 20010101

Serotonergic heterotypic sprouting in the unilaterally dopamine-depleted mouse neostriatum.

Developmental neuroscience 20010101

Septal cholinergic neurons suppress seizure development in hippocampal kindling in rats: comparison with noradrenergic neurons.

Neuroscience 20010101

Ingrowth of sympathetic innervation occurs concomitantly with a decrease of ANP in the growing rat cardiac ventricles.

Anatomy and embryology 20010101

High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats.

Journal of neuropathology and experimental neurology 20010101

Co-transmitter function of ATP in central catecholaminergic neurons of the rat.

Neuroscience 20010101

Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents.

Brain research bulletin 20010101

Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons.

Neuroscience 20010101

Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells.

Cell transplantation 20010101

Inhibition of 6-hydroxydopamine-induced p53 expression and survival of neuroblastoma cells following interaction with astrocytes.

Neuroscience 20010101

Dopaminergic mRNA expression in the intact substantia nigra of unilaterally 6-OHDA-lesioned and grafted rats: an in situ hybridization study.

Journal of neural transmission (Vienna, Austria : 1996) 20010101

Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat.

Journal of neural transmission (Vienna, Austria : 1996) 20010101

Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist.

Neurochemical research 20010101

Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum.

Neuroscience 20010101

Disruption of spinal cord white matter and sciatic nerve geometry inhibits axonal growth in vitro in the absence of glial scarring.

BMC neuroscience 20010101

Myelin contributes to the parallel orientation of axonal growth on white matter in vitro.

BMC neuroscience 20010101

Dopamine depletion with 6-OHDA enhances dopamine D1-receptor modulation of potassium currents in retinal bipolar cells.

Visual neuroscience 20010101

Nigrostriatal dopaminergic denervation enhances dopamine D(4) receptor binding in rat caudate-putamen.

Pharmacology, biochemistry, and behavior 20010101

Influence of social isolation and 6-OHDA lesion on the effects of quinelorane.

Pharmacology, biochemistry, and behavior 20010101

Cultured human foetal cerebral cortex, transfected with tyrosine hydroxylase cDNA, as a source of neural transplant material.

Journal of neural transmission (Vienna, Austria : 1996) 20010101

Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.

Neuroscience 20010101

Medullary neurones regulate hypothalamic corticotropin-releasing factor cell responses to an emotional stressor.

Neuroscience 20010101

Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement.

Neuroscience 20010101

Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats.

Cell transplantation 20010101

Regional differences in the expression of corticostriatal synaptic plasticity.

Neuroscience 20010101

Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network.

Neuroscience 20010101

Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-DOPA treatment.

Neuroscience 20010101

[Effect of chemical sympathectomy on myoelectric activity of the small bowel].

Folia medica Cracoviensia 20010101

Brain microdialysis in exercise research.

Sports medicine (Auckland, N.Z.) 20010101

Noradrenergic inhibition of TNF upregulation in hemorrhagic shock.

Neuroimmunomodulation 20010101

Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat.

Redox report : communications in free radical research 20010101

6-Hydroxydopamine infusions into the structures of mesolimbic dopaminergic system alter the memory enhancing effect of CK-8US and caerulein in rats.

Folia histochemica et cytobiologica 20010101

Effect of interleukin 1beta on rat thymus microenvironment.

European journal of histochemistry : EJH 20010101

Behavioral alterations after unilateral 6-hydroxydopamine lesions of the striatum. Effect of alpha-tocopherol.

Polish journal of pharmacology 20010101

Involvement of nicotinic acetylcholine receptors in the protection of dopamine terminals in experimental parkinsonism.

Functional neurology 20010101

Apoptotic morphology in phenotypically defined dopaminergic neurons of the substantia nigra.

Methods in molecular medicine 20010101

Oxidative stress indices in Parkinson's disease : biochemical determination.

Methods in molecular medicine 20010101

Regulation of EphB1 expression by dopamine signaling.

Brain research. Molecular brain research 20001228

Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.

Experimental neurology 20001101

Expression of metallothionein-III mRNA and its regulation by levodopa in the basal ganglia of hemi-parkinsonian rats.

Neuroscience letters 20001020

Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.

Synapse (New York, N.Y.) 20000901

Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats.

Pharmacology, biochemistry, and behavior 20000801

Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Brain : a journal of neurology 20000701

Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys.

Pharmacology, biochemistry, and behavior 20000301

Effects of oligonucleotide antisense to dopamine D(1A) receptor messenger RNA in a rodent model of levodopa-induced dyskinesia.

Neuroscience 20000101

The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats.

Journal of neural transmission (Vienna, Austria : 1996) 20000101

Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease.

Neurobiology of disease 19991201

Cocaine-induced hypertension: role of the peripheral sympathetic system.

Pharmacological research 19990801

Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK.

Journal of neuroscience research 19990701

The toxicity of 6-hydroxydopamine on PC12 and P19 cells.

Brain research. Molecular brain research 19990521

Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage.

Brain research 19990213

The effect of fenoldopam on the blood pressure of the rat.

General pharmacology 19990101

Effects of single and multiple treatments with L-dihydroxyphenylalanine (L-DOPA) on dopamine receptor-G protein interactions and supersensitive immediate early gene responses in striata of rats after reserpine treatment or with unilateral nigrostriatal lesions.

Journal of neuroscience research 19990101

Role of sympathetic nervous system in experimental hypertension and diabetes mellitus.

Clinical and experimental hypertension (New York, N.Y. : 1993) 19990101

Involvement of 5-HT6 receptors in nigro-striatal function in rodents.

British journal of pharmacology 19981201

Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine.

Journal of neuroscience research 19981015

Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity.

The Journal of neuroscience : the official journal of the Society for Neuroscience 19981001

Pharmacological effects of BAM-1120, a novel ergoline derivative, on central dopaminergic functions in rats.

Methods and findings in experimental and clinical pharmacology 19980901

L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.

The European journal of neuroscience 19980801

Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells.

Journal of neurochemistry 19980601

Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Experimental neurology 19980601

Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.

Annals of neurology 19980501

Nitric oxide synthase is co-localized with vasoactive intestinal polypeptide in postganglionic parasympathetic nerves innervating the rat vas deferens.

Neuroscience 19980301

Involvement of the central catecholaminergic system in nicotine-induced tail-tremor in rats.

Acta medica Okayama 19980201

Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo.

Journal of medicinal chemistry 19970523

Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.

Naunyn-Schmiedeberg's archives of pharmacology 19970501

The selective dopamine D1 receptor agonist A-86929 maintains efficacy with repeated treatment in rodent and primate models of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 19970401

A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease.

Neuroreport 19970210

Role of beta-adrenoceptors in gastric mucosal integrity and gastroprotection induced by epidermal growth factor.

Digestion 19970101

Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431.

European journal of pharmacology 19961219

Dopaminergic regulation of AP-1 transcription factor DNA binding activity in rat striatum.

Neuroscience 19961201

Picrotoxin induces both hypertension and dopamine release in the rat amygdala.

Neuroscience letters 19961108

The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice.

Pharmacology, biochemistry, and behavior 19960901

Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats.

Journal of cardiovascular pharmacology 19960801

Dose-related effects of continuous levodopa infusion in rats with unilateral lesions of the substantia nigra.

Brain research 19960701

Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors.

The Journal of neuroscience : the official journal of the Society for Neuroscience 19960301

Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.

The European journal of neuroscience 19960201

ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics 19960101

Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine.

Neuroscience 19950501

Activation of arc, a putative 'effector' immediate early gene, by cocaine in rat brain.

Journal of neurochemistry 19950501

A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons.

Proceedings of the National Academy of Sciences of the United States of America 19950227

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.

Nature genetics 19941001

Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens: effects of pharmacological and behaviorally activating stimuli.

Brain research 19940404

The role of activation of the sympathetic nervous system in the central pressor action of calcitonin gene-related peptide in conscious rats.

Naunyn-Schmiedeberg's archives of pharmacology 19940401

Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy.

Neuropharmacology 19930301

Pharmacologic evaluation of SCH-39166, A-69024, NO-0756, and SCH-23390 in neonatal-6-OHDA-lesioned rats. Further evidence that self-mutilatory behavior induced by L-dopa is related to D1 dopamine receptors.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 19920901

Upregulation of postsynaptic dopamine receptors in the striatum does not influence haloperidol-induced catalepsy in mice.

Pharmacology, biochemistry, and behavior 19920801

Baroreflex changes produced by serotonergic or catecholaminergic lesions in the rat nucleus tractus solitarius.

The Journal of pharmacology and experimental therapeutics 19920401

Modulation of testicular functions by testicular opioid peptides.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 19911201

Dopaminergic denervation reverses behavioral deficits induced by prenatal exposure to phenobarbital.

Brain research. Developmental brain research 19890801

Endogenous opiate system and dihydropyridine-induced central regulation of sympathetic tone in rats.

European journal of pharmacology 19881206

Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses.

The Journal of neuroscience : the official journal of the Society for Neuroscience 19880401

Increased sensitivity to amphetamine and facilitation of amphetamine self-administration after 6-hydroxydopamine lesions of the amygdala.

Psychopharmacology 19880101

Norepinephrine modulates seizures induced by quinolinic acid in rats: selective and distinct roles of alpha-adrenoceptor subtypes.

European journal of pharmacology 19870626

Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system.

European journal of pharmacology 19870317

The visualisation of cardiovascular innervation in the guinea pig using an antiserum to protein gene product 9.5 (PGP 9.5).

Journal of the autonomic nervous system 19870301

Nerve fibers containing neuropeptide Y in the cerebrovascular bed: immunocytochemistry, radioimmunoassay, and vasomotor effects.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 19870201

Pharmacological characterization of spinal alpha adrenoceptors related to blood pressure control in rats.

The Journal of pharmacology and experimental therapeutics 19870101

Noradrenergic involvement in catalepsy induced by delta 9-tetrahydrocannabinol.

Neuropharmacology 19870101

Cerebrovascular permeability to horseradish peroxidase in hypertensive rats: effects of unilateral locus ceruleus lesion.

Acta neuropathologica 19870101

Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study.

Naunyn-Schmiedeberg's archives of pharmacology 19861101

6-Hydroxydopamine treatment enhances excitation of cultured cerebellar neurons by glutamate.

Canadian journal of physiology and pharmacology 19861001

Transient contralateral rotation following unilateral substantia nigra lesion reflects susceptibility of the nigrostriatal system to exhaustion by amphetamine.

Life sciences 19860707

Effect of 6-OHDA injected into the locus coeruleus on apomorphine-induced aggression.

Pharmacology, biochemistry, and behavior 19860301

Modulation of peripheral beta-1 and alpha-2 receptor sensitivities by the administration of the tricyclic antidepressant, imipramine, alone and in combination with alpha-2 antagonists to rats.

The Journal of pharmacology and experimental therapeutics 19860201

Chemical lesions of the nucleus accumbens septi in rats: effects on muricide and apomorphine-induced aggression.

Behavioural brain research 19860201

Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.

Psychopharmacology 19860101

DOCA-salt induced myocardial sensitization to ventricular fibrillation by isoprenaline in rats. Role of the autonomic nervous system.

Journal of autonomic pharmacology 19851201

Modulation of striatal enkephalinergic neurons by antipsychotic drugs.

Federation proceedings 19850601

Components of functional sympathetic control of heart rate in neonatal rats.

The American journal of physiology 19850501

Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake.

European journal of pharmacology 19840817

Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.

European journal of pharmacology 19840713

Functional recovery following transplantation of ventral mesencephalic cells in rat subjected to 6-OHDA lesions of the mesolimbic dopaminergic neurons.

Brain research 19840618

Irritable aggression induced by delta 9-tetrahydrocannabinol in rats pretreated with 6-hydroxydopamine.

Pharmacology, biochemistry, and behavior 19840301

Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat.

Life sciences 19840227

On some central effects of elymoclavine.

Acta physiologica et pharmacologica Bulgarica 19840101

Electrophysiological effects of ouabain in 6-hydroxydopamine pretreated dogs.

Canadian journal of physiology and pharmacology 19830301

Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.

Brain research 19820722

Studies on the behavioral and hypotensive effects of intraventricular prostacyclin (PGI2) in rats.

Polish journal of pharmacology and pharmacy 19811101

Pharmacological characterisation of the alpha-adrenoceptors responsible for a decrease of blood pressure in the nucleus tractus solitarii of the rat.

Naunyn-Schmiedeberg's archives of pharmacology 19810901

Turning in MFB-lesioned rats and antagonism of neuroleptic-induced catalepsy after lisuride and LSD.

Life sciences 19780508

Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat.

Naunyn-Schmiedeberg's archives of pharmacology 19770501

Potentiation of morphine-induced seizure by 6-hydroxydopamine.

Archives internationales de pharmacodynamie et de therapie 19761001

Antinociceptive and stimulant effects of morphine after chemical sympathectomy.

Pharmacology 19760101

Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine.

Brain research 19750815

1199-18-4 | 1,2,4-Benzenetriol, 5-(2-aminoethyl)-

Product Description

Properties

Literature

Related Products

Featured Products